[
  {
    "claim_id": "Q45982518$F33CEA4F-A019-48F1-8978-7FCFB4043DCC",
    "theme": "ChemicalCompound",
    "subject_label": "Acute MDMA and ethanol interaction effects on psychomotor performance.",
    "subject_id": "Q45982518",
    "subject_description": "scientific article published in April 2007",
    "property_label": "issue",
    "property_id": "P433",
    "object_label": "4",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Acute MDMA and ethanol interaction effects on psychomotor performance. Issue 4.",
    "subjectCQ": "What is the main effect of MDMA and ethanol on psychomotor performance?",
    "propertyCQ": "What is the number 4 of the effects of MDMA and ethanol on psychomotor performance?",
    "objectCQ": "What is the number of issues that affect psychomotor performance?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50630839$7FD1C940-2CBB-4615-B370-95D0D010ED6F",
    "theme": "ChemicalCompound",
    "subject_label": "The psychobiology of MDMA or 'ecstasy': symposium arranged by the Psychobiology Section, at the Annual Conference of the British Psychological Society, Heriot-Watt University, Edinburgh, April 1997.",
    "subject_id": "Q50630839",
    "subject_description": "scientific article published in January 1998",
    "property_label": "issue",
    "property_id": "P433",
    "object_label": "1",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The psychobiology of MDMA or 'ecstasy': symposium arranged by the Psychobiology Section, at the Annual Conference of the British Psychological Society, Heriot-Watt University, Edinburgh, April 1997. Issue 1 was published.",
    "subjectCQ": "What was the name of the symposium?",
    "propertyCQ": "What was the first issue of the symposium?",
    "objectCQ": "What was the title of the issue of the symposium?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q42455664$7157375C-7236-45C5-9CC2-1034238F4590",
    "theme": "ChemicalCompound",
    "subject_label": "3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) disrupts blood-brain barrier integrity through a mechanism involving P2X7 receptors.",
    "subject_id": "Q42455664",
    "subject_description": "scientific article published on 14 March 2014",
    "property_label": "issue",
    "property_id": "P433",
    "object_label": "8",
    "object_id": "",
    "object_description": "no-desc",
    "context": "3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) disrupts blood-brain barrier integrity through a mechanism involving P2X7 receptors. Issue 8:",
    "subjectCQ": "What is the main effect of MDMA?",
    "propertyCQ": "What is the number 8 of the causes of MDMA?",
    "objectCQ": "What is the number of issues with MDMA?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q57986566$66E99430-13C7-423A-9CF7-87AE61B73092",
    "theme": "ChemicalCompound",
    "subject_label": "An assessment of the stability of MDMA, methamphetamine and THC in oral fluid",
    "subject_id": "Q57986566",
    "subject_description": "no-desc",
    "property_label": "issue",
    "property_id": "P433",
    "object_label": "4",
    "object_id": "",
    "object_description": "no-desc",
    "context": "An assessment of the stability of MDMA, methamphetamine and THC in oral fluid is issue 4.",
    "subjectCQ": "What is issue 4?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q44811433$A1C29F98-2878-4DA3-9785-3341F66381BC",
    "theme": "ChemicalCompound",
    "subject_label": "Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys.",
    "subject_id": "Q44811433",
    "subject_description": "scientific article published in July 2004",
    "property_label": "issue",
    "property_id": "P433",
    "object_label": "7",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys. Issue 7.",
    "subjectCQ": "What is the main topic of this study?",
    "propertyCQ": "What is the number 7 of the consequences of MDMA and its enantiomers?",
    "objectCQ": "What is the number of issues that have been analyzed?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q48608076$492DA6F5-F695-43BE-A425-CEE7B4567796",
    "theme": "ChemicalCompound",
    "subject_label": "Effects of salicylate on 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats.",
    "subject_id": "Q48608076",
    "subject_description": "scientific article published in November 1997",
    "property_label": "issue",
    "property_id": "P433",
    "object_label": "3",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Effects of salicylate on 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats. Issue 3.",
    "subjectCQ": "What is the main effect of salicylate on rats?",
    "propertyCQ": "What is the number 3 of the study?",
    "objectCQ": "What is the number of issues?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q44915720$44BA4E70-083F-4A68-9FDF-8762F6F065E7",
    "theme": "ChemicalCompound",
    "subject_label": "Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994-2003).",
    "subject_id": "Q44915720",
    "subject_description": "scientific article",
    "property_label": "issue",
    "property_id": "P433",
    "object_label": "3",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994-2003). Issue 3.",
    "subjectCQ": "What was the main cause of deaths in the UK?",
    "propertyCQ": "What is the third issue of Ecstasy in the UK?",
    "objectCQ": "What is the number of issues of Ecstasy in the UK?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q40529624$15D6831C-11F6-4E2D-ACC2-B8BA941947C2",
    "theme": "ChemicalCompound",
    "subject_label": "Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use.",
    "subject_id": "Q40529624",
    "subject_description": "scientific article published on February 2004",
    "property_label": "issue",
    "property_id": "P433",
    "object_label": "2",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use. Issue 2.",
    "subjectCQ": "What is the importance of clinically significant patterns of use?",
    "propertyCQ": "What is issue 2 of the study?",
    "objectCQ": "What is the issue of MDMA?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q44599215$163091E0-4FDB-4E87-9F87-6FED1AF211C0",
    "theme": "ChemicalCompound",
    "subject_label": "Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility.",
    "subject_id": "Q44599215",
    "subject_description": "scientific article published on 15 November 2012",
    "property_label": "issue",
    "property_id": "P433",
    "object_label": "1",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility. Issue 1.",
    "subjectCQ": "What is the effect of MDMA on the body?",
    "propertyCQ": "What is the first issue with MDMA?",
    "objectCQ": "What is the issue of MDMA in mice?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q33907331$1231AECC-9375-44DB-B94F-C4262E9EB428",
    "theme": "ChemicalCompound",
    "subject_label": "Acute psychological and physiological effects of MDMA (\"Ecstasy\") after haloperidol pretreatment in healthy humans.",
    "subject_id": "Q33907331",
    "subject_description": "scientific article",
    "property_label": "issue",
    "property_id": "P433",
    "object_label": "4",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Acute psychological and physiological effects of MDMA (\"Ecstasy\") after haloperidol pretreatment in healthy humans. Issue 4.",
    "subjectCQ": "What is the main effect of MDMA?",
    "propertyCQ": "What is the fourth issue of MDMA?",
    "objectCQ": "What is the number of issues that are related to MDMA?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q38220603$54664EEA-3C1E-4843-BFF6-AB5C14953C40",
    "theme": "ChemicalCompound",
    "subject_label": "Hallucinogen persisting perception disorder and the serotonergic system: a comprehensive review including new MDMA-related clinical cases.",
    "subject_id": "Q38220603",
    "subject_description": "scientific article",
    "property_label": "issue",
    "property_id": "P433",
    "object_label": "8",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The issue 8 of Hallucinogen persisting perception disorder and the serotonergic system: a comprehensive review including new MDMA-related clinical cases.",
    "subjectCQ": "What is the issue 8 of?",
    "propertyCQ": "What is issue 8 of Hallucinogen persisting perception disorder?",
    "objectCQ": "What is the issue of Hallucinogen persisting perception disorder?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q212774$6E9084D1-70CF-4160-A542-2A9B316829A0",
    "theme": "ChemicalCompound",
    "subject_label": "α-D-xylopyranose",
    "subject_id": "Q212774",
    "subject_description": "chemical compound",
    "property_label": "stereoisomer of",
    "property_id": "P3364",
    "object_label": "α-D-arabinopyranose",
    "object_id": "Q27120749",
    "object_description": "chemical compound",
    "context": "α-D-xylopyranose is a stereoisomer of α-D-arabinopyranose.",
    "subjectCQ": "What is a stereoisomer of <unk>-D-arabinopyranose?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q76513171$408f516b-4669-04b3-8ac0-7db57e193707",
    "theme": "ChemicalCompound",
    "subject_label": "bradanicline",
    "subject_id": "Q76513171",
    "subject_description": "chemical compound",
    "property_label": "stereoisomer of",
    "property_id": "P3364",
    "object_label": "N-[(2S,3S)-2-(pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]octan-3-yl]-1-benzofuran-2-carboxamide",
    "object_id": "Q7669595",
    "object_description": "chemical compound",
    "context": "The stereoisomer of bradanicline is N-[(2S,3S)-2-(pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]octan-3-yl]-1-benzofuran-2-carboxamide.",
    "subjectCQ": "What is the stereoisomer of?",
    "propertyCQ": "",
    "objectCQ": "What is the stereoisomer of bradanicline?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27180466$0E00CBF0-FC95-4206-B80F-54BDE48E6C33",
    "theme": "ChemicalCompound",
    "subject_label": "1-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea",
    "subject_id": "Q27180466",
    "subject_description": "chemical compound",
    "property_label": "stereoisomer of",
    "property_id": "P3364",
    "object_label": "1-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea",
    "object_id": "Q27180561",
    "object_description": "chemical compound",
    "context": "1-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea is",
    "subjectCQ": "What is the name of the compound that is used to describe it?",
    "propertyCQ": "What is the function of the methyl group?",
    "objectCQ": "What is the name of the compound that is used to describe it?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q212774$F6ACC0EF-559F-4250-ABFE-C6B5EC1D185E",
    "theme": "ChemicalCompound",
    "subject_label": "α-D-xylopyranose",
    "subject_id": "Q212774",
    "subject_description": "chemical compound",
    "property_label": "stereoisomer of",
    "property_id": "P3364",
    "object_label": "β-L-arabinopyranose",
    "object_id": "Q27120409",
    "object_description": "chemical compound",
    "context": "α-D-xylopyranose is a stereoisomer of β-L-arabinopyranose.",
    "subjectCQ": "What is a stereoisomer of <unk>-L-arabinopyranose?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q74417505$7408bd48-444e-4785-1526-362049377b3c",
    "theme": "ChemicalCompound",
    "subject_label": "β-L-arabinofuranose",
    "subject_id": "Q74417505",
    "subject_description": "chemical compound",
    "property_label": "stereoisomer of",
    "property_id": "P3364",
    "object_label": "α-D-arabinofuanose",
    "object_id": "Q85552423",
    "object_description": "chemical compound",
    "context": "β-L-arabinofuranose is a stereoisomer of α-D-arabinofuanose.",
    "subjectCQ": "What is a stereoisomer of <unk>-D-arabinofuanose?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27120759$d9c28f85-4529-dc10-b90b-3cde51763c52",
    "theme": "ChemicalCompound",
    "subject_label": "aldehydo-D-ribose",
    "subject_id": "Q27120759",
    "subject_description": "chemical compound",
    "property_label": "stereoisomer of",
    "property_id": "P3364",
    "object_label": "aldehydo-L-xylose",
    "object_id": "Q27082478",
    "object_description": "chemical compound",
    "context": "Aldehydo-D-ribose is a stereoisomer of aldehydo-L-xylose.",
    "subjectCQ": "What is a stereoisomer of aldehydo-L-xylose?",
    "propertyCQ": "What is aldehydo-D-ribose?",
    "objectCQ": "Aldehydo-D-ribose is a stereoisomer of what?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27092902$bf7eaf11-45e5-6064-b610-d63709ed6ef7",
    "theme": "ChemicalCompound",
    "subject_label": "L-allo-Isoleucine",
    "subject_id": "Q27092902",
    "subject_description": "chemical compound",
    "property_label": "stereoisomer of",
    "property_id": "P3364",
    "object_label": "D-alloisoleucine",
    "object_id": "Q27109362",
    "object_description": "chemical compound",
    "context": "L-allo-Isoleucine is a stereoisomer of D-alloisoleucine.",
    "subjectCQ": "What is a stereoisomer of D-alloisoleucine?",
    "propertyCQ": "What is L-allo-Isoleucine?",
    "objectCQ": "What is L-allo-Isoleucine a stereoisomer of?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q415007$0A6B6751-3779-40B1-ACCB-179615CF6113",
    "theme": "ChemicalCompound",
    "subject_label": "(+)-catechin",
    "subject_id": "Q415007",
    "subject_description": "chemical compound",
    "property_label": "stereoisomer of",
    "property_id": "P3364",
    "object_label": "(+)-epicatechin",
    "object_id": "Q27145771",
    "object_description": "chemical compound",
    "context": "(+)-catechin is a stereoisomer of (+)-epicatechin.",
    "subjectCQ": "What is a stereoisomer of (+)-epicatechin?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q19903943$d2738b0d-4ad4-467f-26f9-3eb089c463c3",
    "theme": "ChemicalCompound",
    "subject_label": "desacetoxyvindoline",
    "subject_id": "Q19903943",
    "subject_description": "chemical compound",
    "property_label": "stereoisomer of",
    "property_id": "P3364",
    "object_label": "deacetoxyvindoline",
    "object_id": "Q27102152",
    "object_description": "chemical compound",
    "context": "The stereoisomer of deacetoxyvindoline is deacetoxyvindoline.",
    "subjectCQ": "What is the stereoisomer of deacetoxyvindoline?",
    "propertyCQ": "What is deacetoxyvindoline?",
    "objectCQ": "What is the stereoisomer of deacetoxyvindoline?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27104150$0511a022-4dc5-a486-4098-fb0bb72c80a2",
    "theme": "ChemicalCompound",
    "subject_label": "L-malic acid",
    "subject_id": "Q27104150",
    "subject_description": "chemical compound",
    "property_label": "stereoisomer of",
    "property_id": "P3364",
    "object_label": "D-malic acid",
    "object_id": "Q27104149",
    "object_description": "chemical compound",
    "context": "L-malic acid is a stereoisomer of D-malic acid.",
    "subjectCQ": "What is a stereoisomer of D-malic acid?",
    "propertyCQ": "What is L-malic acid?",
    "objectCQ": "What is L-malic acid a stereoisomer of?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27120749$959FA93B-92A2-4834-A887-A6F373A4555E",
    "theme": "ChemicalCompound",
    "subject_label": "α-D-arabinopyranose",
    "subject_id": "Q27120749",
    "subject_description": "chemical compound",
    "property_label": "stereoisomer of",
    "property_id": "P3364",
    "object_label": "α-L-xylopyranose",
    "object_id": "Q27461216",
    "object_description": "chemical compound",
    "context": "α-D-arabinopyranose is a stereoisomer of α-L-xylopyranose.",
    "subjectCQ": "What is a stereoisomer of <unk>-L-xylopyranose?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27093808$fececd2a-43d0-0771-02d4-14ecd2876b4b",
    "theme": "ChemicalCompound",
    "subject_label": "(R)-timonacic",
    "subject_id": "Q27093808",
    "subject_description": "chemical compound",
    "property_label": "stereoisomer of",
    "property_id": "P3364",
    "object_label": "(S)-timonacic",
    "object_id": "Q27133347",
    "object_description": "chemical compound",
    "context": "The stereoisomer of (S)-timonacic is (R)-timonacic.",
    "subjectCQ": "What is the stereoisomer of (S)-timonacic?",
    "propertyCQ": "",
    "objectCQ": "What is the stereoisomer of?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q35745285$A0D413FA-495A-4D57-B04B-3B20AD1F6422",
    "theme": "ChemicalCompound",
    "subject_label": "Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.",
    "subject_id": "Q35745285",
    "subject_description": "scientific article published on 9 April 2004",
    "property_label": "volume",
    "property_id": "P478",
    "object_label": "173",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. Volume 173.",
    "subjectCQ": "What is the main topic of the study?",
    "propertyCQ": "What is the name of the book that describes the effects of MDMA on dopamine biochemistry and function?",
    "objectCQ": "What is the volume of the study?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50426792$F3EC6173-BA85-40AD-86A5-48CB6EF56EA2",
    "theme": "ChemicalCompound",
    "subject_label": "Environmental concentrations of 3,4-methylenedioxymethamphetamine (MDMA)-induced cellular stress and modulated antioxidant enzyme activity in the zebra mussel.",
    "subject_id": "Q50426792",
    "subject_description": "scientific article published in June 2014",
    "property_label": "volume",
    "property_id": "P478",
    "object_label": "21",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The zebra mussel has 21 volumes and is the subject of environmental concentrations of 3,4-methylenedioxymethamphetamine (MDMA)-induced cellular stress and modulated antioxidant enzyme activity.",
    "subjectCQ": "What is the zebra mussel subject to?",
    "propertyCQ": "How many volumes does the zebra mussel have?",
    "objectCQ": "How many volumes does the zebra mussel have?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q47744785$9A240FD6-882D-4C9B-B15A-2D61C83EFCC5",
    "theme": "ChemicalCompound",
    "subject_label": "Assessment of the abuse potential of MDMA in the conditioned place preference paradigm: role of CB1 receptors.",
    "subject_id": "Q47744785",
    "subject_description": "scientific article",
    "property_label": "volume",
    "property_id": "P478",
    "object_label": "47",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Assessment of the abuse potential of MDMA in the conditioned place preference paradigm: role of CB1 receptors. Volume 47.",
    "subjectCQ": "What is the purpose of Volume 47?",
    "propertyCQ": "What is the number of the volume of the study?",
    "objectCQ": "What is the volume of the study?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q44387904$2555C8C8-8EFB-47CF-9AB3-3B6B384B2657",
    "theme": "ChemicalCompound",
    "subject_label": "Altered gene expression in frontal cortex and midbrain of 3,4-methylenedioxymethamphetamine (MDMA) treated mice: differential regulation of GABA transporter subtypes.",
    "subject_id": "Q44387904",
    "subject_description": "scientific article published in April 2003",
    "property_label": "volume",
    "property_id": "P478",
    "object_label": "72",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Altered gene expression in frontal cortex and midbrain of 3,4-methylenedioxymethamphetamine (MDMA) treated mice: differential regulation of GABA transporter subtypes. Volume 72.",
    "subjectCQ": "What is the effect of MDMA on the GABA transporter?",
    "propertyCQ": "What is the number of volumes of the study?",
    "objectCQ": "What is the volume of the study?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q46627187$E7A12EF1-6DA0-4916-A5D8-D49AC4DB83CD",
    "theme": "ChemicalCompound",
    "subject_label": "Chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA].",
    "subject_id": "Q46627187",
    "subject_description": "scientific article published on 28 July 2005",
    "property_label": "volume",
    "property_id": "P478",
    "object_label": "81",
    "object_id": "",
    "object_description": "no-desc",
    "context": "A chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA]. The volume is 81.",
    "subjectCQ": "What is the effect of a serotonin(2) receptor?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q46726341$606748F3-002B-41AF-9C3C-9BE7435C52E2",
    "theme": "ChemicalCompound",
    "subject_label": "Long-term effects of MDMA (Ecstasy) on the human central nervous system revealed by visual evoked potentials.",
    "subject_id": "Q46726341",
    "subject_description": "scientific article published in June 2005",
    "property_label": "volume",
    "property_id": "P478",
    "object_label": "10",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The long-term effects of MDMA (Ecstasy) on the human central nervous system are revealed by visual evoked potentials. Volume 10.",
    "subjectCQ": "What is the effect of MDMA on the human nervous system revealed by visual evoked potentials?",
    "propertyCQ": "What is the number 10 of visual evoked potentials?",
    "objectCQ": "What is the volume of the visual evoked potentials?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q92808146$6D7EF6F6-F481-4658-BCEF-9FB4EFAE3711",
    "theme": "ChemicalCompound",
    "subject_label": "An investigation of the reinforcing effects of MDMA in rats trained to self-administer heroin",
    "subject_id": "Q92808146",
    "subject_description": "scientific article published on 01 September 2019",
    "property_label": "volume",
    "property_id": "P478",
    "object_label": "99",
    "object_id": "",
    "object_description": "no-desc",
    "context": "An investigation of the reinforcing effects of MDMA in rats trained to self-administer heroin has a volume of 99.",
    "subjectCQ": "What has a volume of 99?",
    "propertyCQ": "What is the number of studies that have been done on rats trained to self-administer heroin?",
    "objectCQ": "What is the volume of the study?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q46862552$686C9350-FD6D-487E-866E-637355624429",
    "theme": "ChemicalCompound",
    "subject_label": "An analysis of spontaneous behavior following acute MDMA treatment in male and female rats.",
    "subject_id": "Q46862552",
    "subject_description": "scientific article published in December 2007",
    "property_label": "volume",
    "property_id": "P478",
    "object_label": "28",
    "object_id": "",
    "object_description": "no-desc",
    "context": "An analysis of spontaneous behavior following acute MDMA treatment in male and female rats. Volume 28.",
    "subjectCQ": "What is the purpose of Volume 28?",
    "propertyCQ": "What is the name of the volume 28?",
    "objectCQ": "What is the volume of the study?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q33907331$F755F9F3-31E6-49EA-A78F-43EF8E6C7DE9",
    "theme": "ChemicalCompound",
    "subject_label": "Acute psychological and physiological effects of MDMA (\"Ecstasy\") after haloperidol pretreatment in healthy humans.",
    "subject_id": "Q33907331",
    "subject_description": "scientific article",
    "property_label": "volume",
    "property_id": "P478",
    "object_label": "10",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Acute psychological and physiological effects of MDMA (\"Ecstasy\") after haloperidol pretreatment in healthy humans. Volume 10.",
    "subjectCQ": "What is the main effect of MDMA?",
    "propertyCQ": "What is the name of the book that describes the effects of MDMA on the body?",
    "objectCQ": "What is the volume of the study?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q37149027$E2762EC9-9331-4699-B830-3D5A94B2B403",
    "theme": "ChemicalCompound",
    "subject_label": "MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology",
    "subject_id": "Q37149027",
    "subject_description": "scientific article published on September 2013",
    "property_label": "volume",
    "property_id": "P478",
    "object_label": "11",
    "object_id": "",
    "object_description": "no-desc",
    "context": "MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology is published in volume 11.",
    "subjectCQ": "What is the title of the book?",
    "propertyCQ": "",
    "objectCQ": "What is the volume number of MDMA Analogues as Tools to Characterize MDMA-Like Effects?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q48166493$CB68A423-3712-4C66-B556-EF998BC3E342",
    "theme": "ChemicalCompound",
    "subject_label": "Novel object recognition memory: measurement issues and effects of MDMA self-administration following short inter-trial intervals.",
    "subject_id": "Q48166493",
    "subject_description": "scientific article",
    "property_label": "volume",
    "property_id": "P478",
    "object_label": "25",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Novel object recognition memory: measurement issues and effects of MDMA self-administration following short inter-trial intervals. Volume 25.",
    "subjectCQ": "What is the purpose of Volume 25?",
    "propertyCQ": "What is the name of the book that discusses the effects of MDMA self administration?",
    "objectCQ": "What is the volume of the journal that discusses the effects of MDMA self administration?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q35576531$49C54578-88E0-4C8B-9922-AA00C6A515C3",
    "theme": "ChemicalCompound",
    "subject_label": "Heat increases MDMA-enhanced NAcc 5-HT and body temperature, but not MDMA self-administration.",
    "subject_id": "Q35576531",
    "subject_description": "scientific article published on December 2010",
    "property_label": "volume",
    "property_id": "P478",
    "object_label": "20",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The volume of MDMA-enhanced NAcc 5-HT and body temperature increases, but not MDMA self-administration.",
    "subjectCQ": "Does the volume of MDMA-enhanced NAcc 5-HT increase or decrease?",
    "propertyCQ": "What does MDMA-enhanced NAcc 5-HT increase in relation to body temperature?",
    "objectCQ": "How many times does MDMA increase body temperature?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q44824030$7D05868B-424D-402A-9C7A-D0025ED5BF28",
    "theme": "ChemicalCompound",
    "subject_label": "Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats.",
    "subject_id": "Q44824030",
    "subject_description": "scientific article published in May 2004",
    "property_label": "page(s)",
    "property_id": "P304",
    "object_label": "185-189",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats. Page(s) 185-189.",
    "subjectCQ": "What is the purpose of this study?",
    "propertyCQ": "What is the number of pages that describe the validity of the in vivo [123I]beta-CIT SPECT?",
    "objectCQ": "What are the page numbers for the Validity of in vivo [123I]beta-CIT SPECT?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q57574540$68D8055E-EC03-4C42-90A9-9A2342E5338A",
    "theme": "ChemicalCompound",
    "subject_label": "Erratum: Involvement of Inferior Parietal Lobules in Prospective Memory Impairment During Acute MDMA (Ecstasy) Intoxication: An Event-Related fMRI Study",
    "subject_id": "Q57574540",
    "subject_description": "no-desc",
    "property_label": "page(s)",
    "property_id": "P304",
    "object_label": "1883-1884",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Erratum: Involvement of Inferior Parietal Lobules in Prospective Memory Impairment During Acute MDMA (Ecstasy) Intoxication: An Event-Related fMRI Study is 1883-1884.",
    "subjectCQ": "What is the name of the study?",
    "propertyCQ": "How many pages did the fMRI study cover?",
    "objectCQ": "When was the fMRI study?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q31114156$5CD3000A-2828-4BB5-9C6C-7EEAD07CEAF0",
    "theme": "ChemicalCompound",
    "subject_label": "Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data",
    "subject_id": "Q31114156",
    "subject_description": "scientific article",
    "property_label": "page(s)",
    "property_id": "P304",
    "object_label": "81",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data is page(s) 81.",
    "subjectCQ": "What is page(s) 81 of?",
    "propertyCQ": "",
    "objectCQ": "What is the number of pages that explore MDMA wastewater data?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q91787556$DC37215C-EE01-4719-8CBC-8037151F5821",
    "theme": "ChemicalCompound",
    "subject_label": "A proof-of-principle study of the short-term effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus and neural connectivity",
    "subject_id": "Q91787556",
    "subject_description": "scientific article published on 06 January 2020",
    "property_label": "page(s)",
    "property_id": "P304",
    "object_label": "01-Dec",
    "object_id": "",
    "object_description": "no-desc",
    "context": "A proof-of-principle study of the short-term effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus and neural connectivity, page(s) 1-12.",
    "subjectCQ": "What is the purpose of the study?",
    "propertyCQ": "What is the number of pages in the proof-of-principle study?",
    "objectCQ": "When did MDMA begin to have a positive effect on tinnitus?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q69378319$ACB4FE96-29A0-4B27-A93E-3DC149A931AE",
    "theme": "ChemicalCompound",
    "subject_label": "Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats",
    "subject_id": "Q69378319",
    "subject_description": "scientific article published on 01 August 1989",
    "property_label": "page(s)",
    "property_id": "P304",
    "object_label": "741-747",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats are shown in page(s) 741-747.",
    "subjectCQ": "What is shown in page(s) 741-747?",
    "propertyCQ": "",
    "objectCQ": "What pages show the effects of MDMA on brain dopaminergic activity in rats?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q41022190$3D0AAE98-A1A4-4748-B38D-F4669BF2BE45",
    "theme": "ChemicalCompound",
    "subject_label": "CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA).",
    "subject_id": "Q41022190",
    "subject_description": "scientific article published on August 1994",
    "property_label": "page(s)",
    "property_id": "P304",
    "object_label": "259-262",
    "object_id": "",
    "object_description": "no-desc",
    "context": "CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA). Page(s) 259-262.",
    "subjectCQ": "What is the effect of CuZnSOD on mice?",
    "propertyCQ": "How many pages are there?",
    "objectCQ": "How many pages are there?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50426792$D6472393-9C0D-4F9E-A591-2AA88D3ACCA6",
    "theme": "ChemicalCompound",
    "subject_label": "Environmental concentrations of 3,4-methylenedioxymethamphetamine (MDMA)-induced cellular stress and modulated antioxidant enzyme activity in the zebra mussel.",
    "subject_id": "Q50426792",
    "subject_description": "scientific article published in June 2014",
    "property_label": "page(s)",
    "property_id": "P304",
    "object_label": "11099-11106",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The page(s) 11099-11106 is about the environmental concentrations of 3,4-methylenedioxymethamphetamine (MDMA)-induced cellular stress and modulated antioxidant enzyme activity in the zebra mussel.",
    "subjectCQ": "What is the topic of the page 11099-11106?",
    "propertyCQ": "What is the name of the page that describes the concentrations of MDMA in the zebra mussel?",
    "objectCQ": "What is the name of the page that is about the concentrations of MDMA in the zebra mussel?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q68306116$B5B55D28-C4F2-482D-931C-2F70017FA5D4",
    "theme": "ChemicalCompound",
    "subject_label": "Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia",
    "subject_id": "Q68306116",
    "subject_description": "scientific article published on 01 June 1991",
    "property_label": "page(s)",
    "property_id": "P304",
    "object_label": "371",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia, has page(s) 371.",
    "subjectCQ": "What is the fatality of MDMA?",
    "propertyCQ": "How many pages does MDMA have?",
    "objectCQ": "How many pages does MDMA have?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q83159822$1161DE4C-56B8-48BE-941C-3A91773E9094",
    "theme": "ChemicalCompound",
    "subject_label": "Differences in binding affinities of MDA, MDMA, MDEA, Amphetamine, Methamphetamine, and their deuterated analogues to solid-phase extraction cartridges",
    "subject_id": "Q83159822",
    "subject_description": "scientific article published on 01 January 2011",
    "property_label": "page(s)",
    "property_id": "P304",
    "object_label": "15-22",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The differences in binding affinities of MDA, MDMA, MDEA, Amphetamine, Methamphetamine, and their deuterated analogues to solid-phase extraction cartridges are page(s) 15-22.",
    "subjectCQ": "What are page(s) 15-22?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q40678302$9C9EDC03-4BBD-4617-977E-98269D205FD9",
    "theme": "ChemicalCompound",
    "subject_label": "Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing.",
    "subject_id": "Q40678302",
    "subject_description": "scientific article published on November 1995",
    "property_label": "page(s)",
    "property_id": "P304",
    "object_label": "877-882",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing.",
    "subjectCQ": "What is the effect of MDMA on rats?",
    "propertyCQ": "How many pages are there?",
    "objectCQ": "What is the number of days of the week that MDMA is given to rats?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q35745285$861193DD-A180-4BA3-8D20-DB0DF92638B2",
    "theme": "ChemicalCompound",
    "subject_label": "Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.",
    "subject_id": "Q35745285",
    "subject_description": "scientific article published on 9 April 2004",
    "property_label": "page(s)",
    "property_id": "P304",
    "object_label": "249-263",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. page(s) 249-263.",
    "subjectCQ": "What is the main effect of MDMA?",
    "propertyCQ": "249-263.",
    "objectCQ": "What are the page numbers for MDMA?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q42499116$DE2EE736-B952-490E-850E-1A7E4BDA6784",
    "theme": "ChemicalCompound",
    "subject_label": "Context-dependent behavioural and neuronal sensitization in striatum to MDMA (ecstasy) administration in rats.",
    "subject_id": "Q42499116",
    "subject_description": "scientific article",
    "property_label": "page(s)",
    "property_id": "P304",
    "object_label": "217-228",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Context-dependent behavioural and neuronal sensitization in striatum to MDMA (ecstasy) administration in rats. Page(s) 217-228.",
    "subjectCQ": "What is the purpose of this study?",
    "propertyCQ": "How many pages are there in this study?",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q44824030$76B67B54-B5D2-44BE-B22B-6A867A737970",
    "theme": "ChemicalCompound",
    "subject_label": "Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats.",
    "subject_id": "Q44824030",
    "subject_description": "scientific article published in May 2004",
    "property_label": "publication date",
    "property_id": "P577",
    "object_label": "01/05/2004",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats. Published on 01/05/2004.",
    "subjectCQ": "What is the purpose of this study?",
    "propertyCQ": "What was the publication date?",
    "objectCQ": "When was the validation of in vivo [123I]beta-CIT SPECT published?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q57574540$55BB12E4-9FAF-4142-8FBC-1319FE455323",
    "theme": "ChemicalCompound",
    "subject_label": "Erratum: Involvement of Inferior Parietal Lobules in Prospective Memory Impairment During Acute MDMA (Ecstasy) Intoxication: An Event-Related fMRI Study",
    "subject_id": "Q57574540",
    "subject_description": "no-desc",
    "property_label": "publication date",
    "property_id": "P577",
    "object_label": "12/05/2009",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Erratum: Involvement of Inferior Parietal Lobules in Prospective Memory Impairment During Acute MDMA (Ecstasy) Intoxication: An Event-Related fMRI Study was published on 12/05/2009.",
    "subjectCQ": "What was published on 12/05/2009?",
    "propertyCQ": "",
    "objectCQ": "When was the fMRI study published?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q33907331$5CD02190-F381-400E-83B3-955141FBC214",
    "theme": "ChemicalCompound",
    "subject_label": "Acute psychological and physiological effects of MDMA (\"Ecstasy\") after haloperidol pretreatment in healthy humans.",
    "subject_id": "Q33907331",
    "subject_description": "scientific article",
    "property_label": "publication date",
    "property_id": "P577",
    "object_label": "01/07/2000",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Acute psychological and physiological effects of MDMA (\"Ecstasy\") after haloperidol pretreatment in healthy humans. Published on 01/07/2000.",
    "subjectCQ": "What is the main effect of MDMA?",
    "propertyCQ": "What was the publication date of the study?",
    "objectCQ": "When was this study published?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q91787556$9CF7E043-FB6E-43B6-9EE0-E7324B8E4430",
    "theme": "ChemicalCompound",
    "subject_label": "A proof-of-principle study of the short-term effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus and neural connectivity",
    "subject_id": "Q91787556",
    "subject_description": "scientific article published on 06 January 2020",
    "property_label": "publication date",
    "property_id": "P577",
    "object_label": "06/01/2020",
    "object_id": "",
    "object_description": "no-desc",
    "context": "A proof-of-principle study of the short-term effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus and neural connectivity was published on 06/01/2020.",
    "subjectCQ": "What was published on 06/01/2020?",
    "propertyCQ": "",
    "objectCQ": "When was the proof-of-principle study published?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q69378319$98E6DDF5-16BB-4BA6-AEDF-B3E665D83CEC",
    "theme": "ChemicalCompound",
    "subject_label": "Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats",
    "subject_id": "Q69378319",
    "subject_description": "scientific article published on 01 August 1989",
    "property_label": "publication date",
    "property_id": "P577",
    "object_label": "01/08/1989",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats were published on 01/08/1989.",
    "subjectCQ": "What was published on 01/08/1989?",
    "propertyCQ": "",
    "objectCQ": "When was MDMA first used in rats?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q41022190$E4E87DCD-2472-43EC-976A-3AC8553ADCD4",
    "theme": "ChemicalCompound",
    "subject_label": "CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA).",
    "subject_id": "Q41022190",
    "subject_description": "scientific article published on August 1994",
    "property_label": "publication date",
    "property_id": "P577",
    "object_label": "01/08/1994",
    "object_id": "",
    "object_description": "no-desc",
    "context": "CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA). The publication date was 01/08/1994.",
    "subjectCQ": "What does CuZnSOD do?",
    "propertyCQ": "What was the release date of the CuZnSOD transgenic mice?",
    "objectCQ": "When was the publication date of the CuZnSOD transgenic mice?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50426792$9B950F9E-1D03-4F42-9F8E-76C1202390A0",
    "theme": "ChemicalCompound",
    "subject_label": "Environmental concentrations of 3,4-methylenedioxymethamphetamine (MDMA)-induced cellular stress and modulated antioxidant enzyme activity in the zebra mussel.",
    "subject_id": "Q50426792",
    "subject_description": "scientific article published in June 2014",
    "property_label": "publication date",
    "property_id": "P577",
    "object_label": "01/06/2014",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The zebra mussel was published on the 1st of June, 2014 and has an antioxidant enzyme activity that is modulated by environmental concentrations of 3,4-methylenedioxymethamphetamine (MDMA).",
    "subjectCQ": "What is the effect of the concentrations of MDMA on the antioxidant activity of zebra mussel?",
    "propertyCQ": "What was the date of the zebra mussel's publication?",
    "objectCQ": "When was the zebra mussel published?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q68306116$4A5B4D2A-9FC2-46D5-977E-074D3ADA03BA",
    "theme": "ChemicalCompound",
    "subject_label": "Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia",
    "subject_id": "Q68306116",
    "subject_description": "scientific article published on 01 June 1991",
    "property_label": "publication date",
    "property_id": "P577",
    "object_label": "01/06/1991",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia, was published on 01/06/1991.",
    "subjectCQ": "What was the name of the fatality associated with MDMA?",
    "propertyCQ": "What was the death date of MDMA?",
    "objectCQ": "When was MDMA first published?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q83159822$5E626FF1-A0B9-4B2F-B789-3F82779D2367",
    "theme": "ChemicalCompound",
    "subject_label": "Differences in binding affinities of MDA, MDMA, MDEA, Amphetamine, Methamphetamine, and their deuterated analogues to solid-phase extraction cartridges",
    "subject_id": "Q83159822",
    "subject_description": "scientific article published on 01 January 2011",
    "property_label": "publication date",
    "property_id": "P577",
    "object_label": "01/01/2011",
    "object_id": "",
    "object_description": "no-desc",
    "context": "MDA, MDMA, MDEA, Amphetamine, Methamphetamine, and their deuterated analogues to solid-phase extraction cartridges were published on 01/01/2011.",
    "subjectCQ": "What was published on 01/01/2011",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q40678302$2F8DB588-793A-4918-A040-1F2CF7783B95",
    "theme": "ChemicalCompound",
    "subject_label": "Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing.",
    "subject_id": "Q40678302",
    "subject_description": "scientific article published on November 1995",
    "property_label": "publication date",
    "property_id": "P577",
    "object_label": "01/11/1995",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing. Published on 01/11/1995.",
    "subjectCQ": "What is the effect of MDMA on rats?",
    "propertyCQ": "What was the publication date?",
    "objectCQ": "When was this study published?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q35745285$8778D803-1301-445C-B57E-ADC1300C1FF1",
    "theme": "ChemicalCompound",
    "subject_label": "Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.",
    "subject_id": "Q35745285",
    "subject_description": "scientific article published on 9 April 2004",
    "property_label": "publication date",
    "property_id": "P577",
    "object_label": "09/04/2004",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. Published on 09/04/2004.",
    "subjectCQ": "What is the main effect of MDMA on the brain?",
    "propertyCQ": "What was the date of the study?",
    "objectCQ": "When was this article published?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q42499116$6DD9739C-CD55-4B4C-9BDA-C84AD7E395BE",
    "theme": "ChemicalCompound",
    "subject_label": "Context-dependent behavioural and neuronal sensitization in striatum to MDMA (ecstasy) administration in rats.",
    "subject_id": "Q42499116",
    "subject_description": "scientific article",
    "property_label": "publication date",
    "property_id": "P577",
    "object_label": "01/07/2006",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Context-dependent behavioural and neuronal sensitization in striatum to MDMA (ecstasy) administration in rats. Published on 01/07/2006.",
    "subjectCQ": "What is the purpose of this study?",
    "propertyCQ": "What was the publication date?",
    "objectCQ": "When was this study published?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q44824030$E95D8729-BBB5-40C0-8729-D664448AA2A9",
    "theme": "ChemicalCompound",
    "subject_label": "Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats.",
    "subject_id": "Q44824030",
    "subject_description": "scientific article published in May 2004",
    "property_label": "title",
    "property_id": "P1476",
    "object_label": "Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats.",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats.",
    "subjectCQ": "What is the purpose of the study?",
    "propertyCQ": "What is the title of the study?",
    "objectCQ": "What is the purpose of the study?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q51807530$36696656-19E5-4606-BB7A-10EA7C917215",
    "theme": "ChemicalCompound",
    "subject_label": "Effects of MDMA (ecstasy) and two of its metabolites on rat embryos in vitro.",
    "subject_id": "Q51807530",
    "subject_description": "scientific article published on 27 February 2012",
    "property_label": "title",
    "property_id": "P1476",
    "object_label": "Effects of MDMA (ecstasy) and two of its metabolites on rat embryos in vitro",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Effects of MDMA (ecstasy) and two of its metabolites on rat embryos in vitro.",
    "subjectCQ": "What is the effect of MDMA on rat embryos?",
    "propertyCQ": "What is the title of the study?",
    "objectCQ": "What is the effect of MDMA on rat embryos?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q31114156$CA10FDD5-0689-4F2C-8A49-E6AD3A72A0A3",
    "theme": "ChemicalCompound",
    "subject_label": "Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data",
    "subject_id": "Q31114156",
    "subject_description": "scientific article",
    "property_label": "title",
    "property_id": "P1476",
    "object_label": "Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data has the title \"Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data\".",
    "subjectCQ": "What is the title of the study?",
    "propertyCQ": "",
    "objectCQ": "What is the title of the study?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q91787556$3428D789-229B-48BA-8AD7-6F4DEC14C9F1",
    "theme": "ChemicalCompound",
    "subject_label": "A proof-of-principle study of the short-term effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus and neural connectivity",
    "subject_id": "Q91787556",
    "subject_description": "scientific article published on 06 January 2020",
    "property_label": "title",
    "property_id": "P1476",
    "object_label": "A proof-of-principle study of the short-term effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus and neural connectivity",
    "object_id": "",
    "object_description": "no-desc",
    "context": "A proof-of-principle study of the short-term effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus and neural connectivity is entitled \"A proof-of-principle study of the short-term effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus and neural connectivity\".",
    "subjectCQ": "What is the name of the study?",
    "propertyCQ": "What is the name of the proof-of-principle study?",
    "objectCQ": "What is the name of the study?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q69378319$E9E2FF67-4D7E-4164-B6F7-D4E6E4B67ADF",
    "theme": "ChemicalCompound",
    "subject_label": "Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats",
    "subject_id": "Q69378319",
    "subject_description": "scientific article published on 01 August 1989",
    "property_label": "title",
    "property_id": "P1476",
    "object_label": "Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The title of the study \"Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats\" is \"Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats\".",
    "subjectCQ": "What is the title of the study?",
    "propertyCQ": "What is the study's title?",
    "objectCQ": "What is the title of the study?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q41022190$30E34E6E-1471-40C3-8444-74D50CA33C18",
    "theme": "ChemicalCompound",
    "subject_label": "CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA).",
    "subject_id": "Q41022190",
    "subject_description": "scientific article published on August 1994",
    "property_label": "title",
    "property_id": "P1476",
    "object_label": "CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA).",
    "object_id": "",
    "object_description": "no-desc",
    "context": "CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA).",
    "subjectCQ": "What does CuZnSOD do?",
    "propertyCQ": "What is the name of the article that describes the resistance of CuZnSOD transgenic mice to the lethal effects of MDA and MDMA?",
    "objectCQ": "What does CuZnSOD do?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50426792$C81E7A3E-C066-455E-B916-0B1C6603805B",
    "theme": "ChemicalCompound",
    "subject_label": "Environmental concentrations of 3,4-methylenedioxymethamphetamine (MDMA)-induced cellular stress and modulated antioxidant enzyme activity in the zebra mussel.",
    "subject_id": "Q50426792",
    "subject_description": "scientific article published in June 2014",
    "property_label": "title",
    "property_id": "P1476",
    "object_label": "Environmental concentrations of 3,4-methylenedioxymethamphetamine (MDMA)-induced cellular stress and modulated antioxidant enzyme activity in the zebra mussel.",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Environmental concentrations of 3,4-methylenedioxymethamphetamine (MDMA)-induced cellular stress and modulated antioxidant enzyme activity in the zebra mussel.",
    "subjectCQ": "What is the effect of MDMA on the zebra mussel?",
    "propertyCQ": "What is the title of the study?",
    "objectCQ": "What is the effect of MDMA on the zebra mussel?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q63212988$b52af881-42e9-d79e-64e7-61902d16d24d",
    "theme": "ChemicalCompound",
    "subject_label": "Amphoteronolide B",
    "subject_id": "Q63212988",
    "subject_description": "chemical compound, polypropionate",
    "property_label": "title",
    "property_id": "P1476",
    "object_label": "Total synthesis of amphoteronolide B",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Amphoteronolide B is a total synthesis of amphoteronolide B.",
    "subjectCQ": "What is a total synthesis of amphoteronolide B?",
    "propertyCQ": "What is the name of the synthesis?",
    "objectCQ": "What is amphoteronolide B?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q83159822$1E0C0C77-5EA9-42A2-8128-9D669958A258",
    "theme": "ChemicalCompound",
    "subject_label": "Differences in binding affinities of MDA, MDMA, MDEA, Amphetamine, Methamphetamine, and their deuterated analogues to solid-phase extraction cartridges",
    "subject_id": "Q83159822",
    "subject_description": "scientific article published on 01 January 2011",
    "property_label": "title",
    "property_id": "P1476",
    "object_label": "Differences in binding affinities of MDA, MDMA, MDEA, Amphetamine, Methamphetamine, and their deuterated analogues to solid-phase extraction cartridges",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The title of the book \"Differences in binding affinities of MDA, MDMA, MDEA, Amphetamine, Methamphetamine, and their deuterated analogues to solid-phase extraction cartridges\" is \"Differences in binding affinities of MDA, MDMA, MDEA, Amphetamine, Methamphetamine, and their deuterated analogues to solid-phase extraction cartridges\".",
    "subjectCQ": "What is the title of the book?",
    "propertyCQ": "What is the title of the book?",
    "objectCQ": "What is the title of the book?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q40678302$354E5432-2A3F-43E8-82CA-BDC536BD5F7D",
    "theme": "ChemicalCompound",
    "subject_label": "Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing.",
    "subject_id": "Q40678302",
    "subject_description": "scientific article published on November 1995",
    "property_label": "title",
    "property_id": "P1476",
    "object_label": "Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing.",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing.",
    "subjectCQ": "What is the effect of MDMA on rats?",
    "propertyCQ": "What is the title of the article?",
    "objectCQ": "What is the effect of MDMA on rats?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q35745285$C800AA6D-177A-48AE-940A-ED339751C26B",
    "theme": "ChemicalCompound",
    "subject_label": "Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.",
    "subject_id": "Q35745285",
    "subject_description": "scientific article published on 9 April 2004",
    "property_label": "title",
    "property_id": "P1476",
    "object_label": "Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.",
    "subjectCQ": "What is the effect of MDMA on the brain?",
    "propertyCQ": "What is the title of the study?",
    "objectCQ": "What is the effect of MDMA on the brain?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q42499116$F953B4AF-959A-403F-9454-7DFC5E4347E5",
    "theme": "ChemicalCompound",
    "subject_label": "Context-dependent behavioural and neuronal sensitization in striatum to MDMA (ecstasy) administration in rats.",
    "subject_id": "Q42499116",
    "subject_description": "scientific article",
    "property_label": "title",
    "property_id": "P1476",
    "object_label": "Context-dependent behavioural and neuronal sensitization in striatum to MDMA (ecstasy) administration in rats.",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Context-dependent behavioural and neuronal sensitization in striatum to MDMA (ecstasy) administration in rats.",
    "subjectCQ": "What is the effect of MDMA on the rat?",
    "propertyCQ": "What is the title of the study?",
    "objectCQ": "What is the effect of MDMA on the rat?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q69379487$60D82478-5CFF-4D4E-8071-3B7129878BF5",
    "theme": "ChemicalCompound",
    "subject_label": "Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine",
    "subject_id": "Q69379487",
    "subject_description": "scientific article published on 01 January 1989",
    "property_label": "published in",
    "property_id": "P1433",
    "object_label": "NIDA research monograph",
    "object_id": "Q27712234",
    "object_description": "journal",
    "context": "Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine was published in the NIDA research monograph.",
    "subjectCQ": "What was published in the NIDA research monograph?",
    "propertyCQ": "What was the NIDA research monograph?",
    "objectCQ": "Where was the comparison of the behavioral and neurochemical effects of MDMA and MDMA published?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q51073688$080B863C-7FB5-40EA-84F9-9B41C4D45610",
    "theme": "ChemicalCompound",
    "subject_label": "(+/-)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats.",
    "subject_id": "Q51073688",
    "subject_description": "scientific article published in November 2000",
    "property_label": "published in",
    "property_id": "P1433",
    "object_label": "European Journal of Pharmacology",
    "object_id": "Q1376712",
    "object_description": "journal",
    "context": "(+/-)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats. Published in the European Journal of Pharmacology.",
    "subjectCQ": "What does MDMA do to increase social interaction in rats?",
    "propertyCQ": "What journal is MDMA published in?",
    "objectCQ": "Where is MDMA published?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q47731855$7EA0805E-FFED-435A-BB10-9518F66D2E87",
    "theme": "ChemicalCompound",
    "subject_label": "Oxytocin and MDMA ('Ecstasy') enhance social reward in rats.",
    "subject_id": "Q47731855",
    "subject_description": "scientific article published on 15 March 2015",
    "property_label": "published in",
    "property_id": "P1433",
    "object_label": "Psychopharmacology",
    "object_id": "Q1422802",
    "object_description": "journal",
    "context": "Oxytocin and MDMA ('Ecstasy') enhance social reward in rats. Published in Psychopharmacology.",
    "subjectCQ": "What are the two drugs that are used to treat addiction?",
    "propertyCQ": "What is the name of the journal that studies the effects of MDMA and Oxytocin on rats?",
    "objectCQ": "Where was Ecstasy published?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q41022190$89D1654D-EA0B-4B79-B90A-B8BF0A4FD0D2",
    "theme": "ChemicalCompound",
    "subject_label": "CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA).",
    "subject_id": "Q41022190",
    "subject_description": "scientific article published on August 1994",
    "property_label": "published in",
    "property_id": "P1433",
    "object_label": "Brain Research",
    "object_id": "Q4955782",
    "object_description": "scientific journal",
    "context": "CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA). This study was published in Brain Research.",
    "subjectCQ": "What is the effect of the cuZnSOD on mice?",
    "propertyCQ": "What journal did the study on CuZnSOD be published in?",
    "objectCQ": "What journal was the study published in?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50064627$1D53F9EA-C822-4A69-9414-7871BBF400D8",
    "theme": "ChemicalCompound",
    "subject_label": "Development of microwave-assisted extraction procedure for organic impurity profiling of seized 3,4-methylenedioxymethamphetamine (MDMA).",
    "subject_id": "Q50064627",
    "subject_description": "scientific article published on 25 July 2011",
    "property_label": "published in",
    "property_id": "P1433",
    "object_label": "Journal of Forensic Sciences",
    "object_id": "Q15760026",
    "object_description": "journal",
    "context": "Development of microwave-assisted extraction procedure for organic impurity profiling of seized 3,4-methylenedioxymethamphetamine (MDMA) was published in the Journal of Forensic Sciences.",
    "subjectCQ": "What was published in the Journal of Forensic Sciences?",
    "propertyCQ": "What journal was the development of the microwave-assisted extraction procedure published in?",
    "objectCQ": "What journal was the development of the microwave-assisted extraction procedure published in?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q46913606$500B663B-25BC-4F1F-9C35-CFA3D3A93EBC",
    "theme": "ChemicalCompound",
    "subject_label": "MDMA, politics and medical research: have we thrown the baby out with the bathwater?",
    "subject_id": "Q46913606",
    "subject_description": "scientific article published in November 2007",
    "property_label": "published in",
    "property_id": "P1433",
    "object_label": "Journal of Psychopharmacology",
    "object_id": "Q6295819",
    "object_description": "peer-reviewed scientific journal",
    "context": "MDMA, politics and medical research: have we thrown the baby out with the bathwater? was published in the Journal of Psychopharmacology.",
    "subjectCQ": "What was published in the Journal of Psychopharmacology?",
    "propertyCQ": "What journal was the Journal of Psychopharmacology published in?",
    "objectCQ": "Where was MDMA published?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q48608076$684EB37E-504A-407C-AA03-4A68C586AC5D",
    "theme": "ChemicalCompound",
    "subject_label": "Effects of salicylate on 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats.",
    "subject_id": "Q48608076",
    "subject_description": "scientific article published in November 1997",
    "property_label": "published in",
    "property_id": "P1433",
    "object_label": "Pharmacology, Biochemistry and Behavior",
    "object_id": "Q15716554",
    "object_description": "journal",
    "context": "Effects of salicylate on 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats. Published in Pharmacology, Biochemistry and Behavior.",
    "subjectCQ": "What is the effect of salicylate on neurotoxicity in rats?",
    "propertyCQ": "What is the name of the journal that published the study?",
    "objectCQ": "What journal was the study published in?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50921579$85FFCCA6-F297-4495-A00A-3C348ADF4DFA",
    "theme": "ChemicalCompound",
    "subject_label": "The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans.",
    "subject_id": "Q50921579",
    "subject_description": "scientific article published on 18 October 2006",
    "property_label": "published in",
    "property_id": "P1433",
    "object_label": "Psychopharmacology",
    "object_id": "Q1422802",
    "object_description": "journal",
    "context": "The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans was published in Psychopharmacology.",
    "subjectCQ": "What was published in Psychopharmacology?",
    "propertyCQ": "What journal was the study of the effects of fluoxetine on MDMA in humans published in?",
    "objectCQ": "What journal published the study?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q46416925$E5C952E0-824E-4C67-ABA3-DCBF1507155A",
    "theme": "ChemicalCompound",
    "subject_label": "Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide.",
    "subject_id": "Q46416925",
    "subject_description": "scientific article",
    "property_label": "published in",
    "property_id": "P1433",
    "object_label": "Brain Research",
    "object_id": "Q4955782",
    "object_description": "scientific journal",
    "context": "Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide. Published in Brain Research.",
    "subjectCQ": "What is the effect of MDMA and para-methoxyamphetamine on striatal 5-HT?",
    "propertyCQ": "What journal was the study published in?",
    "objectCQ": "What journal was the study published in?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q43453796$8079CEDD-23D3-4085-87C3-78957EF448D4",
    "theme": "ChemicalCompound",
    "subject_label": "Effects of repeated treatment with MDMA on working memory and behavioural flexibility in mice.",
    "subject_id": "Q43453796",
    "subject_description": "scientific article published on 19 January 2012",
    "property_label": "published in",
    "property_id": "P1433",
    "object_label": "Addiction Biology",
    "object_id": "Q4681109",
    "object_description": "journal",
    "context": "The study of the effects of repeated treatment with MDMA on working memory and behavioural flexibility in mice was published in Addiction Biology.",
    "subjectCQ": "What was the study published in Addiction Biology?",
    "propertyCQ": "What journal was the study published in?",
    "objectCQ": "What journal published the study?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q35745285$3877EFB6-C6BA-4079-9BF5-394AC2317C4F",
    "theme": "ChemicalCompound",
    "subject_label": "Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.",
    "subject_id": "Q35745285",
    "subject_description": "scientific article published on 9 April 2004",
    "property_label": "published in",
    "property_id": "P1433",
    "object_label": "Psychopharmacology",
    "object_id": "Q1422802",
    "object_description": "journal",
    "context": "Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. Published in Psychopharmacology.",
    "subjectCQ": "What is the main effect of MDMA on the brain?",
    "propertyCQ": "What is the name of the journal that studies the effects of MDMA on dopamine biochemistry?",
    "objectCQ": "What journal is this article published in?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q37392237$002EA348-E57F-4F7A-8F94-8FC9E6101CB7",
    "theme": "ChemicalCompound",
    "subject_label": "Effects of MDMA, methamphetamine and methylphenidate on repeated acquisition and performance in rats.",
    "subject_id": "Q37392237",
    "subject_description": "scientific article published on 19 September 2009",
    "property_label": "published in",
    "property_id": "P1433",
    "object_label": "Pharmacology, Biochemistry and Behavior",
    "object_id": "Q15716554",
    "object_description": "journal",
    "context": "The study of the effects of MDMA, methamphetamine and methylphenidate on repeated acquisition and performance in rats was published in Pharmacology, Biochemistry and Behavior.",
    "subjectCQ": "What was the study published in Pharmacology, Biochemistry and Behavior?",
    "propertyCQ": "",
    "objectCQ": "What journal was the study published in?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27591930$2F5C1A60-729C-41EF-94C6-EB0674D5C76C",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-3195",
    "subject_id": "Q27591930",
    "subject_description": "human precursor microRNA",
    "property_label": "encoded by",
    "property_id": "P702",
    "object_label": "MIR3195",
    "object_id": "Q20781704",
    "object_description": "non-coding RNA in the species Homo sapiens",
    "context": "Hsa-mir-3195 is encoded by MIR3195.",
    "subjectCQ": "What is encoded by MIR3195?",
    "propertyCQ": "What is the Hsa-mir-3195?",
    "objectCQ": "What is the name of the encoder that encodes Hsa-mir-3195?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27591435$B7236BFB-AE14-4FFB-AF78-6D4BB56BA3E6",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-1180",
    "subject_id": "Q27591435",
    "subject_description": "human precursor microRNA",
    "property_label": "encoded by",
    "property_id": "P702",
    "object_label": "MIR1180",
    "object_id": "Q18065920",
    "object_description": "non-coding RNA in the species Homo sapiens",
    "context": "Hsa-mir-1180 is encoded by MIR1180.",
    "subjectCQ": "What is encoded by MIR1180?",
    "propertyCQ": "What is the Hsa-mir-1180?",
    "objectCQ": "What is the name of the device that encodes Hsa-mir-1180?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27592196$6B71EAC5-1E35-4AD9-BAFC-79224B2B578D",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-4636",
    "subject_id": "Q27592196",
    "subject_description": "human precursor microRNA",
    "property_label": "encoded by",
    "property_id": "P702",
    "object_label": "MIR4636",
    "object_id": "Q18068731",
    "object_description": "non-coding RNA in the species Homo sapiens",
    "context": "Hsa-mir-4636 is encoded by MIR4636.",
    "subjectCQ": "What is encoded by MIR4636?",
    "propertyCQ": "What is Hsa-mir-4636?",
    "objectCQ": "What is the name of the encoder that encodes Hsa-mir-4636?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27592523$692A91CF-0EC4-48B9-85EE-9C2763CD16D8",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-3651",
    "subject_id": "Q27592523",
    "subject_description": "human precursor microRNA",
    "property_label": "encoded by",
    "property_id": "P702",
    "object_label": "MIR3651",
    "object_id": "Q20782053",
    "object_description": "non-coding RNA in the species Homo sapiens",
    "context": "Hsa-mir-3651 is encoded by MIR3651.",
    "subjectCQ": "What is encoded by MIR3651?",
    "propertyCQ": "What is Hsa-mir-3651?",
    "objectCQ": "What is the encoder of Hsa-mir-3651?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50422748$008F7D7B-0249-4005-80DB-91BE1975D7CE",
    "theme": "ChemicalCompound",
    "subject_label": "tRNA-Tyr encoded by: tyrU b3977",
    "subject_id": "Q50422748",
    "subject_description": "Microbial non-coding RNA 'tRNA' found in Escherichia coli str. K-12 substr. MG1655, Note: anticodon: GUA",
    "property_label": "encoded by",
    "property_id": "P702",
    "object_label": "tyrU encodes: tRNA-Tyr b3977",
    "object_id": "Q50422733",
    "object_description": "Microbial gene encodes a non-coding RNA 'tRNA' found in Escherichia coli str. K-12 substr. MG1655, Note: anticodon: GUA",
    "context": "TRNA-Tyr is encoded by: tyrU b3977 and tyrU encodes tRNA-Tyr b3977.",
    "subjectCQ": "What is tyrU encoded by?",
    "propertyCQ": "What is TRNA-Tyr?",
    "objectCQ": "What does tyrU encode?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27592300$AB766E47-82F0-447C-96A2-91BE409D2EAE",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-548u",
    "subject_id": "Q27592300",
    "subject_description": "human precursor microRNA",
    "property_label": "encoded by",
    "property_id": "P702",
    "object_label": "MIR548U",
    "object_id": "Q20773952",
    "object_description": "non-coding RNA in the species Homo sapiens",
    "context": "Hsa-mir-548u is encoded by MIR548U.",
    "subjectCQ": "What is encoded by MIR548U?",
    "propertyCQ": "What is the Hsa-mir-548u?",
    "objectCQ": "What is the name of the device that encodes Hsa-mir-548u?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q483745$956614D7-0823-4DB1-936E-66522556643D",
    "theme": "ChemicalCompound",
    "subject_label": "L-leucine",
    "subject_id": "Q483745",
    "subject_description": "chemical compound",
    "property_label": "encoded by",
    "property_id": "P702",
    "object_label": "CUG",
    "object_id": "Q29018180",
    "object_description": "codon",
    "context": "L-leucine is encoded by CUG.",
    "subjectCQ": "What is encoded by CUG?",
    "propertyCQ": "What is L-leucine encoded by?",
    "objectCQ": "What is the name of the entity that encodes L-leucine?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27591978$302E3BBD-BD47-4010-A4B4-ECA91DFB0B89",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-1306",
    "subject_id": "Q27591978",
    "subject_description": "human precursor microRNA",
    "property_label": "encoded by",
    "property_id": "P702",
    "object_label": "GGT2",
    "object_id": "Q18061420",
    "object_description": "protein-coding gene in the species Homo sapiens",
    "context": "Hsa-mir-1306 is encoded by GGT2.",
    "subjectCQ": "What is encoded by GGT2?",
    "propertyCQ": "What is the Hsa-mir-1306 encoded by?",
    "objectCQ": "What is the encoder of Hsa-mir-1306?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27591294$76ED00EF-7135-49DB-890F-C080FB3CBCB4",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-190a",
    "subject_id": "Q27591294",
    "subject_description": "human precursor microRNA",
    "property_label": "encoded by",
    "property_id": "P702",
    "object_label": "MIR190A",
    "object_id": "Q18058090",
    "object_description": "non-coding RNA in the species Homo sapiens",
    "context": "Hsa-mir-190a is encoded by MIR190A.",
    "subjectCQ": "What is encoded by MIR190A?",
    "propertyCQ": "What is the Hsa-mir-190a?",
    "objectCQ": "What is the encoder of Hsa-mir-190a?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27590969$55C9641A-58BC-4AC4-AD26-0D96B6433CAF",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-6748",
    "subject_id": "Q27590969",
    "subject_description": "human precursor microRNA",
    "property_label": "encoded by",
    "property_id": "P702",
    "object_label": "MIR6748",
    "object_id": "Q18075153",
    "object_description": "non-coding RNA in the species Homo sapiens",
    "context": "Hsa-mir-6748 is encoded by MIR6748.",
    "subjectCQ": "What is encoded by MIR6748?",
    "propertyCQ": "What is the Hsa-mir-6748?",
    "objectCQ": "What is the name of the encoder that encodes Hsa-mir-6748?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27591319$7D7ABD0B-7086-4C4A-A91E-09CE9EC544F8",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-3529",
    "subject_id": "Q27591319",
    "subject_description": "human precursor microRNA",
    "property_label": "encoded by",
    "property_id": "P702",
    "object_label": "DDX11L5",
    "object_id": "Q18065540",
    "object_description": "pseudogene in the species Homo sapiens",
    "context": "Hsa-mir-3529 is encoded by DDX11L5.",
    "subjectCQ": "What is encoded by DDX11L5?",
    "propertyCQ": "What is the DDX11L5?",
    "objectCQ": "What is the code used by?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27592349$71512AE2-5650-43E1-BE96-5F8A71747C12",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-6837",
    "subject_id": "Q27592349",
    "subject_description": "human precursor microRNA",
    "property_label": "encoded by",
    "property_id": "P702",
    "object_label": "MIR6837",
    "object_id": "Q18080790",
    "object_description": "non-coding RNA in the species Homo sapiens",
    "context": "Hsa-mir-6837 is encoded by MIR6837.",
    "subjectCQ": "What is encoded by MIR6837?",
    "propertyCQ": "What is the name of the MIR6837?",
    "objectCQ": "What is the name of the encoder that encodes Hsa-mir-6837?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q421862$26511AC2-9A7C-4147-A726-6B2BABA67A9C",
    "theme": "ChemicalCompound",
    "subject_label": "ribavirin",
    "subject_id": "Q421862",
    "subject_description": "chemical compound",
    "property_label": "active ingredient in",
    "property_id": "P3780",
    "object_label": "Virazole",
    "object_id": "Q47522301",
    "object_description": "pharmaceutical product",
    "context": "Virazole is an active ingredient of ribavirin.",
    "subjectCQ": "What is Virazole an active ingredient of?",
    "propertyCQ": "What is virazole?",
    "objectCQ": "What is the active ingredient of ribavirin?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q238490$690523A9-944B-4F2D-A4C2-7449FDD525B9",
    "theme": "ChemicalCompound",
    "subject_label": "5-fluorocytosine",
    "subject_id": "Q238490",
    "subject_description": "chemical compound",
    "property_label": "active ingredient in",
    "property_id": "P3780",
    "object_label": "Ancobon",
    "object_id": "Q47521050",
    "object_description": "pharmaceutical product",
    "context": "Ancobon contains the active ingredient 5-fluorocytosine.",
    "subjectCQ": "What is the active ingredient in Ancobon?",
    "propertyCQ": "What is 5-fluorocytosine?",
    "objectCQ": "What contains the active ingredient 5-fluorocytosine?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q4391540$2bfbda36-4fd9-6e12-ecb0-a41691e0e522",
    "theme": "ChemicalCompound",
    "subject_label": "interferon Alfa-2b, Recombinant",
    "subject_id": "Q4391540",
    "subject_description": "pharmaceutical drug",
    "property_label": "active ingredient in",
    "property_id": "P3780",
    "object_label": "Oftalmoferon",
    "object_id": "Q4340338",
    "object_description": "no-desc",
    "context": "The active ingredient in oftalmoferon is interferon Alfa-2b, recombinant.",
    "subjectCQ": "What is the active ingredient in oftalmoferon?",
    "propertyCQ": "What is interferon Alfa-2b?",
    "objectCQ": "What is the active ingredient in?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q2552927$B1571833-DD48-4ACA-9A64-E6C656AF2C8C",
    "theme": "ChemicalCompound",
    "subject_label": "cefepime",
    "subject_id": "Q2552927",
    "subject_description": "chemical compound",
    "property_label": "active ingredient in",
    "property_id": "P3780",
    "object_label": "Maxipime",
    "object_id": "Q47521328",
    "object_description": "pharmaceutical product",
    "context": "Cefepime is an active ingredient in Maxipime.",
    "subjectCQ": "What is an active ingredient in Maxipime?",
    "propertyCQ": "What is Cefepime?",
    "objectCQ": "What drug contains Cefepime?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q3315722$6CB41239-58B6-4306-BDEF-60485A243B2A",
    "theme": "ChemicalCompound",
    "subject_label": "mipomersen",
    "subject_id": "Q3315722",
    "subject_description": "pharmaceutical drug",
    "property_label": "active ingredient in",
    "property_id": "P3780",
    "object_label": "Kynamro",
    "object_id": "Q29006100",
    "object_description": "pharmaceutical product",
    "context": "Kynamro is an active ingredient in mipomersen.",
    "subjectCQ": "What is Kynamro an active ingredient in?",
    "propertyCQ": "What is Kynamro?",
    "objectCQ": "What is an active ingredient in mipomersen?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q194974$EFFA1BD8-C850-4B9D-94DA-6E3EC0204069",
    "theme": "ChemicalCompound",
    "subject_label": "letrozole",
    "subject_id": "Q194974",
    "subject_description": "chemical compound",
    "property_label": "active ingredient in",
    "property_id": "P3780",
    "object_label": "Femara",
    "object_id": "Q47521599",
    "object_description": "pharmaceutical product",
    "context": "Letrozole is an active ingredient in Femara.",
    "subjectCQ": "What is an active ingredient in Femara?",
    "propertyCQ": "What is Letrozole?",
    "objectCQ": "What is Letrozole an active ingredient in?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q412174$D319241B-8898-4E9F-AE1A-ECA239A0EB7C",
    "theme": "ChemicalCompound",
    "subject_label": "pregabalin",
    "subject_id": "Q412174",
    "subject_description": "chemical compound",
    "property_label": "active ingredient in",
    "property_id": "P3780",
    "object_label": "Pregabalin Sandoz Gmbh",
    "object_id": "Q29006364",
    "object_description": "pharmaceutical product",
    "context": "Pregabalin is an active ingredient in Pregabalin Sandoz Gmbh.",
    "subjectCQ": "What is the active ingredient in Pregabalin Sandoz Gmbh?",
    "propertyCQ": "What is Pregabalin?",
    "objectCQ": "Pregabalin is an active ingredient in what drug?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q409251$04C55BAD-1364-4401-8108-1139B77DF1B9",
    "theme": "ChemicalCompound",
    "subject_label": "calcium acetate",
    "subject_id": "Q409251",
    "subject_description": "chemical compound",
    "property_label": "active ingredient in",
    "property_id": "P3780",
    "object_label": "Eliphos",
    "object_id": "Q48828221",
    "object_description": "pharmaceutical product",
    "context": "Eliphos contains calcium acetate as an active ingredient.",
    "subjectCQ": "What is the active ingredient in Eliphos?",
    "propertyCQ": "What does Eliphos contain calcium acetate as?",
    "objectCQ": "What is the name of the product that contains calcium acetate?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q412174$90A7645F-7C74-44F9-B829-D0A1C658CBAB",
    "theme": "ChemicalCompound",
    "subject_label": "pregabalin",
    "subject_id": "Q412174",
    "subject_description": "chemical compound",
    "property_label": "active ingredient in",
    "property_id": "P3780",
    "object_label": "Pregabalin Accord",
    "object_id": "Q29006359",
    "object_description": "pharmaceutical product",
    "context": "Pregabalin Accord contains pregabalin as an active ingredient.",
    "subjectCQ": "What is the active ingredient in Pregabalin Accord?",
    "propertyCQ": "What does Pregabalin Accord contain?",
    "objectCQ": "What contains pregabalin as an active ingredient?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q166825$859DBFF7-42D0-4988-92C5-4F0A9DEAD6F2",
    "theme": "ChemicalCompound",
    "subject_label": "ibandronic acid",
    "subject_id": "Q166825",
    "subject_description": "chemical compound",
    "property_label": "active ingredient in",
    "property_id": "P3780",
    "object_label": "Bondenza",
    "object_id": "Q29004907",
    "object_description": "pharmaceutical product",
    "context": "Ibandronic acid is an active ingredient in Bondenza.",
    "subjectCQ": "What is an active ingredient in Bondenza?",
    "propertyCQ": "What is Ibandronic acid?",
    "objectCQ": "Ibandronic acid is an active ingredient in what drug?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q684379$56A0F928-FD52-41F2-8582-B9D121A1EFE4",
    "theme": "ChemicalCompound",
    "subject_label": "nepafenac",
    "subject_id": "Q684379",
    "subject_description": "chemical compound",
    "property_label": "active ingredient in",
    "property_id": "P3780",
    "object_label": "Ilevro",
    "object_id": "Q48828192",
    "object_description": "pharmaceutical product",
    "context": "Nepafenac is an active ingredient in ilevro.",
    "subjectCQ": "What is the active ingredient in ilevro?",
    "propertyCQ": "What is Nepafenac?",
    "objectCQ": "Nepafenac is an active ingredient in what drug?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q415909$032AA816-5D9E-4F62-8C34-33347D34AF0A",
    "theme": "ChemicalCompound",
    "subject_label": "capreomycin",
    "subject_id": "Q415909",
    "subject_description": "pharmaceutical drug",
    "property_label": "active ingredient in",
    "property_id": "P3780",
    "object_label": "Capastat",
    "object_id": "Q47521312",
    "object_description": "pharmaceutical product",
    "context": "Capastat is an active ingredient of capreomycin.",
    "subjectCQ": "What is capastat an active ingredient of?",
    "propertyCQ": "What is capastat?",
    "objectCQ": "What is the active ingredient of capreomycin?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q183554$296C6740-D71E-41A7-8981-5002190AFB0E",
    "theme": "ChemicalCompound",
    "subject_label": "fosfomycin",
    "subject_id": "Q183554",
    "subject_description": "chemical compound",
    "property_label": "World Health Organisation International Nonproprietary Name",
    "property_id": "P2275",
    "object_label": "fosfomycin",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The World Health Organisation International Nonproprietary Name of fosfomycin is fosfomycin.",
    "subjectCQ": "What is the World Health Organization's International Nonproprietary Name?",
    "propertyCQ": "What is fosfomycin?",
    "objectCQ": "What is the World Health Organization's International Nonproprietary Name?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q2937681$A98F8532-F04E-408F-A590-BBC3816D5813",
    "theme": "ChemicalCompound",
    "subject_label": "captodiame",
    "subject_id": "Q2937681",
    "subject_description": "chemical compound",
    "property_label": "World Health Organisation International Nonproprietary Name",
    "property_id": "P2275",
    "object_label": "Captodiame",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Captodiame is a World Health Organisation International Nonproprietary Name.",
    "subjectCQ": "What is the World Health Organization's International Nonproprietary Name?",
    "propertyCQ": "What is Captodiame?",
    "objectCQ": "What is the World Health Organization's Nonproprietary Name?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q5057303$3413B2DF-0291-4B88-926D-2E8A96DAB6CC",
    "theme": "ChemicalCompound",
    "subject_label": "cefuzonam",
    "subject_id": "Q5057303",
    "subject_description": "chemical compound",
    "property_label": "World Health Organisation International Nonproprietary Name",
    "property_id": "P2275",
    "object_label": "cefuzonam",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Cefuzonam is a World Health Organisation International Nonproprietary Name.",
    "subjectCQ": "What is the name of the World Health Organization's Nonproprietary Name?",
    "propertyCQ": "What is Cefuzonam?",
    "objectCQ": "What is the name of the World Health Organization's Nonproprietary Name?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q71969$25AAFBD3-4561-413E-80E5-EE496BC8CBC4",
    "theme": "ChemicalCompound",
    "subject_label": "methenamine",
    "subject_id": "Q71969",
    "subject_description": "chemical compound",
    "property_label": "World Health Organisation International Nonproprietary Name",
    "property_id": "P2275",
    "object_label": "methenamine",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Methenamine is an international nonproprietary name of the World Health Organisation.",
    "subjectCQ": "What is the name of the nonproprietary name of the World Health Organization?",
    "propertyCQ": "What is Methenamine?",
    "objectCQ": "What is the name of the nonproprietary name of the World Health Organization?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q416427$0A6A5BD7-0440-490E-936E-8A6D8BCD5332",
    "theme": "ChemicalCompound",
    "subject_label": "cromoglicic acid",
    "subject_id": "Q416427",
    "subject_description": "chemical compound",
    "property_label": "World Health Organisation International Nonproprietary Name",
    "property_id": "P2275",
    "object_label": "cromoglicic acid",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Cromoglicic acid is a World Health Organisation International Nonproprietary Name.",
    "subjectCQ": "What is the World Health Organization's International Nonproprietary Name?",
    "propertyCQ": "What is Cromoglicic acid?",
    "objectCQ": "What is the World Health Organization's International Nonproprietary Name?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q3800087$B450A5C1-9134-4A97-A1DC-A6AE5773BA96",
    "theme": "ChemicalCompound",
    "subject_label": "pyrilamine",
    "subject_id": "Q3800087",
    "subject_description": "chemical compound",
    "property_label": "World Health Organisation International Nonproprietary Name",
    "property_id": "P2275",
    "object_label": "Mepyramine",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The International Nonproprietary Name of pyrilamine is Mepyramine and the World Health Organisation.",
    "subjectCQ": "What is the International Nonproprietary Name of?",
    "propertyCQ": "What is the name of pyrilamine?",
    "objectCQ": "What is the International Nonproprietary Name of pyrilamine?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q176533$F7D9DE5A-712E-4EC6-ADC3-47694E3C8340",
    "theme": "ChemicalCompound",
    "subject_label": "alfentanil",
    "subject_id": "Q176533",
    "subject_description": "chemical compound",
    "property_label": "World Health Organisation International Nonproprietary Name",
    "property_id": "P2275",
    "object_label": "alfentanil",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The World Health Organisation International Nonproprietary Name of alfentanil is alfentanil.",
    "subjectCQ": "What is the World Health Organization's International Nonproprietary Name?",
    "propertyCQ": "What is the name of the drug alfentanil?",
    "objectCQ": "What is the World Health Organization's International Nonproprietary Name?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q7107372$82F965C7-33B1-4B3A-A6CA-63F6ADA1E2E8",
    "theme": "ChemicalCompound",
    "subject_label": "ospemifene",
    "subject_id": "Q7107372",
    "subject_description": "chemical compound",
    "property_label": "World Health Organisation International Nonproprietary Name",
    "property_id": "P2275",
    "object_label": "Ospemifene",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Ospemifene is a World Health Organisation International Nonproprietary Name.",
    "subjectCQ": "What is the World Health Organization's International Nonproprietary Name?",
    "propertyCQ": "What is Ospemifene?",
    "objectCQ": "What is the World Health Organization's International Nonproprietary Name?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q24255323$179CA84C-2213-40CC-85F6-26B51FB9CFDD",
    "theme": "ChemicalCompound",
    "subject_label": "esatenolol",
    "subject_id": "Q24255323",
    "subject_description": "chemical compound",
    "property_label": "World Health Organisation International Nonproprietary Name",
    "property_id": "P2275",
    "object_label": "esatenolol",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Esatenolol is a World Health Organisation International Nonproprietary Name.",
    "subjectCQ": "What is the World Health Organization's Nonproprietary Name?",
    "propertyCQ": "What is Esatenolol?",
    "objectCQ": "What is the World Health Organization's Nonproprietary Name?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q422438$03C30FF6-D046-4B47-ACED-DA5D22A8E146",
    "theme": "ChemicalCompound",
    "subject_label": "chloroquine",
    "subject_id": "Q422438",
    "subject_description": "chemical compound",
    "property_label": "World Health Organisation International Nonproprietary Name",
    "property_id": "P2275",
    "object_label": "chloroquine",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The World Health Organisation International Nonproprietary Name of chloroquine is chloroquine.",
    "subjectCQ": "What is the World Health Organization's International Nonproprietary Name?",
    "propertyCQ": "What is the name of chloroquine?",
    "objectCQ": "What is the World Health Organization's International Nonproprietary Name?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20817136$05223814-EB9F-406D-BDED-417F10578B32",
    "theme": "ChemicalCompound",
    "subject_label": "Hydroxystilbamidine Isethionate",
    "subject_id": "Q20817136",
    "subject_description": "pharmaceutical drug",
    "property_label": "World Health Organisation International Nonproprietary Name",
    "property_id": "P2275",
    "object_label": "Hydroxystilbamidine isethionate",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The World Health Organisation International Nonproprietary Name of Hydroxystilbamidine is Hydroxystilbamidine isethionate.",
    "subjectCQ": "What is the World Health Organization's International Nonproprietary Name?",
    "propertyCQ": "What is Hydroxystilbamidine isethionate?",
    "objectCQ": "What is the World Health Organization's International Nonproprietary Name of Hydroxystilbamidine?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27124363$E3D273F1-C8B1-4CC3-A758-446079B32D5A",
    "theme": "ChemicalCompound",
    "subject_label": "4-amino-m-cresol",
    "subject_id": "Q27124363",
    "subject_description": "chemical compound",
    "property_label": "World Health Organisation International Nonproprietary Name",
    "property_id": "P2275",
    "object_label": "sulfamoxole",
    "object_id": "",
    "object_description": "no-desc",
    "context": "4-amino-m-cresol is the World Health Organisation International Nonproprietary Name of sulfamoxole.",
    "subjectCQ": "What is the World Health Organization's Nonproprietary Name of sulfamoxole?",
    "propertyCQ": "What is 4-amino-m-cresol?",
    "objectCQ": "What is the World Health Organization's Nonproprietary Name of?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q58375$C979D86C-547D-4324-B0D6-C7750A5B77CA",
    "theme": "ChemicalCompound",
    "subject_label": "thioridazine",
    "subject_id": "Q58375",
    "subject_description": "chemical compound",
    "property_label": "significant drug interaction",
    "property_id": "P769",
    "object_label": "dofetilide",
    "object_id": "Q3712521",
    "object_description": "chemical compound",
    "context": "Dofetilide is a significant drug interaction between thioridazine and dofetilide.",
    "subjectCQ": "Dofetilide is a significant drug interaction between dofetilide and what other drug?",
    "propertyCQ": "What is dofetilide?",
    "objectCQ": "What is a significant drug interaction between thioridazine and?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q58375$EA8BF589-1925-46BF-929A-25F3DFFB9A96",
    "theme": "ChemicalCompound",
    "subject_label": "thioridazine",
    "subject_id": "Q58375",
    "subject_description": "chemical compound",
    "property_label": "significant drug interaction",
    "property_id": "P769",
    "object_label": "quinidine",
    "object_id": "Q412496",
    "object_description": "pharmaceutical agent that acts as a class I antiarrhythmic agent (Ia) in the heart",
    "context": "Thioridazine has a significant drug interaction with quinidine.",
    "subjectCQ": "What drug has a significant drug interaction with quinidine?",
    "propertyCQ": "What does Thioridazine have with quinidine?",
    "objectCQ": "Thioridazine has a significant drug interaction with what?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q425120$5735B29D-593F-41A2-B9C9-70ECB0C9588A",
    "theme": "ChemicalCompound",
    "subject_label": "disopyramide",
    "subject_id": "Q425120",
    "subject_description": "chemical compound",
    "property_label": "significant drug interaction",
    "property_id": "P769",
    "object_label": "probucol",
    "object_id": "Q10354103",
    "object_description": "chemical compound",
    "context": "Disopyramide has a significant drug interaction with probucol.",
    "subjectCQ": "What drug has a significant drug interaction with probucol?",
    "propertyCQ": "What does disopyramide have with probucol?",
    "objectCQ": "Disopyramide has a significant drug interaction with what?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q7739$C62F5C56-77FD-493E-BD6B-D7C343261A8A",
    "theme": "ChemicalCompound",
    "subject_label": "arsenic trioxide",
    "subject_id": "Q7739",
    "subject_description": "pharmaceutical drug",
    "property_label": "significant drug interaction",
    "property_id": "P769",
    "object_label": "escitalopram",
    "object_id": "Q423757",
    "object_description": "antidepressant of the selective serotonin reuptake inhibitor (SSRI) class",
    "context": "Escitalopram has a significant drug interaction with arsenic trioxide.",
    "subjectCQ": "What does Escitalopram have a significant drug interaction with?",
    "propertyCQ": "What does escalopram have with arsenic trioxide?",
    "objectCQ": "What drug has a significant drug interaction with arsenic trioxide?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q1649219$62E5DC41-76B5-4551-82BF-9DB6FE51BD1F",
    "theme": "ChemicalCompound",
    "subject_label": "phendimetrazine",
    "subject_id": "Q1649219",
    "subject_description": "pharmaceutical drug",
    "property_label": "significant drug interaction",
    "property_id": "P769",
    "object_label": "phenelzine",
    "object_id": "Q1747559",
    "object_description": "chemical compound",
    "context": "Phenelzine is a significant drug interaction with phendimetrazine.",
    "subjectCQ": "Phenelzine is a significant drug interaction with what?",
    "propertyCQ": "What is phenelzine?",
    "objectCQ": "What is a significant drug interaction with phendimetrazine?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q6821618$B927277A-9D1A-4E3B-B347-0BA12F882160",
    "theme": "ChemicalCompound",
    "subject_label": "mesoridazine",
    "subject_id": "Q6821618",
    "subject_description": "chemical compound",
    "property_label": "significant drug interaction",
    "property_id": "P769",
    "object_label": "pimozide",
    "object_id": "Q144085",
    "object_description": "chemical compound",
    "context": "Mesoridazine has a significant drug interaction with pimozide.",
    "subjectCQ": "What drug has a significant drug interaction with pimozide?",
    "propertyCQ": "What is the relationship between pimozide and mesoridazine?",
    "objectCQ": "Mesoridazine has a significant drug interaction with what?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q6821618$FA41A5F2-0360-49D7-B01F-6BF24B3888BB",
    "theme": "ChemicalCompound",
    "subject_label": "mesoridazine",
    "subject_id": "Q6821618",
    "subject_description": "chemical compound",
    "property_label": "significant drug interaction",
    "property_id": "P769",
    "object_label": "chlorpromazine",
    "object_id": "Q407972",
    "object_description": "chemical compound",
    "context": "Mesoridazine has a significant drug interaction with chlorpromazine.",
    "subjectCQ": "What drug has a significant drug interaction with chlorpromazine?",
    "propertyCQ": "What does mesoridazine have with chlorpromazine?",
    "objectCQ": "Mesoridazine has a significant drug interaction with what?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q425120$FE2AAC73-CC86-4AB4-ABD9-0E4EAB7C8388",
    "theme": "ChemicalCompound",
    "subject_label": "disopyramide",
    "subject_id": "Q425120",
    "subject_description": "chemical compound",
    "property_label": "significant drug interaction",
    "property_id": "P769",
    "object_label": "astemizole",
    "object_id": "Q423437",
    "object_description": "chemical compound",
    "context": "Astemizole has a significant drug interaction with disopyramide.",
    "subjectCQ": "Astemizole has a significant drug interaction with what?",
    "propertyCQ": "What does astemizole have with disopyramide?",
    "objectCQ": "What drug has a significant drug interaction with disopyramide?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q251347$07FCFB4E-2A00-47F6-A376-F8735376C2E6",
    "theme": "ChemicalCompound",
    "subject_label": "haloperidol",
    "subject_id": "Q251347",
    "subject_description": "chemical compound",
    "property_label": "significant drug interaction",
    "property_id": "P769",
    "object_label": "sparfloxacin",
    "object_id": "Q976559",
    "object_description": "chemical compound",
    "context": "Haloperidol and sparfloxacin are significant drug interactions.",
    "subjectCQ": "What is the name of the drug that is associated with sparfloxacin?",
    "propertyCQ": "What are haloperidol and sparfloxacin?",
    "objectCQ": "Haloperidol and what other drug are significant drug interactions?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q58375$9239CEC0-0773-4722-9045-656A4DCF62A4",
    "theme": "ChemicalCompound",
    "subject_label": "thioridazine",
    "subject_id": "Q58375",
    "subject_description": "chemical compound",
    "property_label": "significant drug interaction",
    "property_id": "P769",
    "object_label": "pimozide",
    "object_id": "Q144085",
    "object_description": "chemical compound",
    "context": "Thioridazine has a significant drug interaction with pimozide.",
    "subjectCQ": "What drug has a significant drug interaction with pimozide?",
    "propertyCQ": "What is the relationship between Thioridazine and pimozide?",
    "objectCQ": "Thioridazine has a significant drug interaction with what?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q58375$798ECADD-A64B-4BE8-8BDA-9FFB0643E18F",
    "theme": "ChemicalCompound",
    "subject_label": "thioridazine",
    "subject_id": "Q58375",
    "subject_description": "chemical compound",
    "property_label": "significant drug interaction",
    "property_id": "P769",
    "object_label": "terfenadine",
    "object_id": "Q417909",
    "object_description": "chemical compound",
    "context": "Thioridazine has a significant drug interaction with terfenadine.",
    "subjectCQ": "What drug has a significant drug interaction with terfenadine?",
    "propertyCQ": "What is the relationship between thioridazine and terfenadine?",
    "objectCQ": "Thioridazine has a significant drug interaction with what?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q7739$3F6915AD-D8B2-4B0C-9AB8-B953BFEEE124",
    "theme": "ChemicalCompound",
    "subject_label": "arsenic trioxide",
    "subject_id": "Q7739",
    "subject_description": "pharmaceutical drug",
    "property_label": "significant drug interaction",
    "property_id": "P769",
    "object_label": "domperidone",
    "object_id": "Q424238",
    "object_description": "peripherally selective dopamine D2 receptor antagonist and is used as an antiemetic, gastroprokinetic agent, and galactagogue",
    "context": "Domperidone is a significant drug interaction with arsenic trioxide.",
    "subjectCQ": "What is Domperidone a significant drug interaction with?",
    "propertyCQ": "What is Domperidone?",
    "objectCQ": "What is a drug that has a significant interaction with arsenic trioxide?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q11498826$3d956cd8-4ab7-a570-bc3c-4114d79f2d1a",
    "theme": "ChemicalCompound",
    "subject_label": "Shikotsu Onsen",
    "subject_id": "Q11498826",
    "subject_description": "building in Hokkaidō Prefecture, Japan",
    "property_label": "located in the administrative territorial entity",
    "property_id": "P131",
    "object_label": "Chitose",
    "object_id": "Q693237",
    "object_description": "city in Hokkaido, Japan",
    "context": "Shikotsu Onsen is located in the administrative territorial entity of Chitose.",
    "subjectCQ": "What is the name of the city in Chitose?",
    "propertyCQ": "Where is Shikotsu Onsen located?",
    "objectCQ": "Shikotsu Onsen is located in what administrative territorial entity?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q3137477$93b70547-4a2b-d6ba-d1ce-57e96ff59ec2",
    "theme": "ChemicalCompound",
    "subject_label": "Kusatsu Onsen",
    "subject_id": "Q3137477",
    "subject_description": "building in Gunma Prefecture, Japan",
    "property_label": "located in the administrative territorial entity",
    "property_id": "P131",
    "object_label": "Kusatsu",
    "object_id": "Q1358949",
    "object_description": "town in Agatsuma district, Gunma prefecture, Japan",
    "context": "Kusatsu Onsen is located in the administrative territorial entity of Kusatsu.",
    "subjectCQ": "What is the name of the entity located in Kusatsu?",
    "propertyCQ": "Where is Kusatsu Onsen located?",
    "objectCQ": "Where is Kusatsu Onsen located?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q11642937$d497f935-4694-3323-db78-67c9b4a28ba6",
    "theme": "ChemicalCompound",
    "subject_label": "那須温泉郷",
    "subject_id": "Q11642937",
    "subject_description": "building in Tochigi Prefecture, Japan",
    "property_label": "located in the administrative territorial entity",
    "property_id": "P131",
    "object_label": "Kantō region",
    "object_id": "Q132480",
    "object_description": "one of 8 regions in Japan encompassing 7 prefectures",
    "context": "那須温泉郷 is located in the administrative territorial entity of the Kantō region.",
    "subjectCQ": "What is the name of the city in the Kanta region?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q11580978$49384a28-45b5-b7d4-ffa9-31794a7ea7be",
    "theme": "ChemicalCompound",
    "subject_label": "Kaike Onsen",
    "subject_id": "Q11580978",
    "subject_description": "building in Tottori Prefecture, Japan",
    "property_label": "located in the administrative territorial entity",
    "property_id": "P131",
    "object_label": "Tottori Prefecture",
    "object_id": "Q133935",
    "object_description": "prefecture of Japan",
    "context": "Kaike Onsen is located in the administrative territorial entity of Tottori Prefecture.",
    "subjectCQ": "What is the name of the town in Tottori Prefecture?",
    "propertyCQ": "Where is Kaike Onsen located?",
    "objectCQ": "What is Kaike Onsen located in?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q908993$c5014ee2-4769-b96f-cc94-87ccda60bea4",
    "theme": "ChemicalCompound",
    "subject_label": "Hakone Onsen",
    "subject_id": "Q908993",
    "subject_description": "onsen",
    "property_label": "located in the administrative territorial entity",
    "property_id": "P131",
    "object_label": "Hakone",
    "object_id": "Q671040",
    "object_description": "town in Ashigarashimo district, Kanagawa prefecture, Japan",
    "context": "Hakone Onsen is located in the administrative territorial entity of Hakone.",
    "subjectCQ": "What is the name of the island located in the administrative territorial entity of Hakone?",
    "propertyCQ": "Where is Hakone Onsen located?",
    "objectCQ": "What is the administrative territorial entity of?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q7849922$bc55b09e-41d1-c86d-6abe-fc69d885c42d",
    "theme": "ChemicalCompound",
    "subject_label": "Tsuchiyu Onsen",
    "subject_id": "Q7849922",
    "subject_description": "building in Fukushima Prefecture, Japan",
    "property_label": "located in the administrative territorial entity",
    "property_id": "P131",
    "object_label": "Fukushima",
    "object_id": "Q161176",
    "object_description": "city in Fukushima prefecture, Japan",
    "context": "Tsuchiyu Onsen is located in the administrative territorial entity of Fukushima.",
    "subjectCQ": "What is the name of the city located in Fukushima?",
    "propertyCQ": "Where is Tsuchiyu Onsen located?",
    "objectCQ": "Where is Tsuchiyu Onsen located?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q11645764$83b7b66c-4068-d05e-b6ab-942caff3281c",
    "theme": "ChemicalCompound",
    "subject_label": "Nozawa Onsen",
    "subject_id": "Q11645764",
    "subject_description": "building in Nagano Prefecture, Japan",
    "property_label": "located in the administrative territorial entity",
    "property_id": "P131",
    "object_label": "Nozawaonsen",
    "object_id": "Q1354760",
    "object_description": "village in Shimotakai district, Nagano prefecture, Japan",
    "context": "Nozawa Onsen is located in the administrative territorial entity of Nozawaonsen.",
    "subjectCQ": "What is the name of the island located in the administrative territorial entity of Nozawaonsen?",
    "propertyCQ": "Where is Nozawa Onsen located?",
    "objectCQ": "What is the administrative territorial entity of?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q11563450$db1ae6b7-43c3-3911-bccd-0802b2b415c2",
    "theme": "ChemicalCompound",
    "subject_label": "湯ヶ島温泉",
    "subject_id": "Q11563450",
    "subject_description": "building in Shizuoka Prefecture, Japan",
    "property_label": "located in the administrative territorial entity",
    "property_id": "P131",
    "object_label": "Shizuoka Prefecture",
    "object_id": "Q131320",
    "object_description": "prefecture of Japan",
    "context": "湯ヶ島温泉 is located in the administrative territorial entity of Shizuoka Prefecture.",
    "subjectCQ": "What is the name of the city in Shizuoka Prefecture?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q11356664$9ce1fd32-4e66-50a7-612a-367a4fab7aa8",
    "theme": "ChemicalCompound",
    "subject_label": "三瓶温泉",
    "subject_id": "Q11356664",
    "subject_description": "building in Shimane Prefecture, Japan",
    "property_label": "located in the administrative territorial entity",
    "property_id": "P131",
    "object_label": "Shimane Prefecture",
    "object_id": "Q132751",
    "object_description": "prefecture of Japan",
    "context": "三瓶温泉 is located in the administrative territorial entity of Shimane Prefecture.",
    "subjectCQ": "What is the name of the city in Shimane Prefecture?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q28692475$0b54a8e9-478d-1877-264f-e6737052f997",
    "theme": "ChemicalCompound",
    "subject_label": "海津温泉",
    "subject_id": "Q28692475",
    "subject_description": "building in Gifu Prefecture, Japan",
    "property_label": "located in the administrative territorial entity",
    "property_id": "P131",
    "object_label": "Kaizu",
    "object_id": "Q844056",
    "object_description": "city in Gifu Prefecture, Japan",
    "context": "海津温泉 is located in the administrative territorial entity of Kaizu.",
    "subjectCQ": "What is the name of the <unk>?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q11585331$c5660343-46d6-907c-d8d1-910018cfc71b",
    "theme": "ChemicalCompound",
    "subject_label": "石和温泉",
    "subject_id": "Q11585331",
    "subject_description": "building in Yamanashi Prefecture, Japan",
    "property_label": "located in the administrative territorial entity",
    "property_id": "P131",
    "object_label": "Kōshin'etsu region",
    "object_id": "Q398208",
    "object_description": "no-desc",
    "context": "石和温泉 is located in the administrative territorial entity of the Kōshin'etsu region.",
    "subjectCQ": "What is the name of the city located in the administrative territorial entity of the K<unk>shin'etsu region?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q11572001$15cb8257-4087-e097-e04e-3be38c30797b",
    "theme": "ChemicalCompound",
    "subject_label": "猫啼温泉",
    "subject_id": "Q11572001",
    "subject_description": "no-desc",
    "property_label": "located in the administrative territorial entity",
    "property_id": "P131",
    "object_label": "Ishikawa",
    "object_id": "Q1205335",
    "object_description": "town in Ishikawa district, Fukushima prefecture, Japan",
    "context": "猫啼温泉 is located in the administrative territorial entity of Ishikawa.",
    "subjectCQ": "What is the name of the city located in Ishikawa?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q421930$B4D0388E-A3D1-4497-AFB4-722A26C4451B",
    "theme": "ChemicalCompound",
    "subject_label": "mirtazapine",
    "subject_id": "Q421930",
    "subject_description": "Antidepressant",
    "property_label": "physically interacts with",
    "property_id": "P129",
    "object_label": "Adrenoceptor alpha 2A",
    "object_id": "Q4734892",
    "object_description": "mammalian protein found in Homo sapiens",
    "context": "Mirtazapine interacts physically with Adrenoceptor alpha 2A.",
    "subjectCQ": "What drug interacts with Adrenoceptor alpha 2A?",
    "propertyCQ": "How does Mirtazapine interact with Adrenoceptor alpha 2A?",
    "objectCQ": "What does Mirtazapine interact with?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q4646881$25011DE2-19C8-46F8-A49E-8E01F9A4AF2E",
    "theme": "ChemicalCompound",
    "subject_label": "A-68930",
    "subject_id": "Q4646881",
    "subject_description": "chemical compound",
    "property_label": "physically interacts with",
    "property_id": "P129",
    "object_label": "Dopamine receptor D5",
    "object_id": "Q21131500",
    "object_description": "mammalian protein found in Homo sapiens",
    "context": "A-68930 interacts physically with the Dopamine receptor D5.",
    "subjectCQ": "What is the name of the molecule that interacts with the Dopamine receptor D5?",
    "propertyCQ": "How does A-68930 interact with the Dopamine receptor?",
    "objectCQ": "What does A-68930 interact with?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q407426$0B052587-DAE3-444B-82EC-941109DA7CB1",
    "theme": "ChemicalCompound",
    "subject_label": "linoleic acid",
    "subject_id": "Q407426",
    "subject_description": "chemical compound and essential nutrient",
    "property_label": "physically interacts with",
    "property_id": "P129",
    "object_label": "Potassium voltage-gated channel subfamily B member 1",
    "object_id": "Q21107884",
    "object_description": "mammalian protein found in Homo sapiens",
    "context": "Linoleic acid physically interacts with Potassium voltage-gated channel subfamily B member 1.",
    "subjectCQ": "What chemical is involved in the Potassium voltage-gated channel subfamily B member 1?",
    "propertyCQ": "How does linoleic acid interact with Potassium voltage-gated channel subfamily B member 1?",
    "objectCQ": "What does linoleic acid physically interact with?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q12745785$6FA01608-3EE1-4FD9-8DB9-0EEBEF23A5EF",
    "theme": "ChemicalCompound",
    "subject_label": "lorglumide",
    "subject_id": "Q12745785",
    "subject_description": "chemical compound",
    "property_label": "physically interacts with",
    "property_id": "P129",
    "object_label": "Cholecystokinin B receptor",
    "object_id": "Q21110901",
    "object_description": "mammalian protein found in Homo sapiens",
    "context": "Lorglumide interacts physically with the Cholecystokinin B receptor.",
    "subjectCQ": "What is the name of the substance that interacts with the Cholecystokinin B receptor?",
    "propertyCQ": "How does Lorglumide interact with the Cholecystokinin B receptor?",
    "objectCQ": "What does Lorglumide interact with?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q6085784$B1EB45DF-2450-430D-9FE9-FB260CF8970C",
    "theme": "ChemicalCompound",
    "subject_label": "isoguvacine",
    "subject_id": "Q6085784",
    "subject_description": "chemical compound",
    "property_label": "physically interacts with",
    "property_id": "P129",
    "object_label": "Gamma-aminobutyric acid type A receptor subunit alpha4",
    "object_id": "Q5512777",
    "object_description": "mammalian protein found in Homo sapiens",
    "context": "The isoguvacine interacts with the Gamma-aminobutyric acid type A receptor subunit alpha4.",
    "subjectCQ": "What is the name of the drug that interacts with the receptor?",
    "propertyCQ": "How does isoguvacine interact with the receptor subunit alpha4?",
    "objectCQ": "What does isoguvacine interact with?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q4652514$477C2956-455B-4D29-8B35-97DECA036EDE",
    "theme": "ChemicalCompound",
    "subject_label": "AM-251",
    "subject_id": "Q4652514",
    "subject_description": "chemical compound",
    "property_label": "physically interacts with",
    "property_id": "P129",
    "object_label": "G protein-coupled receptor 55",
    "object_id": "Q21110942",
    "object_description": "mammalian protein found in Homo sapiens",
    "context": "AM-251 interacts physically with the G protein-coupled receptor 55.",
    "subjectCQ": "What is the name of the protein that interacts with the G protein-coupled receptor 55?",
    "propertyCQ": "How does AM-251 interact with the G protein-coupled receptor 55?",
    "objectCQ": "What does AM-251 interact with?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q384295$6409B2EF-6398-4B2E-A9D1-8D3AEFF0ABA2",
    "theme": "ChemicalCompound",
    "subject_label": "gemfibrozil",
    "subject_id": "Q384295",
    "subject_description": "chemical compound",
    "property_label": "physically interacts with",
    "property_id": "P129",
    "object_label": "Solute carrier organic anion transporter family member 1B3",
    "object_id": "Q21125248",
    "object_description": "mammalian protein found in Homo sapiens",
    "context": "Gemfibrozil interacts physically with the Solute carrier organic anion transporter family member 1B3.",
    "subjectCQ": "What substance interacts with the Solute carrier organic anion transporter family member 1B3?",
    "propertyCQ": "How does Gemfibrozil interact with the Solute carrier organic anion transporter family member 1B3?",
    "objectCQ": "Gemfibrozil interacts physically with what?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q417240$6942C98F-4B2A-4ABC-8577-F76EB29F730C",
    "theme": "ChemicalCompound",
    "subject_label": "atomoxetine",
    "subject_id": "Q417240",
    "subject_description": "chemical compound",
    "property_label": "physically interacts with",
    "property_id": "P129",
    "object_label": "Solute carrier family 6 member 3",
    "object_id": "Q2271947",
    "object_description": "mammalian protein found in Homo sapiens",
    "context": "Atomoxetine physically interacts with Solute carrier family 6 member 3.",
    "subjectCQ": "What chemical is involved in Solute carrier family 6 member 3?",
    "propertyCQ": "How does Atomoxetine interact with Solute carrier family 6 member 3?",
    "objectCQ": "Atomoxetine physically interacts with what?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q7784686$23C9576D-0665-42E4-B905-78BFD67D7C61",
    "theme": "ChemicalCompound",
    "subject_label": "thioperamide",
    "subject_id": "Q7784686",
    "subject_description": "chemical compound",
    "property_label": "physically interacts with",
    "property_id": "P129",
    "object_label": "Histamine receptor H3",
    "object_id": "Q288395",
    "object_description": "mammalian protein found in Homo sapiens",
    "context": "Thioperamide interacts physically with histamine receptor H3.",
    "subjectCQ": "What is the name of the drug that interacts with the histamine receptor?",
    "propertyCQ": "How does thioperamide interact with histamine receptor H3?",
    "objectCQ": "Thioperamide interacts physically with what?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q407426$64455096-FE27-4691-8BB8-E89AF291DBF4",
    "theme": "ChemicalCompound",
    "subject_label": "linoleic acid",
    "subject_id": "Q407426",
    "subject_description": "chemical compound and essential nutrient",
    "property_label": "physically interacts with",
    "property_id": "P129",
    "object_label": "Hepatocyte nuclear factor 4 alpha",
    "object_id": "Q21114166",
    "object_description": "mammalian protein found in Homo sapiens",
    "context": "Linoleic acid interacts physically with the Hepatocyte nuclear factor 4 alpha.",
    "subjectCQ": "What chemical is involved in the Hepatocyte nuclear factor 4 alpha?",
    "propertyCQ": "How does linoleic acid interact with the Hepatocyte nuclear factor 4 alpha?",
    "objectCQ": "What does linoleic acid interact with?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q6004821$0060844F-7043-461B-80D7-AE9D294BCE73",
    "theme": "ChemicalCompound",
    "subject_label": "Immepip",
    "subject_id": "Q6004821",
    "subject_description": "chemical compound",
    "property_label": "physically interacts with",
    "property_id": "P129",
    "object_label": "Histamine receptor H3",
    "object_id": "Q288395",
    "object_description": "mammalian protein found in Homo sapiens",
    "context": "Immepip interacts physically with the Histamine receptor H3.",
    "subjectCQ": "What drug interacts with the H3 receptor?",
    "propertyCQ": "How does Immepip interact with the Histamine receptor?",
    "objectCQ": "What does Immepip interact with?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q223068$A9BC1F9C-1122-4972-A2C4-F9D1DB42A472",
    "theme": "ChemicalCompound",
    "subject_label": "3-quinuclidinyl-benzilate",
    "subject_id": "Q223068",
    "subject_description": "chemical compound",
    "property_label": "physically interacts with",
    "property_id": "P129",
    "object_label": "Cholinergic receptor muscarinic 4",
    "object_id": "Q4847907",
    "object_description": "mammalian protein found in Homo sapiens",
    "context": "3-quinuclidinyl-benzilate interacts physically with the Cholinergic receptor muscarinic 4.",
    "subjectCQ": "What is the name of the chemical that interacts with the Cholinergic receptor muscarinic 4?",
    "propertyCQ": "How does 3-quinuclidinyl-benzilate interact with the Cholinergic receptor?",
    "objectCQ": "What does 3-quinuclidinyl-benzilate interact with?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q251347$F8E3B9A9-4CA9-4FB7-B17E-B0011776B7CB",
    "theme": "ChemicalCompound",
    "subject_label": "haloperidol",
    "subject_id": "Q251347",
    "subject_description": "chemical compound",
    "property_label": "medical condition treated",
    "property_id": "P2175",
    "object_label": "anxiety",
    "object_id": "Q154430",
    "object_description": "unpleasant complex combination of emotions that includes fear, apprehension and worry, and is often accompanied by physical sensations such as palpitations, nausea, chest pain and/or shortness of breath",
    "context": "Haloperidol is a medical condition treated with anxiety.",
    "subjectCQ": "What is a medical condition treated with anxiety?",
    "propertyCQ": "What is haloperidol?",
    "objectCQ": "What is Haloperidol treated with?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q411325$DD0AB3BE-852C-48CC-B03D-E6C1FCF73436",
    "theme": "ChemicalCompound",
    "subject_label": "atenolol",
    "subject_id": "Q411325",
    "subject_description": "beta blocker medication primarily used to treat high blood pressure",
    "property_label": "medical condition treated",
    "property_id": "P2175",
    "object_label": "ventricular fibrillation",
    "object_id": "Q848662",
    "object_description": "disorganized electrical activity in the ventricles. It is a type of cardiac arrhythmia Ventricular fibrillation results in cardiac arrest",
    "context": "Atenolol is used to treat ventricular fibrillation.",
    "subjectCQ": "What is used to treat ventricular fibrillation?",
    "propertyCQ": "What is ventricular fibrillation?",
    "objectCQ": "What is Atenolol used to treat?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q241150$1B3561EB-FECB-461E-B024-4C0C58AE8FE7",
    "theme": "ChemicalCompound",
    "subject_label": "aminoglutethimide",
    "subject_id": "Q241150",
    "subject_description": "chemical compound",
    "property_label": "medical condition treated",
    "property_id": "P2175",
    "object_label": "breast cancer",
    "object_id": "Q128581",
    "object_description": "cancer that originates in the mammary gland",
    "context": "The medical condition of breast cancer is treated with aminoglutethimide.",
    "subjectCQ": "What is used to treat breast cancer?",
    "propertyCQ": "What is aminoglutethimide used for?",
    "objectCQ": "What is treated with aminoglutethimide?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q417555$476547F5-383E-4248-A622-57AC32A6898C",
    "theme": "ChemicalCompound",
    "subject_label": "teniposide",
    "subject_id": "Q417555",
    "subject_description": "chemical compound",
    "property_label": "medical condition treated",
    "property_id": "P2175",
    "object_label": "lymphoblastic leukemia",
    "object_id": "Q18553852",
    "object_description": "leukemia that has material basis in lymphoblasts (immature white blood cells)",
    "context": "Teniposide is a medical condition treated by lymphoblastic leukemia.",
    "subjectCQ": "What is a medical condition treated by lymphoblastic leukemia?",
    "propertyCQ": "What is teniposide?",
    "objectCQ": "What is the medical condition that treats teniposide?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q408471$733B240F-0A0E-4FC7-9471-79B6B13A12AD",
    "theme": "ChemicalCompound",
    "subject_label": "paroxetine",
    "subject_id": "Q408471",
    "subject_description": "pharmaceutical drug",
    "property_label": "medical condition treated",
    "property_id": "P2175",
    "object_label": "anxiety disorder",
    "object_id": "Q544006",
    "object_description": "cognitive disorder with an excessive, irrational dread of everyday situations",
    "context": "Anxiety disorder is a medical condition treated with paroxetine.",
    "subjectCQ": "What is anxiety disorder treated with?",
    "propertyCQ": "What is anxiety disorder?",
    "objectCQ": "What is a medical condition treated with paroxetine?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q244150$471F7BDB-B7F2-41BB-B2AB-C6785187B7F9",
    "theme": "ChemicalCompound",
    "subject_label": "ampicillin",
    "subject_id": "Q244150",
    "subject_description": "chemical compound",
    "property_label": "medical condition treated",
    "property_id": "P2175",
    "object_label": "staphylococcal infection",
    "object_id": "Q34879",
    "object_description": "human disease",
    "context": "The medical condition of ampicillin is staphylococcal infection.",
    "subjectCQ": "What is staphylococcal infection?",
    "propertyCQ": "What is staphylococcal infection?",
    "objectCQ": "What is the medical condition of ampicillin?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q412443$3B7D6613-B4F6-4A70-8442-36B00023FB13",
    "theme": "ChemicalCompound",
    "subject_label": "risperidone",
    "subject_id": "Q412443",
    "subject_description": "chemical compound",
    "property_label": "medical condition treated",
    "property_id": "P2175",
    "object_label": "oppositional defiant disorder",
    "object_id": "Q1328833",
    "object_description": "human disorder involving hostility and defiance",
    "context": "Risperidone is used to treat the oppositional defiant disorder.",
    "subjectCQ": "What is used to treat oppositional defiant disorder?",
    "propertyCQ": "What is oppositional defiant disorder?",
    "objectCQ": "What is Risperidone used to treat?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q3151081$3843CB4B-DC4D-4D70-B4A9-5C52B4AEA42C",
    "theme": "ChemicalCompound",
    "subject_label": "filgrastim",
    "subject_id": "Q3151081",
    "subject_description": "pharmaceutical drug",
    "property_label": "medical condition treated",
    "property_id": "P2175",
    "object_label": "acute myeloid leukemia",
    "object_id": "Q264118",
    "object_description": "myeloid leukemia that is characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells",
    "context": "The medical condition of filgrastim is acute myeloid leukemia.",
    "subjectCQ": "What is the medical condition of acute myeloid leukemia?",
    "propertyCQ": "What is filgrastim?",
    "objectCQ": "What is the medical condition of filgrastim?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q3896970$A5EFFD11-740B-4610-A93F-E0A37E82C1EE",
    "theme": "ChemicalCompound",
    "subject_label": "Pasireotide",
    "subject_id": "Q3896970",
    "subject_description": "pharmaceutical drug",
    "property_label": "medical condition treated",
    "property_id": "P2175",
    "object_label": "pituitary-dependent Cushing's disease",
    "object_id": "Q11312280",
    "object_description": "Human disease",
    "context": "Pasireotide is a medical condition treated with pituitary-dependent Cushing's disease.",
    "subjectCQ": "What is the name of the condition that is treated with Cushing's disease?",
    "propertyCQ": "What is Pasireotide?",
    "objectCQ": "What is the medical condition Pasireotide treated with?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q413762$285B2A0D-4BB3-4282-BFC6-45D875B414F1",
    "theme": "ChemicalCompound",
    "subject_label": "Hyoscyamine",
    "subject_id": "Q413762",
    "subject_description": "pharmaceutical drug",
    "property_label": "medical condition treated",
    "property_id": "P2175",
    "object_label": "tremor",
    "object_id": "Q223907",
    "object_description": "involuntary muscle contraction",
    "context": "Hyoscyamine is used to treat tremors.",
    "subjectCQ": "What is used to treat tremors?",
    "propertyCQ": "What is hyoscyamine used for?",
    "objectCQ": "What is hyoscyamine used to treat?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q425386$6DFA3706-C19A-48A7-A346-852A3EBB30B3",
    "theme": "ChemicalCompound",
    "subject_label": "dyclonine",
    "subject_id": "Q425386",
    "subject_description": "chemical compound",
    "property_label": "medical condition treated",
    "property_id": "P2175",
    "object_label": "pain",
    "object_id": "Q81938",
    "object_description": "type of unpleasant feeling",
    "context": "Dyclonine is used to treat pain.",
    "subjectCQ": "What is used to treat pain?",
    "propertyCQ": "What is Dyclonine used for?",
    "objectCQ": "What is Dyclonine used to treat?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q408283$5A1E4860-1A87-4D3F-8E91-C77C626C3D2E",
    "theme": "ChemicalCompound",
    "subject_label": "denosumab",
    "subject_id": "Q408283",
    "subject_description": "pharmaceutical drug",
    "property_label": "medical condition treated",
    "property_id": "P2175",
    "object_label": "rare breast tumor",
    "object_id": "Q55785783",
    "object_description": "no-desc",
    "context": "Denosumab is used to treat a rare breast tumor.",
    "subjectCQ": "What is used to treat a rare breast tumor?",
    "propertyCQ": "What is Denosumab used for?",
    "objectCQ": "What is Denosumab used to treat?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q56047788$7C37FFB7-792B-455F-8F53-10E5713902BC",
    "theme": "ChemicalCompound",
    "subject_label": "Pharmacology of MDMA in Humans",
    "subject_id": "Q56047788",
    "subject_description": "scientific article published on 01 September 2000",
    "property_label": "author name string",
    "property_id": "P2093",
    "object_label": "de la Torre R",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The author name of Pharmacology of MDMA in Humans is de la Torre R.",
    "subjectCQ": "What is the author name of?",
    "propertyCQ": "What is the author name of Pharmacology of MDMA in Humans?",
    "objectCQ": "What is the author name of Pharmacology of MDMA in Humans?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q37351168$E598875E-3749-4D73-9E7B-BE2A518715A2",
    "theme": "ChemicalCompound",
    "subject_label": "The high prevalence of substance use disorders among recent MDMA users compared with other drug users: Implications for intervention.",
    "subject_id": "Q37351168",
    "subject_description": "scientific article published on April 2009",
    "property_label": "author name string",
    "property_id": "P2093",
    "object_label": "Andy C Parrott",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The high prevalence of substance use disorders among recent MDMA users compared with other drug users: Implications for intervention. The author name is Andy C Parrott.",
    "subjectCQ": "What is the impact of MDMA on the patient?",
    "propertyCQ": "What is Andy C Parrott's last name?",
    "objectCQ": "Who is the author of this article?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q40940013$6BD007D2-479D-4A47-B291-8D5A8B937B16",
    "theme": "ChemicalCompound",
    "subject_label": "Involvement of NMDA glutamate receptors in the acquisition and reinstatement of the conditioned place preference induced by MDMA.",
    "subject_id": "Q40940013",
    "subject_description": "scientific article published on August 2015",
    "property_label": "author name string",
    "property_id": "P2093",
    "object_label": "Carla Escobar-Valero",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Involvement of NMDA glutamate receptors in the acquisition and reinstatement of the conditioned place preference induced by MDMA. The author name is Carla Escobar-Valero.",
    "subjectCQ": "What is the main purpose of the study?",
    "propertyCQ": "What is the author name of the study?",
    "objectCQ": "Who is the author of this study?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q93921863$CAF40CF3-3F0B-4986-A4F1-EA920F419D71",
    "theme": "ChemicalCompound",
    "subject_label": "Toxic effect of MDMA on brain serotonin neurons",
    "subject_id": "Q93921863",
    "subject_description": "no-desc",
    "property_label": "author name string",
    "property_id": "P2093",
    "object_label": "A Klugman",
    "object_id": "",
    "object_description": "no-desc",
    "context": "A Klugman is the author of Toxic effect of MDMA on brain serotonin neurons.",
    "subjectCQ": "What is the name of the book written by A. Klugman?",
    "propertyCQ": "What is the author name of the book?",
    "objectCQ": "Who is the author of Toxic effect of MDMA on brain serotonin neurons?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q47731855$1BB44EA1-6BF9-4FC9-A721-4E6863AEBC00",
    "theme": "ChemicalCompound",
    "subject_label": "Oxytocin and MDMA ('Ecstasy') enhance social reward in rats.",
    "subject_id": "Q47731855",
    "subject_description": "scientific article published on 15 March 2015",
    "property_label": "author name string",
    "property_id": "P2093",
    "object_label": "Alex Caminer",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Oxytocin and MDMA ('Ecstasy') enhance social reward in rats. The author name is Alex Caminer.",
    "subjectCQ": "What does the author name of the book be?",
    "propertyCQ": "What is the author name of the book?",
    "objectCQ": "What is the author name of Ecstasy?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q43118935$DD04D2AE-C587-45F6-9A1C-9E9286981C93",
    "theme": "ChemicalCompound",
    "subject_label": "Factor structure of the Chinese version of the University of Rhode Island change assessment in Taiwanese adolescents who abuse MDMA or methamphetamine.",
    "subject_id": "Q43118935",
    "subject_description": "scientific article published in March 2010",
    "property_label": "author name string",
    "property_id": "P2093",
    "object_label": "Ya-Shune Huang",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Ya-Shune Huang is the author of Factor structure of the Chinese version of the University of Rhode Island change assessment in Taiwanese adolescents who abuse MDMA or methamphetamine.",
    "subjectCQ": "What is Ya-Shune Huang's work?",
    "propertyCQ": "What is the author name of the book?",
    "objectCQ": "Who is the author of Factor structure of the Chinese version of the University of Rhode Island change assessment?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q28365378$9984ED04-3A7A-4082-9F00-C6412B3AFC9E",
    "theme": "ChemicalCompound",
    "subject_label": "In vitro neuronal and vascular responses to 5-HT in rats chronically exposed to MDMA",
    "subject_id": "Q28365378",
    "subject_description": "scientific article",
    "property_label": "author name string",
    "property_id": "P2093",
    "object_label": "G J McBean",
    "object_id": "",
    "object_description": "no-desc",
    "context": "G J McBean is the author of In vitro neuronal and vascular responses to 5-HT in rats chronically exposed to MDMA.",
    "subjectCQ": "What is McBean's book about?",
    "propertyCQ": "What is the name of the author of In vitro neuronal and vascular responses to 5-HT in rats chronically exposed to MDMA?",
    "objectCQ": "Who is the author of In vitro neuronal and vascular responses to 5-HT in rats chronically exposed to MDMA?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q43291477$2AA30705-CC74-4311-8561-943208AB5B2F",
    "theme": "ChemicalCompound",
    "subject_label": "Chronic exposure to MDMA (ecstasy) increases DNA damage in sperm and alters testes histopathology in male rats.",
    "subject_id": "Q43291477",
    "subject_description": "scientific article published on 13 August 2009",
    "property_label": "author name string",
    "property_id": "P2093",
    "object_label": "Miguel Rodamilans",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The author name of the book is Miguel Rodamilans and the exposure to MDMA (ecstasy) increases DNA damage in sperm and alters testes histopathology in male rats.",
    "subjectCQ": "What is the main effect of MDMA on sperm?",
    "propertyCQ": "What is the author name of the book?",
    "objectCQ": "What is the author name of the book?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q51807530$EFB11733-6D18-4FAF-9C8E-BCFC78011397",
    "theme": "ChemicalCompound",
    "subject_label": "Effects of MDMA (ecstasy) and two of its metabolites on rat embryos in vitro.",
    "subject_id": "Q51807530",
    "subject_description": "scientific article published on 27 February 2012",
    "property_label": "author name string",
    "property_id": "P2093",
    "object_label": "J M Llobet",
    "object_id": "",
    "object_description": "no-desc",
    "context": "J M Llobet is the author of Effects of MDMA (ecstasy) and two of its metabolites on rat embryos in vitro.",
    "subjectCQ": "What is the name of the book that J M Llobet is the author of?",
    "propertyCQ": "What is the name of the author of Effects of MDMA?",
    "objectCQ": "Who is the author of Effects of MDMA and two of its metabolites on rat embryos in vitro?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q37392237$71D5A59E-F9F1-4B4C-8331-314BE1E4A4BF",
    "theme": "ChemicalCompound",
    "subject_label": "Effects of MDMA, methamphetamine and methylphenidate on repeated acquisition and performance in rats.",
    "subject_id": "Q37392237",
    "subject_description": "scientific article published on 19 September 2009",
    "property_label": "author name string",
    "property_id": "P2093",
    "object_label": "P McKinney",
    "object_id": "",
    "object_description": "no-desc",
    "context": "P McKinney is the author of Effects of MDMA, methamphetamine and methylphenidate on repeated acquisition and performance in rats.",
    "subjectCQ": "What is McKinney's book about?",
    "propertyCQ": "What is the author name of the book?",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q58283924$D14FE1A0-40A1-46F1-BA94-31F14982E28C",
    "theme": "ChemicalCompound",
    "subject_label": "Validating the Consumption of Mdma (3,4- Methylenedioxymethamphetamine) in an Examination of the Behavioural Effects of “Ecstasy” Amongst Recreational Users",
    "subject_id": "Q58283924",
    "subject_description": "no-desc",
    "property_label": "author name string",
    "property_id": "P2093",
    "object_label": "Kim Wolff",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Kim Wolff is the author of \"Validating the Consumption of Mdma (3,4- Methylenedioxymethamphetamine) in an Examination of the Behavioural Effects of \"Ecstasy\" Amongst Recreational Users\".",
    "subjectCQ": "What is the title of Kim Wolff's book?",
    "propertyCQ": "What is the name of Kim Wolff?",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q44471968$411BF350-8EBE-4DFC-A6C6-88A1623E8B6E",
    "theme": "ChemicalCompound",
    "subject_label": "3,4-Methylenedioxymethamphetamine (MDMA) abuse may cause oxidative stress and potential free radical damage.",
    "subject_id": "Q44471968",
    "subject_description": "scientific article",
    "property_label": "author name string",
    "property_id": "P2093",
    "object_label": "Liang Zhang",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Liang Zhang is the author of 3,4-Methylenedioxymethamphetamine (MDMA), which can cause oxidative stress and potential free radical damage.",
    "subjectCQ": "What is the main danger of MDMA?",
    "propertyCQ": "What is the name of the author of MDMA?",
    "objectCQ": "Who is the author of MDMA?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q1810456$FAAE10C4-BBEA-49BA-95E6-8465C31D73CE",
    "theme": "ChemicalCompound",
    "subject_label": "Carbadox",
    "subject_id": "Q1810456",
    "subject_description": "chemical compound",
    "property_label": "subject has role",
    "property_id": "P2868",
    "object_label": "mutagen",
    "object_id": "Q221696",
    "object_description": "chemical agent that increases the rate of genetic mutation by interfering with the function of nucleic acids",
    "context": "Carbadox is a mutagen.",
    "subjectCQ": "What is a mutagen?",
    "propertyCQ": "What is the role of the subject?",
    "objectCQ": "What is carbadox?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q21099650$3FBB8134-BDA3-4DF9-9368-A42D6FB7987C",
    "theme": "ChemicalCompound",
    "subject_label": "1-hydroxypyrene",
    "subject_id": "Q21099650",
    "subject_description": "chemical compound",
    "property_label": "subject has role",
    "property_id": "P2868",
    "object_label": "mutagen",
    "object_id": "Q221696",
    "object_description": "chemical agent that increases the rate of genetic mutation by interfering with the function of nucleic acids",
    "context": "1-hydroxypyrene is a mutagen.",
    "subjectCQ": "What is a mutagen?",
    "propertyCQ": "What is the role of the subject?",
    "objectCQ": "What is 1-hydroxypyrene?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27075614$7E192F17-F8AA-4ED1-9595-7FC8F5283486",
    "theme": "ChemicalCompound",
    "subject_label": "3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate",
    "subject_id": "Q27075614",
    "subject_description": "chemical compound",
    "property_label": "subject has role",
    "property_id": "P2868",
    "object_label": "platelet aggregation inhibitors",
    "object_id": "Q721432",
    "object_description": "class of pharmaceuticals that decrease platelet aggregation and inhibit thrombus formation",
    "context": "3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate is a subject that has a role as platelet aggregation inhibitors.",
    "subjectCQ": "What is a subject that has a role as platelet aggregation inhibitors?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q421475$C6CF0FC0-3FAD-49A7-9614-1D454D98E5D9",
    "theme": "ChemicalCompound",
    "subject_label": "beclomethasone dipropionate",
    "subject_id": "Q421475",
    "subject_description": "chemical compound",
    "property_label": "subject has role",
    "property_id": "P2868",
    "object_label": "anti-inflammatory agent",
    "object_id": "Q581996",
    "object_description": "substance that reduces or suppresses inflammation",
    "context": "Beclomethasone dipropionate is an anti-inflammatory agent.",
    "subjectCQ": "What is an anti-inflammatory agent?",
    "propertyCQ": "What is the role of the subject?",
    "objectCQ": "What is beclomethasone dipropionate?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q414873$60554B6B-6A86-4E53-B712-B7FA6FB9ED93",
    "theme": "ChemicalCompound",
    "subject_label": "isradipine",
    "subject_id": "Q414873",
    "subject_description": "chemical compound",
    "property_label": "subject has role",
    "property_id": "P2868",
    "object_label": "vasodilator agent",
    "object_id": "Q4008956",
    "object_description": "drug used to cause dilation of the blood vessels",
    "context": "Isradipine is a vasodilator agent.",
    "subjectCQ": "What is a vasodilator agent?",
    "propertyCQ": "What is the role of the subject?",
    "objectCQ": "What is isradipine?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q425097$472ED0E9-57F4-4999-97C5-9CC160F182E1",
    "theme": "ChemicalCompound",
    "subject_label": "acepromazine",
    "subject_id": "Q425097",
    "subject_description": "chemical compound",
    "property_label": "subject has role",
    "property_id": "P2868",
    "object_label": "antipsychotics",
    "object_id": "Q208144",
    "object_description": "class of medications",
    "context": "Acepromazine has a role in antipsychotics.",
    "subjectCQ": "What is a drug that has a role in antipsychotics?",
    "propertyCQ": "What does acepromazine do?",
    "objectCQ": "What is Acepromazine used for?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q10861380$9503B5E1-7ADC-436F-9984-5588BAE3E047",
    "theme": "ChemicalCompound",
    "subject_label": "Sudan Black B",
    "subject_id": "Q10861380",
    "subject_description": "chemical compound",
    "property_label": "subject has role",
    "property_id": "P2868",
    "object_label": "dye",
    "object_id": "Q189720",
    "object_description": "soluble chemical substance or natural material which can impart color to other materials",
    "context": "The subject of Sudan Black B has a role in the use of dye.",
    "subjectCQ": "What is the name of the subject that plays a role in the use of dye?",
    "propertyCQ": "What does Sudan Black B have in the use of dye?",
    "objectCQ": "What does Sudan Black B have a role in?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q5210829$8B9F8E35-3C7C-4FC0-8851-EA8338A11A9D",
    "theme": "ChemicalCompound",
    "subject_label": "dalfopristin",
    "subject_id": "Q5210829",
    "subject_description": "chemical compound",
    "property_label": "subject has role",
    "property_id": "P2868",
    "object_label": "antibiotic",
    "object_id": "Q12187",
    "object_description": "drug used in the treatment and prevention of bacterial infections",
    "context": "Dalfopristin is an antibiotic.",
    "subjectCQ": "What is an antibiotic?",
    "propertyCQ": "What is the role of the subject?",
    "objectCQ": "What is Dalfopristin?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q423538$810D334E-1C38-4C1E-A783-7AE2A543D9EE",
    "theme": "ChemicalCompound",
    "subject_label": "tizanidine",
    "subject_id": "Q423538",
    "subject_description": "Muscle relaxant medication",
    "property_label": "subject has role",
    "property_id": "P2868",
    "object_label": "central muscle relaxants",
    "object_id": "Q50430093",
    "object_description": "heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents",
    "context": "Tizanidine is a central muscle relaxant.",
    "subjectCQ": "What is a central muscle relaxant?",
    "propertyCQ": "What is the role of Tizanidine?",
    "objectCQ": "What is Tizanidine?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27251372$01583169-AD85-46BD-99E9-ECD6A4DF39EA",
    "theme": "ChemicalCompound",
    "subject_label": "picumast",
    "subject_id": "Q27251372",
    "subject_description": "chemical compound",
    "property_label": "subject has role",
    "property_id": "P2868",
    "object_label": "H1 antagonist",
    "object_id": "Q1328275",
    "object_description": "drugs that block the action of histamine at the H1 receptor helping to relieve allergic reactions",
    "context": "H1 antagonist is a role in picumast.",
    "subjectCQ": "What is H1 antagonist a role in?",
    "propertyCQ": "What is H1 antagonist?",
    "objectCQ": "What is a role in picumast?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q2013780$9B5F422C-70C0-42B7-92E6-3BF025C2259B",
    "theme": "ChemicalCompound",
    "subject_label": "Ocrelizumab",
    "subject_id": "Q2013780",
    "subject_description": "anti-CD20 monoclonal antibody under development for treatment of B cell leukemia and multiple sclerosis",
    "property_label": "subject has role",
    "property_id": "P2868",
    "object_label": "immunologic factor",
    "object_id": "Q50349184",
    "object_description": "biologically active substance whose activities affects or plays a role in the functioning of the immune system",
    "context": "Ocrelizumab has a role in the immunologic factor.",
    "subjectCQ": "What drug plays a role in the immunologic factor?",
    "propertyCQ": "What does Ocrelizumab do to the immunologic factor?",
    "objectCQ": "What does Ocrelizumab play a role in?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q423439$DE0D3DB6-C29E-4542-948D-25C110D14220",
    "theme": "ChemicalCompound",
    "subject_label": "cerivastatin",
    "subject_id": "Q423439",
    "subject_description": "chemical compound",
    "property_label": "subject has role",
    "property_id": "P2868",
    "object_label": "statin",
    "object_id": "Q954845",
    "object_description": "class of drugs used to lower cholesterol levels",
    "context": "Cerivastatin is a statin.",
    "subjectCQ": "What is a statin?",
    "propertyCQ": "What is the role of the subject?",
    "objectCQ": "What is Cerivastatin?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q2467410$83900029-74FA-410E-96D5-F3BA47210A67",
    "theme": "ChemicalCompound",
    "subject_label": "tropine",
    "subject_id": "Q2467410",
    "subject_description": "chemical compound",
    "property_label": "melting point",
    "property_id": "P2101",
    "object_label": "63.0 degree Celsius",
    "object_id": "",
    "object_description": "SI unit of Celsius temperature",
    "context": "The melting point of tropine is 63.0 degrees Celsius.",
    "subjectCQ": "What substance is melting at 63 degrees Celsius?",
    "propertyCQ": "What is the melting point of tropine?",
    "objectCQ": "What is the melting point of tropine?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q72489527$A147D508-76FD-4699-885B-E21216670CB7",
    "theme": "ChemicalCompound",
    "subject_label": "2-(Methoxycarbonyl)phenyl isocyanate",
    "subject_id": "Q72489527",
    "subject_description": "chemical compound",
    "property_label": "melting point",
    "property_id": "P2101",
    "object_label": "47.0 degree Celsius",
    "object_id": "",
    "object_description": "SI unit of Celsius temperature",
    "context": "2-(Methoxycarbonyl)phenyl isocyanate has a melting point of 47 degrees Celsius.",
    "subjectCQ": "What has a melting point of 47 degrees Celsius?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q906080$bb5e1932-4d67-cdb3-5e89-e8c5c7e702a7",
    "theme": "ChemicalCompound",
    "subject_label": "Chrysolaminarin",
    "subject_id": "Q906080",
    "subject_description": "chemical compound",
    "property_label": "melting point",
    "property_id": "P2101",
    "object_label": "273 degree Celsius",
    "object_id": "",
    "object_description": "SI unit of Celsius temperature",
    "context": "Chrysolaminarin has a melting point of 273 degree Celsius.",
    "subjectCQ": "What has a melting point of 273 degrees Celsius?",
    "propertyCQ": "What is Chrysolaminarin's degree Celsius?",
    "objectCQ": "What is Chrysolaminarin's melting point?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q11186388$EA57AC15-90C7-4ACB-B22F-B520FC1FEB76",
    "theme": "ChemicalCompound",
    "subject_label": "2,3-hexanedione",
    "subject_id": "Q11186388",
    "subject_description": "chemical compound",
    "property_label": "melting point",
    "property_id": "P2101",
    "object_label": "-30.0 degree Celsius",
    "object_id": "",
    "object_description": "SI unit of Celsius temperature",
    "context": "2,3-hexanedione has a melting point of -30.0 degree Celsius.",
    "subjectCQ": "What has a melting point of -30.0 degree Celsius?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q72451205$6E75210C-EA4E-49C8-89C4-2F972B8EE5DB",
    "theme": "ChemicalCompound",
    "subject_label": "2-Bromoacetamide",
    "subject_id": "Q72451205",
    "subject_description": "chemical compound",
    "property_label": "melting point",
    "property_id": "P2101",
    "object_label": "89.0 degree Celsius",
    "object_id": "",
    "object_description": "SI unit of Celsius temperature",
    "context": "2-Bromoacetamide has a melting point of 89.0 degree Celsius.",
    "subjectCQ": "What has a melting point of 89.0 degrees Celsius?",
    "propertyCQ": "What is 2-Bromoacetamide's degree Celsius?",
    "objectCQ": "What is the melting point of 2-Bromoacetamide?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q26421079$D9E31202-93B8-4E8F-8FC6-77E8056576E3",
    "theme": "ChemicalCompound",
    "subject_label": "O-bromophenol",
    "subject_id": "Q26421079",
    "subject_description": "chemical compound",
    "property_label": "melting point",
    "property_id": "P2101",
    "object_label": "5.0 degree Celsius",
    "object_id": "",
    "object_description": "SI unit of Celsius temperature",
    "context": "O-bromophenol has a melting point of 5.0 degree Celsius.",
    "subjectCQ": "What has a melting point of 5.0 degrees Celsius?",
    "propertyCQ": "What is the melting point of O-bromophenol?",
    "objectCQ": "What is the melting point of O-bromophenol?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q72467701$55A48ACB-6A17-45B9-B461-FA48796EEA9D",
    "theme": "ChemicalCompound",
    "subject_label": "2,4-Dimethoxybenzyl alcohol",
    "subject_id": "Q72467701",
    "subject_description": "chemical compound",
    "property_label": "melting point",
    "property_id": "P2101",
    "object_label": "37.0 degree Celsius",
    "object_id": "",
    "object_description": "SI unit of Celsius temperature",
    "context": "2,4-Dimethoxybenzyl alcohol has a melting point of 37 degrees Celsius.",
    "subjectCQ": "What has a melting point of 37 degrees Celsius?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q69999956$A2D8A3F9-1748-4132-8681-DEB71E76AC3D",
    "theme": "ChemicalCompound",
    "subject_label": "5-bromo-2-(tert-butoxy)pyrimidine",
    "subject_id": "Q69999956",
    "subject_description": "chemical compound",
    "property_label": "melting point",
    "property_id": "P2101",
    "object_label": "62.0 degree Celsius",
    "object_id": "",
    "object_description": "SI unit of Celsius temperature",
    "context": "5-bromo-2-(tert-butoxy)pyrimidine has a melting point of 62.0 degree Celsius.",
    "subjectCQ": "What has a melting point of 62.0 degrees Celsius?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q72443622$F195B721-3BDE-414D-88BD-E505F994D253",
    "theme": "ChemicalCompound",
    "subject_label": "4-Biphenylacetonitrile",
    "subject_id": "Q72443622",
    "subject_description": "chemical compound",
    "property_label": "melting point",
    "property_id": "P2101",
    "object_label": "95.0 degree Celsius",
    "object_id": "",
    "object_description": "SI unit of Celsius temperature",
    "context": "4-Biphenylacetonitrile has a melting point of 95 degrees Celsius.",
    "subjectCQ": "What has a melting point of 95 degrees Celsius?",
    "propertyCQ": "What is 4-Biphenylacetonitrile's temperature?",
    "objectCQ": "What is 4-Biphenylacetonitrile's melting point?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q72441562$B8C3AD26-E49A-453B-8E27-1CE5C8B03C6C",
    "theme": "ChemicalCompound",
    "subject_label": "5-Amino-2-pyridinecarboxylic acid",
    "subject_id": "Q72441562",
    "subject_description": "chemical compound",
    "property_label": "melting point",
    "property_id": "P2101",
    "object_label": "218.0 degree Celsius",
    "object_id": "",
    "object_description": "SI unit of Celsius temperature",
    "context": "5-Amino-2-pyridinecarboxylic acid has a melting point of 218.0 degree Celsius.",
    "subjectCQ": "What acid has a melting point of 218.0 degree Celsius?",
    "propertyCQ": "What degree Celsius does 5-Amino-2-pyridinecarboxylic acid have?",
    "objectCQ": "What is the melting point of 5-Amino-2-pyridinecarboxylic acid?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q225045$a5163dd8-46c4-22dd-69be-f35e7a5243ec",
    "theme": "ChemicalCompound",
    "subject_label": "carbon tetrachloride",
    "subject_id": "Q225045",
    "subject_description": "chemical compound",
    "property_label": "melting point",
    "property_id": "P2101",
    "object_label": "-22.6 degree Celsius",
    "object_id": "",
    "object_description": "SI unit of Celsius temperature",
    "context": "The melting point of carbon tetrachloride is -22.6 degree Celsius.",
    "subjectCQ": "What is the melting point of?",
    "propertyCQ": "What is the melting point of carbon tetrachloride?",
    "objectCQ": "What is the melting point of carbon tetrachloride?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27261970$468D1AB4-EC6F-48A3-B5F1-B44D709D6BA4",
    "theme": "ChemicalCompound",
    "subject_label": "2-(methanesulfonyl)ethanol",
    "subject_id": "Q27261970",
    "subject_description": "chemical compound",
    "property_label": "melting point",
    "property_id": "P2101",
    "object_label": "29.0 degree Celsius",
    "object_id": "",
    "object_description": "SI unit of Celsius temperature",
    "context": "2-(methanesulfonyl)ethanol has a melting point of 29.0 degree Celsius.",
    "subjectCQ": "What has a melting point of 29.0 degrees Celsius?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27594730$DEA36E59-384E-4210-9EED-E0A1895A7C35",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-378h",
    "subject_id": "Q27594730",
    "subject_description": "human mature microRNA",
    "property_label": "chromosome",
    "property_id": "P1057",
    "object_label": "human chromosome 5",
    "object_id": "Q840741",
    "object_description": "human chromosome",
    "context": "Hsa-miR-378h is a human chromosome 5.",
    "subjectCQ": "What is the human chromosome 5?",
    "propertyCQ": "What part of the human genome is Hsa-miR-378h?",
    "objectCQ": "What is Hsa-miR-378h?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18068514$BF3C5084-83A6-4241-B177-EC9A84F92054",
    "theme": "ChemicalCompound",
    "subject_label": "MIR4483",
    "subject_id": "Q18068514",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "chromosome",
    "property_id": "P1057",
    "object_label": "human chromosome 10",
    "object_id": "Q840737",
    "object_description": "human chromosome",
    "context": "MIR4483 is the chromosome of human chromosome 10.",
    "subjectCQ": "What is the chromosome of human chromosome 10?",
    "propertyCQ": "What part of the human genome is MIR4483?",
    "objectCQ": "What is MIR4483 the chromosome of?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27591938$254610D9-1548-4457-AF51-4970EF0FB03C",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-941-3",
    "subject_id": "Q27591938",
    "subject_description": "human precursor microRNA",
    "property_label": "chromosome",
    "property_id": "P1057",
    "object_label": "human chromosome 20",
    "object_id": "Q666752",
    "object_description": "human chromosome",
    "context": "The human chromosome 20 is the chromosome of hsa-mir-941-3.",
    "subjectCQ": "What is the chromosome of?",
    "propertyCQ": "What part of the human genome is hsa-mir-941-3?",
    "objectCQ": "What is the chromosome of hsa-mir-941-3?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27594558$482078E9-4371-4DEF-BD44-430814484B40",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-4789-3p",
    "subject_id": "Q27594558",
    "subject_description": "human mature microRNA",
    "property_label": "chromosome",
    "property_id": "P1057",
    "object_label": "human chromosome 3",
    "object_id": "Q668633",
    "object_description": "human chromosome",
    "context": "Hsa-miR-4789-3p is a human chromosome 3.",
    "subjectCQ": "What is the human chromosome 3?",
    "propertyCQ": "What part of the body is Hsa-miR-4789-3p?",
    "objectCQ": "What is Hsa-miR-4789-3p?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18068005$16F4B6D1-7EC3-40B9-8620-27DEE3943D21",
    "theme": "ChemicalCompound",
    "subject_label": "SPTY2D1OS",
    "subject_id": "Q18068005",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "chromosome",
    "property_id": "P1057",
    "object_label": "human chromosome 11",
    "object_id": "Q847096",
    "object_description": "human chromosome",
    "context": "The human chromosome 11 is the chromosome of SPTY2D1OS.",
    "subjectCQ": "What is the chromosome 11 of?",
    "propertyCQ": "What part of the human genome is SPTY2D1OS?",
    "objectCQ": "What is the chromosome of SPTY2D1OS?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q66659415$6B27D3E2-A447-4E8A-ACCB-D41A5C1AA5CB",
    "theme": "ChemicalCompound",
    "subject_label": "Gm24389",
    "subject_id": "Q66659415",
    "subject_description": "small nuclear RNA in the species Mus musculus",
    "property_label": "chromosome",
    "property_id": "P1057",
    "object_label": "mouse chromosome 17",
    "object_id": "Q15305616",
    "object_description": "Mus musculus chromosome",
    "context": "The mouse chromosome 17 is the chromosome of Gm24389.",
    "subjectCQ": "What is the chromosome of?",
    "propertyCQ": "What part of the genome is Gm24389?",
    "objectCQ": "What is the chromosome of Gm24389?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18058045$01B0AF94-F6D0-44B5-B59C-F6D50C1D97B2",
    "theme": "ChemicalCompound",
    "subject_label": "MIR134",
    "subject_id": "Q18058045",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "chromosome",
    "property_id": "P1057",
    "object_label": "human chromosome 14",
    "object_id": "Q138955",
    "object_description": "human chromosome",
    "context": "The human chromosome 14 is the MIR134 chromosome.",
    "subjectCQ": "What is the chromosome 14 of the human genome?",
    "propertyCQ": "What is the MIR134?",
    "objectCQ": "What is the MIR134 chromosome?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q66667542$F5E1380C-EE0F-4E29-A2DE-9A788A9CD458",
    "theme": "ChemicalCompound",
    "subject_label": "Gm23795",
    "subject_id": "Q66667542",
    "subject_description": "small nucleolar RNA in the species Mus musculus",
    "property_label": "chromosome",
    "property_id": "P1057",
    "object_label": "mouse chromosome 7",
    "object_id": "Q15305579",
    "object_description": "Mus musculus chromosome",
    "context": "The mouse chromosome 7 is the chromosome of Gm23795.",
    "subjectCQ": "What is the chromosome of?",
    "propertyCQ": "What part of the genome is Gm23795?",
    "objectCQ": "What is the chromosome of Gm23795?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q56473182$F63FB8B9-D8C6-4DD8-B838-3244CA8266CC",
    "theme": "ChemicalCompound",
    "subject_label": "uncharacterized LOC107382577",
    "subject_id": "Q56473182",
    "subject_description": "Gene found in Nothobranchius furzeri",
    "property_label": "chromosome",
    "property_id": "P1057",
    "object_label": "Nothobranchius furzeri chromosome sgr08",
    "object_id": "Q56419076",
    "object_description": "chromosome",
    "context": "The chromosome of Nothobranchius furzeri is sgr08 and is uncharacterized by LOC107382577.",
    "subjectCQ": "What is the chromosome of Nothobranchius furzeri?",
    "propertyCQ": "What part of Nothobranchius furzeri is uncharacterized by LOC107382577?",
    "objectCQ": "What is the chromosome of Nothobranchius furzeri?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18075242$B1E73FE3-7A25-44C3-8D4F-C943729F1665",
    "theme": "ChemicalCompound",
    "subject_label": "MIR6806",
    "subject_id": "Q18075242",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "chromosome",
    "property_id": "P1057",
    "object_label": "human chromosome 19",
    "object_id": "Q510786",
    "object_description": "human chromosome",
    "context": "The human chromosome 19 is the chromosome MIR6806.",
    "subjectCQ": "What is the chromosome 19 of the human body called?",
    "propertyCQ": "What is the MIR6806?",
    "objectCQ": "What is the chromosome MIR6806?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20778046$27EEE89C-45E1-4316-9563-3BA6B7197F2E",
    "theme": "ChemicalCompound",
    "subject_label": "LINC02444",
    "subject_id": "Q20778046",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "chromosome",
    "property_id": "P1057",
    "object_label": "human chromosome 12",
    "object_id": "Q847102",
    "object_description": "chromosome 12 in Homo sapiens",
    "context": "LINC02444 is the chromosome 12 of the human.",
    "subjectCQ": "What is the chromosome 12 of the human?",
    "propertyCQ": "What part of the human genome is LINC02444?",
    "objectCQ": "What is LINC02444?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27592876$A1743F2E-09C1-4DC0-B2EC-7C16FBAFC026",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-4424",
    "subject_id": "Q27592876",
    "subject_description": "human mature microRNA",
    "property_label": "chromosome",
    "property_id": "P1057",
    "object_label": "human chromosome 1",
    "object_id": "Q430258",
    "object_description": "human chromosome",
    "context": "Hsa-miR-4424 is a human chromosome.",
    "subjectCQ": "What is the human chromosome?",
    "propertyCQ": "What is Hsa-miR-4424?",
    "objectCQ": "What is Hsa-miR-4424?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18069434$00ECE410-7819-4F6A-B4F3-97EDD85F4A38",
    "theme": "ChemicalCompound",
    "subject_label": "MIR5584",
    "subject_id": "Q18069434",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "strand orientation",
    "property_id": "P2548",
    "object_label": "forward strand",
    "object_id": "Q22809680",
    "object_description": "Forward oriented strand in a double stranded DNA Molecule",
    "context": "MIR5584 has a forward strand orientation.",
    "subjectCQ": "What has a forward strand orientation?",
    "propertyCQ": "What does MIR5584 have?",
    "objectCQ": "What orientation does MIR5584 have?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27594686$0D24069A-FDC9-4CC5-B42F-4B53513C719E",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-582-3p",
    "subject_id": "Q27594686",
    "subject_description": "human mature microRNA",
    "property_label": "strand orientation",
    "property_id": "P2548",
    "object_label": "reverse strand",
    "object_id": "Q22809711",
    "object_description": "Reverse oriented strand in a double stranded DNA Molecule",
    "context": "Hsa-miR-582-3p has a reverse strand orientation.",
    "subjectCQ": "What has a reverse strand orientation?",
    "propertyCQ": "What is the reverse of the Hsa-miR-582-3p?",
    "objectCQ": "What orientation does the Hsa-miR-582-3p have?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18080800$14BEC6F7-FDEA-4950-AE32-BBD7CEFB45E9",
    "theme": "ChemicalCompound",
    "subject_label": "MIR8053",
    "subject_id": "Q18080800",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "strand orientation",
    "property_id": "P2548",
    "object_label": "forward strand",
    "object_id": "Q22809680",
    "object_description": "Forward oriented strand in a double stranded DNA Molecule",
    "context": "MIR8053 has a forward strand orientation.",
    "subjectCQ": "What has a forward strand orientation?",
    "propertyCQ": "What does MIR8053 have?",
    "objectCQ": "What orientation does MIR8053 have?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q24422494$824D3CF5-4B27-439F-AE6A-D1010091FA44",
    "theme": "ChemicalCompound",
    "subject_label": "Mir872",
    "subject_id": "Q24422494",
    "subject_description": "non-coding RNA in the species Rattus norvegicus",
    "property_label": "strand orientation",
    "property_id": "P2548",
    "object_label": "forward strand",
    "object_id": "Q22809680",
    "object_description": "Forward oriented strand in a double stranded DNA Molecule",
    "context": "Mir872 has a forward strand orientation.",
    "subjectCQ": "What has a forward strand orientation?",
    "propertyCQ": "What is the forward orientation of the Mir872?",
    "objectCQ": "What is the orientation of the Mir872?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27592523$82C7D0F7-266E-4220-B10A-EC64476492EF",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-3651",
    "subject_id": "Q27592523",
    "subject_description": "human precursor microRNA",
    "property_label": "strand orientation",
    "property_id": "P2548",
    "object_label": "reverse strand",
    "object_id": "Q22809711",
    "object_description": "Reverse oriented strand in a double stranded DNA Molecule",
    "context": "Hsa-mir-3651 has a reverse strand orientation.",
    "subjectCQ": "What has a reverse strand orientation?",
    "propertyCQ": "What is the reverse of the Hsa-mir-3651?",
    "objectCQ": "What orientation does Hsa-mir-3651 have?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18062515$D447CA2A-DBD4-4188-B39B-7462FB4B9AE4",
    "theme": "ChemicalCompound",
    "subject_label": "MIR541",
    "subject_id": "Q18062515",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "strand orientation",
    "property_id": "P2548",
    "object_label": "forward strand",
    "object_id": "Q22809680",
    "object_description": "Forward oriented strand in a double stranded DNA Molecule",
    "context": "MIR541 has a forward strand orientation.",
    "subjectCQ": "What has a forward strand orientation?",
    "propertyCQ": "What does MIR541 have?",
    "objectCQ": "What orientation does MIR541 have?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18068076$E8562332-27E1-4104-B305-FA91357C22F5",
    "theme": "ChemicalCompound",
    "subject_label": "CFAP100-DT",
    "subject_id": "Q18068076",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "strand orientation",
    "property_id": "P2548",
    "object_label": "reverse strand",
    "object_id": "Q22809711",
    "object_description": "Reverse oriented strand in a double stranded DNA Molecule",
    "context": "The CFAP100-DT has a reverse strand orientation.",
    "subjectCQ": "What has a reverse strand orientation?",
    "propertyCQ": "What is the reverse orientation of the CFAP100-DT?",
    "objectCQ": "What orientation does the CFAP100-DT have?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27595280$FBFE19FC-103D-46C5-983E-94110AFB2589",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-19b-2-5p",
    "subject_id": "Q27595280",
    "subject_description": "human mature microRNA",
    "property_label": "strand orientation",
    "property_id": "P2548",
    "object_label": "reverse strand",
    "object_id": "Q22809711",
    "object_description": "Reverse oriented strand in a double stranded DNA Molecule",
    "context": "Hsa-miR-19b-2-5p has a reverse strand orientation.",
    "subjectCQ": "What has a reverse strand orientation?",
    "propertyCQ": "What is reversed in Hsa-miR-19b-2-5p?",
    "objectCQ": "What orientation does Hsa-miR-19b-2-5p have?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18311739$6953C7A9-EACA-4F3D-B1BE-C3A9C2D1495C",
    "theme": "ChemicalCompound",
    "subject_label": "Mir429",
    "subject_id": "Q18311739",
    "subject_description": "non-coding RNA in the species Mus musculus",
    "property_label": "strand orientation",
    "property_id": "P2548",
    "object_label": "reverse strand",
    "object_id": "Q22809711",
    "object_description": "Reverse oriented strand in a double stranded DNA Molecule",
    "context": "Mir429 has a reverse strand orientation.",
    "subjectCQ": "What has a reverse strand orientation?",
    "propertyCQ": "What is the reverse of the Mir429?",
    "objectCQ": "What type of orientation does Mir429 have?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20782118$479A1419-908E-4023-AEC6-FF88320985CF",
    "theme": "ChemicalCompound",
    "subject_label": "BISPR",
    "subject_id": "Q20782118",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "strand orientation",
    "property_id": "P2548",
    "object_label": "forward strand",
    "object_id": "Q22809680",
    "object_description": "Forward oriented strand in a double stranded DNA Molecule",
    "context": "BISPR's strand orientation is forward strand.",
    "subjectCQ": "What is the name of the strand that is forward strand?",
    "propertyCQ": "What is forward strand?",
    "objectCQ": "What is BISPR's strand orientation?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27592382$DDCD3C9A-52EE-4ADB-9A31-2808EDF47E68",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-4467",
    "subject_id": "Q27592382",
    "subject_description": "human precursor microRNA",
    "property_label": "strand orientation",
    "property_id": "P2548",
    "object_label": "forward strand",
    "object_id": "Q22809680",
    "object_description": "Forward oriented strand in a double stranded DNA Molecule",
    "context": "Hsa-mir-4467 has a forward strand orientation.",
    "subjectCQ": "What has a forward strand orientation?",
    "propertyCQ": "What is Hsa-mir-4467's forward orientation?",
    "objectCQ": "What orientation does Hsa-mir-4467 have?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18054355$5FFEFAA9-BA3B-4D8D-8996-C752253B2062",
    "theme": "ChemicalCompound",
    "subject_label": "RUSC1-AS1",
    "subject_id": "Q18054355",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "strand orientation",
    "property_id": "P2548",
    "object_label": "reverse strand",
    "object_id": "Q22809711",
    "object_description": "Reverse oriented strand in a double stranded DNA Molecule",
    "context": "RUSC1-AS1 has a reverse strand orientation.",
    "subjectCQ": "What has a reverse strand orientation?",
    "propertyCQ": "What is reversed on RUSC1-AS1?",
    "objectCQ": "What orientation does RUSC1-AS1 have?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18075140$47666F76-D3F5-4963-96A9-330CBE2BABD6",
    "theme": "ChemicalCompound",
    "subject_label": "MIR6740",
    "subject_id": "Q18075140",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "genomic start",
    "property_id": "P644",
    "object_label": "202003124",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The genomic start date for MIR6740 is 202003124.",
    "subjectCQ": "What is the genomic start date for?",
    "propertyCQ": "What is the start date for MIR6740?",
    "objectCQ": "What is the genomic start date for MIR6740?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18068758$605C1828-A4BF-412F-A538-0BC89691F2C3",
    "theme": "ChemicalCompound",
    "subject_label": "MIR548AE2",
    "subject_id": "Q18068758",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "genomic start",
    "property_id": "P644",
    "object_label": "57825870",
    "object_id": "",
    "object_description": "no-desc",
    "context": "MIR548AE2 has a genomic start of 57825870.",
    "subjectCQ": "What has a genomic start of 57825870?",
    "propertyCQ": "What is the start of MIR548AE2?",
    "objectCQ": "What is the genomic start of MIR548AE2?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27591483$2B18B226-DDCD-4948-AED2-4DC9FD27F38F",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-6129",
    "subject_id": "Q27591483",
    "subject_description": "human precursor microRNA",
    "property_label": "genomic start",
    "property_id": "P644",
    "object_label": "49288346",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Hsa-mir-6129 has a genomic start of 49288346.",
    "subjectCQ": "What has a genomic start of 49288346?",
    "propertyCQ": "What is the start of Hsa-mir-6129?",
    "objectCQ": "What is the genomic start of Hsa-mir-6129?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18062569$B316E36A-8352-4D1C-BD5D-F8281C8C9FA3",
    "theme": "ChemicalCompound",
    "subject_label": "GHRLOS",
    "subject_id": "Q18062569",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "genomic start",
    "property_id": "P644",
    "object_label": "10327438",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The genomic start of GHRLOS is 10327438.",
    "subjectCQ": "What is the genomic start of?",
    "propertyCQ": "What is the name of the start of GHRLOS?",
    "objectCQ": "What is the genomic start of GHRLOS?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18068196$14F471A0-56D2-41BF-AFE0-E322400F8747",
    "theme": "ChemicalCompound",
    "subject_label": "EGFR-AS1",
    "subject_id": "Q18068196",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "genomic start",
    "property_id": "P644",
    "object_label": "55247443",
    "object_id": "",
    "object_description": "no-desc",
    "context": "EGFR-AS1 has a genomic start of 55247443.",
    "subjectCQ": "What gene has a genomic start of 55247443?",
    "propertyCQ": "What is the start of EGFR-AS1?",
    "objectCQ": "What is the genomic start of EGFR-AS1?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27591287$EE2B2756-6B3E-4BC3-A474-75C3512CD7CA",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-7973-2",
    "subject_id": "Q27591287",
    "subject_description": "human precursor microRNA",
    "property_label": "genomic start",
    "property_id": "P644",
    "object_label": "51314032",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Hsa-mir-7973-2 has a genomic start of 51314032.",
    "subjectCQ": "What has a genomic start of 51314032?",
    "propertyCQ": "What is the start of Hsa-mir-7973-2?",
    "objectCQ": "What is the genomic start of Hsa-mir-7973-2?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18319209$5C7FC9B1-CAAE-4A75-B76C-0070A33889F4",
    "theme": "ChemicalCompound",
    "subject_label": "Mir1192",
    "subject_id": "Q18319209",
    "subject_description": "non-coding RNA in the species Mus musculus",
    "property_label": "genomic start",
    "property_id": "P644",
    "object_label": "23149431",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Mir1192 has a genomic start of 23149431.",
    "subjectCQ": "What has a genomic start of 23149431?",
    "propertyCQ": "What is Mir1192's unique start?",
    "objectCQ": "Mir1192 has a genomic start of what?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27591995$35EF5C72-E969-4D6B-A845-454EBA712431",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-7109",
    "subject_id": "Q27591995",
    "subject_description": "human precursor microRNA",
    "property_label": "genomic start",
    "property_id": "P644",
    "object_label": "31621467",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Hsa-mir-7109 has a genomic start of 31621467.",
    "subjectCQ": "What has a genomic start of 31621467?",
    "propertyCQ": "What is the start number of Hsa-mir-7109?",
    "objectCQ": "What is the genomic start of Hsa-mir-7109?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20869784$3791801B-B7E8-472A-96A2-F5A4E9822B55",
    "theme": "ChemicalCompound",
    "subject_label": "Gm40418",
    "subject_id": "Q20869784",
    "subject_description": "non-coding RNA in the species Mus musculus",
    "property_label": "genomic start",
    "property_id": "P644",
    "object_label": "50120309",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The genomic start of Gm40418 is 50120309.",
    "subjectCQ": "What is the genomic start of?",
    "propertyCQ": "What is the start number of Gm40418?",
    "objectCQ": "What is the genomic start of Gm40418?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20775423$05AD94DE-D2BC-4FF3-879F-69130148629A",
    "theme": "ChemicalCompound",
    "subject_label": "MIR3182",
    "subject_id": "Q20775423",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "genomic start",
    "property_id": "P644",
    "object_label": "83508346",
    "object_id": "",
    "object_description": "no-desc",
    "context": "MIR3182 has a genomic start of 83508346.",
    "subjectCQ": "What has a genomic start of 83508346?",
    "propertyCQ": "What is the start of MIR3182?",
    "objectCQ": "What is the genomic start of MIR3182?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50384340$7817012E-F39D-452C-A10B-9BFF58F5FC24",
    "theme": "ChemicalCompound",
    "subject_label": "tRNA-Asp encoded by: aspV b0216",
    "subject_id": "Q50384340",
    "subject_description": "Microbial non-coding RNA 'tRNA' found in Escherichia coli str. K-12 substr. MG1655, Note: anticodon: GUC",
    "property_label": "genomic start",
    "property_id": "P644",
    "object_label": "236930",
    "object_id": "",
    "object_description": "no-desc",
    "context": "TRNA-Asp is encoded by: aspV b0216 and has a genomic start of 236930.",
    "subjectCQ": "What is the name of the gene that encodes tRNA-Asp?",
    "propertyCQ": "What is the start of TRNA-Asp?",
    "objectCQ": "What is the genomic start of TRNA-Asp?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27593435$95BEBE88-DDB8-4314-9162-AFF64D8A489F",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-1193",
    "subject_id": "Q27593435",
    "subject_description": "human mature microRNA",
    "property_label": "genomic start",
    "property_id": "P644",
    "object_label": "101030061",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Hsa-miR-1193 has a genomic start of 101030061.",
    "subjectCQ": "What has a genomic start of 101030061?",
    "propertyCQ": "What is the start of Hsa-miR-1193?",
    "objectCQ": "What is the genomic start of Hsa-miR-1193?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18075140$ADF91ACB-1EE4-4EF6-AFC8-D78CAF84EC1D",
    "theme": "ChemicalCompound",
    "subject_label": "MIR6740",
    "subject_id": "Q18075140",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "genomic end",
    "property_id": "P645",
    "object_label": "202003236",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The genomic end of MIR6740 is 202003236.",
    "subjectCQ": "What is the genomic end of?",
    "propertyCQ": "What is the end of MIR6740?",
    "objectCQ": "What is the genomic end of MIR6740?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18068758$70766C8C-B16C-47B0-8D91-2F8BB16C9B73",
    "theme": "ChemicalCompound",
    "subject_label": "MIR548AE2",
    "subject_id": "Q18068758",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "genomic end",
    "property_id": "P645",
    "object_label": "57825936",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The genomic end of MIR548AE2 is 57825936.",
    "subjectCQ": "What is the genomic end of?",
    "propertyCQ": "What is the end of MIR548AE2?",
    "objectCQ": "What is the genomic end of MIR548AE2?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27591483$996FAB23-EF48-46A5-BC84-BD0BAF1AD1D8",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-6129",
    "subject_id": "Q27591483",
    "subject_description": "human precursor microRNA",
    "property_label": "genomic end",
    "property_id": "P645",
    "object_label": "49288454",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The genomic end of hsa-mir-6129 is 49288454.",
    "subjectCQ": "What is the genomic end of?",
    "propertyCQ": "What is the end of hsa-mir-6129?",
    "objectCQ": "What is the genomic end of hsa-mir-6129?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18062569$AD21A721-A94D-42BC-BA93-C35DFE99B4EA",
    "theme": "ChemicalCompound",
    "subject_label": "GHRLOS",
    "subject_id": "Q18062569",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "genomic end",
    "property_id": "P645",
    "object_label": "10335133",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The genomic end of GHRLOS is 10335133.",
    "subjectCQ": "What is the genomic end of?",
    "propertyCQ": "What is the end of GHRLOS?",
    "objectCQ": "What is the genomic end of GHRLOS?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18068196$051F9A88-D677-47DF-929B-E634865E2CE8",
    "theme": "ChemicalCompound",
    "subject_label": "EGFR-AS1",
    "subject_id": "Q18068196",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "genomic end",
    "property_id": "P645",
    "object_label": "55256627",
    "object_id": "",
    "object_description": "no-desc",
    "context": "EGFR-AS1 has a genomic end of 55256627.",
    "subjectCQ": "What gene has a genomic end of 55256627?",
    "propertyCQ": "What is the end of EGFR-AS1?",
    "objectCQ": "What is the genomic end of EGFR-AS1?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27591287$D56B01C0-72BF-45C1-ADCE-6F54F01C238D",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-7973-2",
    "subject_id": "Q27591287",
    "subject_description": "human precursor microRNA",
    "property_label": "genomic end",
    "property_id": "P645",
    "object_label": "51314107",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Hsa-mir-7973-2 has a genomic end of 51314107.",
    "subjectCQ": "What has a genomic end of 51314107?",
    "propertyCQ": "What is the end of Hsa-mir-7973-2?",
    "objectCQ": "What is the genomic end of Hsa-mir-7973-2?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18319209$508419F2-6FB6-4863-8BEA-CB5258A6ABE3",
    "theme": "ChemicalCompound",
    "subject_label": "Mir1192",
    "subject_id": "Q18319209",
    "subject_description": "non-coding RNA in the species Mus musculus",
    "property_label": "genomic end",
    "property_id": "P645",
    "object_label": "23149551",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Mir1192 has a genomic end of 23149551.",
    "subjectCQ": "What has a genomic end of 23149551?",
    "propertyCQ": "What is Mir1192's status?",
    "objectCQ": "What is Mir1192's genomic end?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27591995$14A6A0FE-7DAB-4BA2-AFEC-1E524D5881A6",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-7109",
    "subject_id": "Q27591995",
    "subject_description": "human precursor microRNA",
    "property_label": "genomic end",
    "property_id": "P645",
    "object_label": "31621531",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The genomic end of hsa-mir-7109 is 31621531.",
    "subjectCQ": "What is the genomic end of?",
    "propertyCQ": "What is the end of hsa-mir-7109?",
    "objectCQ": "What is the genomic end of hsa-mir-7109?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20869784$D7DCE79E-F9A1-4101-B289-77EB0BA60CD9",
    "theme": "ChemicalCompound",
    "subject_label": "Gm40418",
    "subject_id": "Q20869784",
    "subject_description": "non-coding RNA in the species Mus musculus",
    "property_label": "genomic end",
    "property_id": "P645",
    "object_label": "50145236",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The genomic end of Gm40418 is 50145236.",
    "subjectCQ": "What is the genomic end of?",
    "propertyCQ": "What is the end of Gm40418?",
    "objectCQ": "What is the genomic end of Gm40418?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20775423$69FAC0BA-BFF6-43B5-AFC2-5336C51C303D",
    "theme": "ChemicalCompound",
    "subject_label": "MIR3182",
    "subject_id": "Q20775423",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "genomic end",
    "property_id": "P645",
    "object_label": "83508408",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The genomic end of MIR3182 is 83508408.",
    "subjectCQ": "What is the genomic end of?",
    "propertyCQ": "What is the end of MIR3182?",
    "objectCQ": "What is the genomic end of MIR3182?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50384340$1FBED83E-1CA0-4705-90CA-9D0B8BC4A4ED",
    "theme": "ChemicalCompound",
    "subject_label": "tRNA-Asp encoded by: aspV b0216",
    "subject_id": "Q50384340",
    "subject_description": "Microbial non-coding RNA 'tRNA' found in Escherichia coli str. K-12 substr. MG1655, Note: anticodon: GUC",
    "property_label": "genomic end",
    "property_id": "P645",
    "object_label": "237007",
    "object_id": "",
    "object_description": "no-desc",
    "context": "TRNA-Asp is encoded by: aspV b0216 and has a genomic end of 237007.",
    "subjectCQ": "What is the genomic end of tRNA-Asp?",
    "propertyCQ": "What is the end of the TRNA-Asp?",
    "objectCQ": "What is the genomic end of TRNA-Asp?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27593435$0E9769BD-3558-49E6-8436-33D28B99ACC7",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-1193",
    "subject_id": "Q27593435",
    "subject_description": "human mature microRNA",
    "property_label": "genomic end",
    "property_id": "P645",
    "object_label": "101030083",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Hsa-miR-1193 has a genomic end of 101030083.",
    "subjectCQ": "What has a genomic end of 101030083?",
    "propertyCQ": "What is the end of Hsa-miR-1193?",
    "objectCQ": "What is the genomic end of Hsa-miR-1193?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20774881$AE064705-0DF1-420E-8AE5-A9ECBF6EF5FD",
    "theme": "ChemicalCompound",
    "subject_label": "LINC01909",
    "subject_id": "Q20774881",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "expressed in",
    "property_id": "P5572",
    "object_label": "Right lobe of liver",
    "object_id": "Q6493472",
    "object_description": "no-desc",
    "context": "LINC01909 is expressed in the right lobe of liver.",
    "subjectCQ": "What is expressed in the right lobe of the liver?",
    "propertyCQ": "Where is LINC01909 found?",
    "objectCQ": "Where is LINC01909 expressed?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18068902$4AA6196B-193B-4BBA-9CD6-F359A1F14C78",
    "theme": "ChemicalCompound",
    "subject_label": "MIR3689E",
    "subject_id": "Q18068902",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "expressed in",
    "property_id": "P5572",
    "object_label": "colon",
    "object_id": "Q5982337",
    "object_description": "part of large intestine",
    "context": "MIR3689E is expressed in a colon.",
    "subjectCQ": "What is expressed in a colon?",
    "propertyCQ": "How is MIR3689E expressed?",
    "objectCQ": "What is MIR3689E expressed in?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18068483$FAB41091-1EC7-4F9B-8E8A-D9C77A67CA59",
    "theme": "ChemicalCompound",
    "subject_label": "MIR4507",
    "subject_id": "Q18068483",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "expressed in",
    "property_id": "P5572",
    "object_label": "lymph node",
    "object_id": "Q170758",
    "object_description": "organ of the lymphatic system",
    "context": "MIR4507 is expressed in the lymph node.",
    "subjectCQ": "What is expressed in the lymph node?",
    "propertyCQ": "Where is MIR4507 found?",
    "objectCQ": "Where is MIR4507 expressed?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18072988$4959726E-4D0C-42D7-BC24-5BAD0C64F743",
    "theme": "ChemicalCompound",
    "subject_label": "LINC01216",
    "subject_id": "Q18072988",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "expressed in",
    "property_id": "P5572",
    "object_label": "putamen",
    "object_id": "Q550934",
    "object_description": "round structure located at the base of the forebrain",
    "context": "LINC01216 is expressed in putamen.",
    "subjectCQ": "What is expressed in putamen?",
    "propertyCQ": "How is LINC01216 expressed?",
    "objectCQ": "What is LINC01216 expressed in?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18074963$C14737EA-B3F9-4BAF-85BC-03A6D6B87C6A",
    "theme": "ChemicalCompound",
    "subject_label": "RNVU1-6",
    "subject_id": "Q18074963",
    "subject_description": "small nuclear RNA in the species Homo sapiens",
    "property_label": "expressed in",
    "property_id": "P5572",
    "object_label": "bone marrow",
    "object_id": "Q546523",
    "object_description": "cells and soft materials in the hollow space of long bones",
    "context": "RNVU1-6 is expressed in bone marrow.",
    "subjectCQ": "What is expressed in bone marrow?",
    "propertyCQ": "How is RNVU1-6 expressed?",
    "objectCQ": "Where is RNVU1-6 expressed?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20763583$ADB8C2BE-1FEA-47AB-B2A8-447530BB50D4",
    "theme": "ChemicalCompound",
    "subject_label": "GLIS2-AS1",
    "subject_id": "Q20763583",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "expressed in",
    "property_id": "P5572",
    "object_label": "brain",
    "object_id": "Q1073",
    "object_description": "organ that serves as the center of the nervous system in all vertebrate and most invertebrate animals",
    "context": "GLIS2-AS1 is expressed in the brain.",
    "subjectCQ": "What is expressed in the brain?",
    "propertyCQ": "Where is GLIS2-AS1 expressed?",
    "objectCQ": "Where is GLIS2-AS1 expressed?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18072978$14121994-174C-47BE-BB64-7E339F4E2B43",
    "theme": "ChemicalCompound",
    "subject_label": "HAO2-IT1",
    "subject_id": "Q18072978",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "expressed in",
    "property_id": "P5572",
    "object_label": "liver",
    "object_id": "Q9368",
    "object_description": "vital organ in vertebrates and some other animals",
    "context": "HAO2-IT1 is expressed in the liver.",
    "subjectCQ": "What is expressed in the liver?",
    "propertyCQ": "Where is HAO2-IT1 expressed?",
    "objectCQ": "Where is HAO2-IT1 expressed?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20762983$E5A080FE-10AC-4765-AADB-C861D09EB035",
    "theme": "ChemicalCompound",
    "subject_label": "LINC02800",
    "subject_id": "Q20762983",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "expressed in",
    "property_id": "P5572",
    "object_label": "prostate",
    "object_id": "Q9625",
    "object_description": "gland of the male reproductive system in most mammals",
    "context": "LINC02800 is expressed in the prostate.",
    "subjectCQ": "What is expressed in the prostate?",
    "propertyCQ": "Where is LINC02800 found?",
    "objectCQ": "Where is LINC02800 expressed?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20774903$211BE4D8-76E9-4D2D-8219-82983CBAE83D",
    "theme": "ChemicalCompound",
    "subject_label": "LOC100130449",
    "subject_id": "Q20774903",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "expressed in",
    "property_id": "P5572",
    "object_label": "cerebellar vermis",
    "object_id": "Q3078809",
    "object_description": "anatomical structure in the brain",
    "context": "LOC100130449 is expressed in the cerebellar vermis.",
    "subjectCQ": "What is expressed in the cerebellar vermis?",
    "propertyCQ": "Where is LOC100130449 found?",
    "objectCQ": "Where is LOC100130449 expressed?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18074244$636E0F6E-E6EA-477E-8C7E-F5FDAEBDEF91",
    "theme": "ChemicalCompound",
    "subject_label": "LINC01163",
    "subject_id": "Q18074244",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "expressed in",
    "property_id": "P5572",
    "object_label": "myometrium",
    "object_id": "Q2562472",
    "object_description": "smooth muscle coat of the uteru",
    "context": "LINC01163 is expressed in myometrium.",
    "subjectCQ": "What is expressed in myometrium?",
    "propertyCQ": "Where is LINC01163 found?",
    "objectCQ": "Where is LINC01163 expressed?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q21180051$FE6C9AB3-8D48-42F4-ACF9-291E80A02418",
    "theme": "ChemicalCompound",
    "subject_label": "MIR3677HG",
    "subject_id": "Q21180051",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "expressed in",
    "property_id": "P5572",
    "object_label": "hippocampus proper",
    "object_id": "Q7308967",
    "object_description": "part of the brain of mammals",
    "context": "MIR3677HG is expressed in hippocampus proper.",
    "subjectCQ": "What is the name of the gene that is expressed in the hippocampus proper?",
    "propertyCQ": "How is MIR3677HG expressed?",
    "objectCQ": "Where is MIR3677HG expressed?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18052359$16B8479B-C63F-4FC2-AD09-1D467AD42806",
    "theme": "ChemicalCompound",
    "subject_label": "LINC02907",
    "subject_id": "Q18052359",
    "subject_description": "protein-coding gene in the species Homo sapiens",
    "property_label": "expressed in",
    "property_id": "P5572",
    "object_label": "hippocampus proper",
    "object_id": "Q7308967",
    "object_description": "part of the brain of mammals",
    "context": "LINC02907 is expressed in the hippocampus proper.",
    "subjectCQ": "What is expressed in the hippocampus proper?",
    "propertyCQ": "Where is LINC02907 located?",
    "objectCQ": "Where is LINC02907 expressed?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q34495787$6C397147-11FA-4084-BE1D-431620FE312E",
    "theme": "ChemicalCompound",
    "subject_label": "The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals.",
    "subject_id": "Q34495787",
    "subject_description": "scientific article",
    "property_label": "cites work",
    "property_id": "P2860",
    "object_label": "Oxytocin shapes the neural circuitry of trust and trust adaptation in humans.",
    "object_id": "Q34781060",
    "object_description": "scientific article",
    "context": "The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals. Oxytocin shapes the neural circuitry of trust and trust adaptation in humans.",
    "subjectCQ": "What is the main effect of MDMA?",
    "propertyCQ": "What does MDMA do?",
    "objectCQ": "What does MDMA do to humans?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q36539089$5942E656-2AAA-4FBB-8300-BB44F51FF4D8",
    "theme": "ChemicalCompound",
    "subject_label": "Neuroimaging research in human MDMA users: a review.",
    "subject_id": "Q36539089",
    "subject_description": "scientific article published on 18 July 2006",
    "property_label": "cites work",
    "property_id": "P2860",
    "object_label": "Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB",
    "object_id": "Q24678394",
    "object_description": "scientific article",
    "context": "Neuroimaging research in human MDMA users: a review. cites work on Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB.",
    "subjectCQ": "What is the name of the research that cites work on Quantitative PET studies of the serotonin transporter in MDMA users and controls?",
    "propertyCQ": "What does the review do?",
    "objectCQ": "What is the focus of the review?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q35745285$068B516B-188D-40AE-94C3-97CD8466AB67",
    "theme": "ChemicalCompound",
    "subject_label": "Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.",
    "subject_id": "Q35745285",
    "subject_description": "scientific article published on 9 April 2004",
    "property_label": "cites work",
    "property_id": "P2860",
    "object_label": "5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine",
    "object_id": "Q24680216",
    "object_description": "scientific article",
    "context": "MDMA, p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine have been shown to have an effect on the long-term and acute effects of MDMA on cerebral dopamine biochemistry and function.",
    "subjectCQ": "What has MDMA, p-chloroamphetamine and fenfluramine been shown to have an effect on?",
    "propertyCQ": "",
    "objectCQ": "What has been shown to have an effect on the long-term and acute effects of MDMA?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q38048826$868A3D35-86C9-453A-BCFD-E75D4AFCC88B",
    "theme": "ChemicalCompound",
    "subject_label": "Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions.",
    "subject_id": "Q38048826",
    "subject_description": "scientific article published on 03 October 2012",
    "property_label": "cites work",
    "property_id": "P2860",
    "object_label": "Patterns of ecstasy-associated hyponatremia in California.",
    "object_id": "Q36644862",
    "object_description": "scientific article published on 3 November 2006",
    "context": "Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions. It cites work on Patterns of ecstasy-associated hyponatremia in California.",
    "subjectCQ": "What is the main difference between MDMA and other drugs?",
    "propertyCQ": "What does the paper do?",
    "objectCQ": "What is the name of the work that is cited?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q30393293$67C26426-54FA-4CF2-89EA-EEE072EEB85E",
    "theme": "ChemicalCompound",
    "subject_label": "Self-Reported Ecstasy/MDMA/\"Molly\" Use in a Sample of Nightclub and Dance Festival Attendees in New York City.",
    "subject_id": "Q30393293",
    "subject_description": "scientific article",
    "property_label": "cites work",
    "property_id": "P2860",
    "object_label": "The rise of new psychoactive substance use in Australia",
    "object_id": "Q57841993",
    "object_description": "article",
    "context": "Self-Reported Ecstasy/MDMA/\"Molly\" Use in a Sample of Nightclub and Dance Festival Attendees in New York City. and cites work on The rise of new psychoactive substance use in Australia.",
    "subjectCQ": "What is the purpose of this study?",
    "propertyCQ": "What does the article do?",
    "objectCQ": "What is the subject of the study?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q43076563$2145E321-C4C3-45FA-9107-46CC0FF67C8D",
    "theme": "ChemicalCompound",
    "subject_label": "Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioural responses to MDMA ('ecstasy').",
    "subject_id": "Q43076563",
    "subject_description": "scientific article published on 2 May 2010",
    "property_label": "cites work",
    "property_id": "P2860",
    "object_label": "Acute effects of 3,4-methylenedioxymethamphetamine on striatal single-unit activity and behavior in freely moving rats: differential involvement of dopamine D(1) and D(2) receptors.",
    "object_id": "Q44671820",
    "object_description": "scientific article",
    "context": "Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioural responses to MDMA ('ecstasy'). It cites work entitled Acute effects of 3,4-methylenedioxymethamphetamine on striatal single-unit activity and behavior in freely moving rats: differential involvement of dopamine D(1) and D(2) receptors.",
    "subjectCQ": "What does caffeine do?",
    "propertyCQ": "What does caffeine do to promote ecstasy?",
    "objectCQ": "What is the name of the work that cites?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q51975344$F704AA57-7500-44A8-A753-8695FE5BE820",
    "theme": "ChemicalCompound",
    "subject_label": "Cognitive performance in light current users and ex-users of ecstasy (MDMA) and controls.",
    "subject_id": "Q51975344",
    "subject_description": "scientific article published in January 2007",
    "property_label": "cites work",
    "property_id": "P2860",
    "object_label": "Cannabis, ecstasy/MDMA and memory: a commentary on Simon & Mattick's recent study.",
    "object_id": "Q44482897",
    "object_description": "scientific article",
    "context": "Cannabis, ecstasy/MDMA and memory: a commentary on Simon & Mattick's recent study. Cognitive performance in light current users and ex-users of ecstasy (MDMA) and controls.",
    "subjectCQ": "What is the purpose of the study?",
    "propertyCQ": "What does the article do?",
    "objectCQ": "What is the topic of the study?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q37416406$0F2CF0B4-1DE2-46F7-BD48-6DFBBAEBF6B0",
    "theme": "ChemicalCompound",
    "subject_label": "Discriminative stimulus effects of psychostimulants and hallucinogens in S(+)-3,4-methylenedioxymethamphetamine (MDMA) and R(-)-MDMA trained mice.",
    "subject_id": "Q37416406",
    "subject_description": "scientific article published on 14 August 2009",
    "property_label": "cites work",
    "property_id": "P2860",
    "object_label": "Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors.",
    "object_id": "Q34316202",
    "object_description": "scientific article",
    "context": "Discriminative stimulus effects of psychostimulants and hallucinogens in S(+)-3,4-methylenedioxymethamphetamine (MDMA) and R(-)-MDMA trained mice. It cites work on Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors.",
    "subjectCQ": "What is the effect of MDMA on the brain?",
    "propertyCQ": "What does the study do?",
    "objectCQ": "What is the main effect of MDMA on the body?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q48865378$830F00E6-BA75-4408-B454-F35F0A761823",
    "theme": "ChemicalCompound",
    "subject_label": "Dopamine D1 receptor-mediated intracellular responses in the hypothalamus after co-administration of caffeine with MDMA.",
    "subject_id": "Q48865378",
    "subject_description": "scientific article",
    "property_label": "cites work",
    "property_id": "P2860",
    "object_label": "Studies on the effect of MDMA ('ecstasy') on the body temperature of rats housed at different ambient room temperatures.",
    "object_id": "Q42112531",
    "object_description": "scientific article published on September 2005",
    "context": "Dopamine D1 receptor-mediated intracellular responses in the hypothalamus after co-administration of caffeine with MDMA. It cites work on the effect of MDMA ('ecstasy') on the body temperature of rats housed at different ambient room temperatures.",
    "subjectCQ": "What does the study cite?",
    "propertyCQ": "What does the study do?",
    "objectCQ": "What does the study cite?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q46808071$F0C42CFE-0B6D-44E0-9624-BE58571AC107",
    "theme": "ChemicalCompound",
    "subject_label": "Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naïve controls.",
    "subject_id": "Q46808071",
    "subject_description": "scientific article",
    "property_label": "cites work",
    "property_id": "P2860",
    "object_label": "Effects of beta-adrenoceptor blockade on components of human decision-making.",
    "object_id": "Q44723650",
    "object_description": "scientific article",
    "context": "The study \"Effects of beta-adrenoceptor blockade on components of human decision-making\" cites the study \"Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naïve controls.",
    "subjectCQ": "What is the study cited?",
    "propertyCQ": "",
    "objectCQ": "What is the title of the study?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q34235666$51950B31-A379-4B5E-8CD2-E1CC19B3D393",
    "theme": "ChemicalCompound",
    "subject_label": "Genetic deletion of trace amine 1 receptors reveals their role in auto-inhibiting the actions of ecstasy (MDMA).",
    "subject_id": "Q34235666",
    "subject_description": "scientific article",
    "property_label": "cites work",
    "property_id": "P2860",
    "object_label": "Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain.",
    "object_id": "Q34734179",
    "object_description": "scientific article",
    "context": "Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain. This study was published in the journal Nature.",
    "subjectCQ": "What is the role of trace amine receptors in ecstasy?",
    "propertyCQ": "What does the journal Nature do with the results of the study?",
    "objectCQ": "What is the effect of beta-phenylethylamine on the brain?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27593297$B61F3D01-0182-4807-8A20-F77BA9188797",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-320d",
    "subject_id": "Q27593297",
    "subject_description": "human mature microRNA",
    "property_label": "part of",
    "property_id": "P361",
    "object_label": "hsa-mir-320d-1",
    "object_id": "Q27591126",
    "object_description": "human precursor microRNA",
    "context": "Hsa-miR-320d is part of hsa-mir-320d-1.",
    "subjectCQ": "What is part of hsa-mir-320d-1?",
    "propertyCQ": "What is hsa-mir-320d-1?",
    "objectCQ": "What is the hsa-miR-320d part of?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50271844$19692596-E945-4142-AAFF-CE8A89C198D5",
    "theme": "ChemicalCompound",
    "subject_label": "NRG1/2:ERBB3 [plasma membrane]",
    "subject_id": "Q50271844",
    "subject_description": "An instance of macromolecular complex in Homo sapiens with Reactome ID (R-HSA-1247495)",
    "property_label": "part of",
    "property_id": "P361",
    "object_label": "ERBB3 binds neuregulins",
    "object_id": "Q50297985",
    "object_description": "An instance of the biological reaction in Homo sapiens with Reactome ID (R-HSA-1247497)",
    "context": "NRG1/2:ERBB3 [plasma membrane] is part of ERBB3 which binds neuregulins.",
    "subjectCQ": "What is part of ERBB3?",
    "propertyCQ": "What is ERBB3?",
    "objectCQ": "What does ERBB3 do?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50255921$1C16BC54-4405-48F8-A37B-C403EB3EDCF4",
    "theme": "ChemicalCompound",
    "subject_label": "Activated FGFR1:p-FRS2:p-PTPN11 [plasma membrane]",
    "subject_id": "Q50255921",
    "subject_description": "An instance of macromolecular complex in Homo sapiens with Reactome ID (R-HSA-5654204)",
    "property_label": "part of",
    "property_id": "P361",
    "object_label": "Activated FGFR:p-FRS2:p-PTPN11:GRB2:GAB1:PIK3R1 [plasma membrane]",
    "object_id": "Q50255920",
    "object_description": "An instance of macromolecular complex in Homo sapiens with Reactome ID (R-HSA-5654185)",
    "context": "Activated FGFR1:p-FRS2:p-PTPN11 is part of FGFR1:p-FRS2:p-PTPN11:GRB2:GAB1:PIK3R1 [plasma membrane].",
    "subjectCQ": "What is part of FGFR1:p-FRS2:p-PTPN11?",
    "propertyCQ": "What is FGFR1:p-FRS2:p-PTPN11?",
    "objectCQ": "What is part of FGFR1:p-FRS2:p-PTPN11?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50267551$6EF284C7-DBB5-4777-8670-07790AE0DF7E",
    "theme": "ChemicalCompound",
    "subject_label": "Exosome:SKI complex [cytosol]",
    "subject_id": "Q50267551",
    "subject_description": "An instance of macromolecular complex in Homo sapiens with Reactome ID (R-HSA-8931494)",
    "property_label": "part of",
    "property_id": "P361",
    "object_label": "Exosome Complex hydrolyzes mRNA by 3' to 5' exoribonuclease digestion",
    "object_id": "Q50295866",
    "object_description": "An instance of the biological reaction in Homo sapiens with Reactome ID (R-HSA-430028)",
    "context": "Exosome:SKI complex (cytosol) is part of Exosome Complex which hydrolyzes mRNA by 3' to 5' exoribonuclease digestion.",
    "subjectCQ": "What is part of Exosome Complex?",
    "propertyCQ": "What is the SKI complex?",
    "objectCQ": "What is the name of the enzyme that is involved in the synthesis of mRNA?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q100147574$7EB79947-48A6-417B-862F-47EF7883E769",
    "theme": "ChemicalCompound",
    "subject_label": "sCD163:MYH9 [cytosol]",
    "subject_id": "Q100147574",
    "subject_description": "An instance of macromolecular complex in Homo sapiens with Reactome ID (R-HSA-9663429)",
    "property_label": "part of",
    "property_id": "P361",
    "object_label": "sCD163 binds MYH9 in T-cells",
    "object_id": "Q100153192",
    "object_description": "An instance of the biological reaction in Homo sapiens with Reactome ID (R-HSA-9663426)",
    "context": "SCD163:MYH9 [cytosol] is part of sCD163 and it binds MYH9 in T-cells.",
    "subjectCQ": "What part of sCD163 is MYH9 a part of?",
    "propertyCQ": "What part of sCD163 is MYH9?",
    "objectCQ": "What does sCD163 do?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50256790$8987ABFE-B6B8-48BC-9D84-FEC8E3838E9C",
    "theme": "ChemicalCompound",
    "subject_label": "Glycosylated, palmitylated and folded HA trimer [plasma membrane]",
    "subject_id": "Q50256790",
    "subject_description": "An instance of macromolecular complex in Influenza A virus with Reactome ID (R-FLU-195738)",
    "property_label": "part of",
    "property_id": "P361",
    "object_label": "Intracellular assembly complex [plasma membrane]",
    "object_id": "Q50256805",
    "object_description": "An instance of macromolecular complex in Influenza A virus with Reactome ID (R-FLU-195925)",
    "context": "Glycosylated, palmitylated and folded HA trimer [plasma membrane] is part of the Intracellular assembly complex [plasma membrane].",
    "subjectCQ": "What is part of the Intracellular assembly complex?",
    "propertyCQ": "What is the HA trimer?",
    "objectCQ": "What is the HA trimer part of?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50264757$CACFD672-547C-4CAA-B57F-F03F8A397AC1",
    "theme": "ChemicalCompound",
    "subject_label": "HSD17B4 dimer [peroxisomal matrix]",
    "subject_id": "Q50264757",
    "subject_description": "An instance of macromolecular complex in Homo sapiens with Reactome ID (R-HSA-389999)",
    "property_label": "part of",
    "property_id": "P361",
    "object_label": "25(S) 3alpha,7alpha-dihydroxy-5beta-cholest-24-enoyl-CoA is hydrated to (24R, 25R) 3alpha,7alpha,24-trihydroxy-5beta-cholestanoyl-CoA",
    "object_id": "Q50294192",
    "object_description": "An instance of the biological reaction in Homo sapiens with Reactome ID (R-HSA-193535)",
    "context": "HSD17B4 dimer [peroxisomal matrix] is part of 25(S) 3alpha,7alpha-dihydroxy-5beta-cholest-24-enoyl-CoA and is hydrated to (24R, 25R) 3alpha,7alpha,24-trihydroxy-5beta-cholestanoyl-CoA.",
    "subjectCQ": "What is part of 25(S) 3alpha,7alpha-dihydroxy-5beta-cholest-24-enoyl-CoA?",
    "propertyCQ": "",
    "objectCQ": "What is the HSD17B4 dimer part of?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27593854$F620F10C-1662-45EB-9FB9-DA352815390F",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-1250-3p",
    "subject_id": "Q27593854",
    "subject_description": "human mature microRNA",
    "property_label": "part of",
    "property_id": "P361",
    "object_label": "hsa-mir-1250",
    "object_id": "Q27591524",
    "object_description": "human precursor microRNA",
    "context": "Hsa-miR-1250-3p is part of hsa-mir-1250.",
    "subjectCQ": "What is part of hsa-mir-1250?",
    "propertyCQ": "What is hsa-mir-1250?",
    "objectCQ": "What is the Hsa-miR-1250-3p part of?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27594455$94372CD8-3713-40D1-9974-3C2F82A34B61",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-563",
    "subject_id": "Q27594455",
    "subject_description": "human mature microRNA",
    "property_label": "part of",
    "property_id": "P361",
    "object_label": "hsa-mir-563",
    "object_id": "Q27592026",
    "object_description": "human precursor microRNA",
    "context": "Hsa-miR-563 is part of hsa-mir-563.",
    "subjectCQ": "What is part of hsa-mir-563?",
    "propertyCQ": "What is hsa-mir-563?",
    "objectCQ": "What is the name of the hsa-miR-563?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50274802$74BD2F7A-7DA7-4D59-AF81-7B42D7C358FC",
    "theme": "ChemicalCompound",
    "subject_label": "spherical HDL:SR-BI complex [plasma membrane]",
    "subject_id": "Q50274802",
    "subject_description": "An instance of macromolecular complex in Homo sapiens with Reactome ID (R-HSA-349649)",
    "property_label": "part of",
    "property_id": "P361",
    "object_label": "Disassembly of SR-BI-bound spherical HDL",
    "object_id": "Q50299805",
    "object_description": "An instance of the biological reaction in Homo sapiens with Reactome ID (R-HSA-349638)",
    "context": "The spherical HDL:SR-BI complex (plasma membrane) is part of the disassembly of SR-BI-bound spherical HDL.",
    "subjectCQ": "What is part of the disassembly of SR-BI-bound spherical HDL?",
    "propertyCQ": "What is the spherical HDL:SR-BI complex?",
    "objectCQ": "What is the SR-BI complex part of?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50256866$59A5241A-D4ED-4C4A-96B9-9E6AA7BDC795",
    "theme": "ChemicalCompound",
    "subject_label": "botA HC:LC dimer:SV2:GT1b [plasma membrane]",
    "subject_id": "Q50256866",
    "subject_description": "An instance of macromolecular complex in Homo sapiens with Reactome ID (R-HSA-5244411)",
    "property_label": "part of",
    "property_id": "P361",
    "object_label": "botA HC:LC binds SV2A, B, or C and GT1b on the target cell surface",
    "object_id": "Q50289572",
    "object_description": "An instance of the biological reaction in Homo sapiens with Reactome ID (R-HSA-5244415)",
    "context": "BotA HC:LC dimer:SV2:GT1b (plasma membrane) is part of botA HC:LC and binds SV2A, B, or C and GT1b on the target cell surface.",
    "subjectCQ": "What is part of botA HC:LC?",
    "propertyCQ": "What part of botA HC:LC is SV2:GT1b?",
    "objectCQ": "What does botA HC:LC do?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q29714083$FCB16B80-FE28-4623-B595-C3CD9FC4076C",
    "theme": "ChemicalCompound",
    "subject_label": "lncRNA:CR44921",
    "subject_id": "Q29714083",
    "subject_description": "non-coding RNA in the species Drosophila melanogaster",
    "property_label": "cytogenetic location",
    "property_id": "P4196",
    "object_label": "83D2-83D2|3-47.5 cM",
    "object_id": "",
    "object_description": "no-desc",
    "context": "LncRNA:CR44921 has a cytogenetic location of 83D2-83D2|3-47.5 cM.",
    "subjectCQ": "What has a cytogenetic location of 83D2-83D2|3-47.5 cM?",
    "propertyCQ": "What is the location of LncRNA:CR44921?",
    "objectCQ": "What is the cytogenetic location of LncRNA:CR44921?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18068645$F098014C-DC47-4CE6-A867-1210F84AEC79",
    "theme": "ChemicalCompound",
    "subject_label": "MIR1587",
    "subject_id": "Q18068645",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "cytogenetic location",
    "property_id": "P4196",
    "object_label": "Xp11.4",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Xp11.4 is the cytogenetic location of MIR1587.",
    "subjectCQ": "What is the cytogenetic location of?",
    "propertyCQ": "What is Xp11.4?",
    "objectCQ": "What is the cytogenetic location of MIR1587?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q24367309$167C30C5-0608-4824-B76D-D88BAA94028D",
    "theme": "ChemicalCompound",
    "subject_label": "LOC102547442",
    "subject_id": "Q24367309",
    "subject_description": "non-coding RNA in the species Rattus norvegicus",
    "property_label": "cytogenetic location",
    "property_id": "P4196",
    "object_label": "16p12",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The cytogenetic location of LOC102547442 is 16p12.",
    "subjectCQ": "What is the cytogenetic location of?",
    "propertyCQ": "What is the location of LOC102547442?",
    "objectCQ": "What is the cytogenetic location of LOC102547442?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q24398790$CF3DF61C-DA4A-4D8D-ABF3-FCDB0E532669",
    "theme": "ChemicalCompound",
    "subject_label": "LOC103694052",
    "subject_id": "Q24398790",
    "subject_description": "non-coding RNA in the species Rattus norvegicus",
    "property_label": "cytogenetic location",
    "property_id": "P4196",
    "object_label": "17p14",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The cytogenetic location of LOC103694052 is 17p14.",
    "subjectCQ": "What is the cytogenetic location of?",
    "propertyCQ": "What is the location of LOC103694052?",
    "objectCQ": "What is the cytogenetic location of LOC103694052?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18271220$9443CB10-8B2D-45F9-B51C-00C58EAAC4FE",
    "theme": "ChemicalCompound",
    "subject_label": "BB031773",
    "subject_id": "Q18271220",
    "subject_description": "non-coding RNA in the species Mus musculus",
    "property_label": "cytogenetic location",
    "property_id": "P4196",
    "object_label": "4|4 C6",
    "object_id": "",
    "object_description": "no-desc",
    "context": "BB031773 has a cytogenetic location of 4|4 C6.",
    "subjectCQ": "What has a cytogenetic location of 4|4 C6?",
    "propertyCQ": "What is the location of BB031773?",
    "objectCQ": "What is the cytogenetic location of BB031773?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18064146$8CA63836-A1E6-4CEA-B6F8-6C8BEC61D443",
    "theme": "ChemicalCompound",
    "subject_label": "TRH-GTG1-4",
    "subject_id": "Q18064146",
    "subject_description": "transfer RNA in the species Homo sapiens",
    "property_label": "cytogenetic location",
    "property_id": "P4196",
    "object_label": "1q21.2",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The cytogenetic location of TRH-GTG1-4 is 1q21.2.",
    "subjectCQ": "What is the cytogenetic location of?",
    "propertyCQ": "What is the location of TRH-GTG1-4?",
    "objectCQ": "What is the cytogenetic location of TRH-GTG1-4?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q29939697$1A8761B3-2EA8-4EBD-BA86-659300948026",
    "theme": "ChemicalCompound",
    "subject_label": "LOC108349963",
    "subject_id": "Q29939697",
    "subject_description": "non-coding RNA in the species Rattus norvegicus",
    "property_label": "cytogenetic location",
    "property_id": "P4196",
    "object_label": "2q16",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The cytogenetic location of LOC108349963 is 2q16.",
    "subjectCQ": "What is the cytogenetic location of?",
    "propertyCQ": "What is the location of LOC108349963?",
    "objectCQ": "What is the cytogenetic location of LOC108349963?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18065823$8E090737-5596-467C-ADCF-E6D5B61A6F4A",
    "theme": "ChemicalCompound",
    "subject_label": "MIR1913",
    "subject_id": "Q18065823",
    "subject_description": "non-coding RNA in the species Homo sapiens",
    "property_label": "cytogenetic location",
    "property_id": "P4196",
    "object_label": "6q27",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The cytogenetic location of MIR1913 is 6q27.",
    "subjectCQ": "What is the cytogenetic location of?",
    "propertyCQ": "What is the location of MIR1913?",
    "objectCQ": "What is the cytogenetic location of MIR1913?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20868901$B91F4A49-2071-42A3-9257-E2A32C663704",
    "theme": "ChemicalCompound",
    "subject_label": "Gm36372",
    "subject_id": "Q20868901",
    "subject_description": "non-coding RNA in the species Mus musculus",
    "property_label": "cytogenetic location",
    "property_id": "P4196",
    "object_label": "12 A1.1|12",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The cytogenetic location of Gm36372 is 12 A1.1|12.",
    "subjectCQ": "What is the cytogenetic location of?",
    "propertyCQ": "What is Gm36372's location?",
    "objectCQ": "What is the cytogenetic location of Gm36372?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q29937138$54FE74CD-E3A9-4EDF-A2A7-285357AF32A1",
    "theme": "ChemicalCompound",
    "subject_label": "LOC108352112",
    "subject_id": "Q29937138",
    "subject_description": "non-coding RNA in the species Rattus norvegicus",
    "property_label": "cytogenetic location",
    "property_id": "P4196",
    "object_label": "10q26",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The cytogenetic location of LOC108352112 is 10q26.",
    "subjectCQ": "What is the cytogenetic location of?",
    "propertyCQ": "What is the location of LOC108352112?",
    "objectCQ": "What is the cytogenetic location of LOC108352112?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20865699$4ADBD175-61E8-4AAA-AA53-ED15BB508488",
    "theme": "ChemicalCompound",
    "subject_label": "Gm39513",
    "subject_id": "Q20865699",
    "subject_description": "non-coding RNA in the species Mus musculus",
    "property_label": "cytogenetic location",
    "property_id": "P4196",
    "object_label": "X A5|X",
    "object_id": "",
    "object_description": "no-desc",
    "context": "X A5|X is the cytogenetic location of Gm39513.",
    "subjectCQ": "What is the cytogenetic location of?",
    "propertyCQ": "What is X A5|X?",
    "objectCQ": "What is the cytogenetic location of Gm39513?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q90554444$0E6334B1-EB7E-4B75-893D-2D15EBE83B0A",
    "theme": "ChemicalCompound",
    "subject_label": "1-Naphthalenesulfonic acid, 3,3′-[1,4-phenylenebis(2,1-ethenediyl-4,1-phenyleneazo)]bis[4-amino-, disodium salt",
    "subject_id": "Q90554444",
    "subject_description": "chemical compound",
    "property_label": "catalog",
    "property_id": "P972",
    "object_label": "CAS COVID-19 Anti-Viral Candidate Compounds",
    "object_id": "Q90481889",
    "object_description": "no-desc",
    "context": "1-Naphthalenesulfonic acid, 3,3′-[1,4-phenylenebis(2,1-ethenediyl-4,1-phenyleneazo)]bis[4-amino-, disodium salt is in the catalog of CAS COVID-19 Anti-Viral Candidate Compounds.",
    "subjectCQ": "What is in the catalog of CAS COVID-19 Anti-Viral Candidate Compounds?",
    "propertyCQ": "Where is 1-Naphthalenesulfonic acid found?",
    "objectCQ": "Where is 1-Naphthalenesulfonic acid found?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q90520585$E689508B-65AD-4104-AC6F-0A5D829F546E",
    "theme": "ChemicalCompound",
    "subject_label": "Carbamic acid, N-[[5-butyl-4′-[(2-ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridin-3-yl)methyl][1,1′-biphenyl]-2-yl]sulfonyl]-, phenylmethyl ester",
    "subject_id": "Q90520585",
    "subject_description": "chemical compound",
    "property_label": "catalog",
    "property_id": "P972",
    "object_label": "CAS COVID-19 Anti-Viral Candidate Compounds",
    "object_id": "Q90481889",
    "object_description": "no-desc",
    "context": "Carbamic acid, N-[[5-butyl-4′-[(2-ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridin-3-yl)methyl][1,1′-biphenyl]-2-yl]sulfonyl]-, phenylmethyl ester is in the catalog of CAS COVID-19 Anti-Viral Candidate Compounds.",
    "subjectCQ": "What is in the catalog of CAS COVID-19 Anti-Viral Candidate Compounds?",
    "propertyCQ": "Where is CAS COVID-19 Anti-Viral Candidate Compounds?",
    "objectCQ": "Where is carbamic acid found?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q90508651$B4FDC350-9C87-4A4F-A58B-999681ACE3A6",
    "theme": "ChemicalCompound",
    "subject_label": "1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione, 12-[(11R)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-3,4,12,12a-tetrahydro-7-(2-methylpropoxy)-, (12aR)-",
    "subject_id": "Q90508651",
    "subject_description": "chemical compound",
    "property_label": "catalog",
    "property_id": "P972",
    "object_label": "CAS COVID-19 Anti-Viral Candidate Compounds",
    "object_id": "Q90481889",
    "object_description": "no-desc",
    "context": "1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione, 12-[(11R)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-3,4,12,12a-tetrahydro-7-(2-methylpropoxy)-, (12aR)-",
    "subjectCQ": "What are the names of the three compounds?",
    "propertyCQ": "What is the name of the chemistry in which the benzene is found?",
    "objectCQ": "What is the name of the compound that is used to treat HIV?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q90486076$A9CD6D51-CF16-4F94-A4A4-9EBFA5A2B367",
    "theme": "ChemicalCompound",
    "subject_label": "2,7,10,12-Tetraazatridecanoic acid, 9-[2-(1H-imidazol-1-yl)ethyl]-12-methyl-13-[2-(1-methylethyl)-4-thiazolyl]-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3R,6R,9S)-",
    "subject_id": "Q90486076",
    "subject_description": "chemical compound",
    "property_label": "catalog",
    "property_id": "P972",
    "object_label": "CAS COVID-19 Anti-Viral Candidate Compounds",
    "object_id": "Q90481889",
    "object_description": "no-desc",
    "context": "2,7,10,12-Tetraazatridecanoic acid, 9-[2-(1H-imidazol-1-yl)ethyl]-12-methyl-13-[2-(1H-methylethyl)-4-thiazolyl]-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3R,6R,9S)- is in the catalog of CAS CO",
    "subjectCQ": "What is in the catalog of CAS CO?",
    "propertyCQ": "Where is the CAS CO ad?",
    "objectCQ": "What is the catalog of CAS COVID-19?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q90507340$B091BE0D-B521-4EFF-A6F2-B82BCA51DE98",
    "theme": "ChemicalCompound",
    "subject_label": "1H-Pyrazole-3-carboxamide, 5-(2-fluorophenyl)-4,5-dihydro-1-pentyl-N-(1-tricyclo[3.3.1.13,7]dec-1-ylethyl)-",
    "subject_id": "Q90507340",
    "subject_description": "chemical compound",
    "property_label": "catalog",
    "property_id": "P972",
    "object_label": "CAS COVID-19 Anti-Viral Candidate Compounds",
    "object_id": "Q90481889",
    "object_description": "no-desc",
    "context": "1H-Pyrazole-3-carboxamide, 5-(2-fluorophenyl)-4,5-dihydro-1-pentyl-N-(1-tricyclo[3.3.1.13,7]dec-1-ylethyl)- is in the catalog of CAS COVID-19 Anti-Viral Candidate Compounds.",
    "subjectCQ": "What is in the catalog of CAS COVID-19 Anti-Viral Candidate Compounds?",
    "propertyCQ": "Where is 1H-Pyrazole-3-carboxamide found?",
    "objectCQ": "What is the name of the product in the catalog?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q90545592$E8EDEBDF-8019-4A15-BDB3-2DBA3B83BA39",
    "theme": "ChemicalCompound",
    "subject_label": "6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(2R,6R)-6-(hydroxymethyl)-1,4-oxaselen-2-yl]-",
    "subject_id": "Q90545592",
    "subject_description": "chemical compound",
    "property_label": "catalog",
    "property_id": "P972",
    "object_label": "CAS COVID-19 Anti-Viral Candidate Compounds",
    "object_id": "Q90481889",
    "object_description": "no-desc",
    "context": "6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(2R,6R)-6-(hydroxymethyl)-1,4-oxaselen-2-yl]- is in the catalog of CAS COVID-19 Anti-Viral Candidate Compounds.",
    "subjectCQ": "What is in the catalog of CAS COVID-19 Anti-Viral Candidate Compounds?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q90534641$EA92A0E9-8C7A-4C34-8DAE-BCE3C878C508",
    "theme": "ChemicalCompound",
    "subject_label": "Benzamide, N-[9-(2-O-methyl-β-D-arabinofuranosyl)-9H-purin-6-yl]-",
    "subject_id": "Q90534641",
    "subject_description": "chemical compound",
    "property_label": "catalog",
    "property_id": "P972",
    "object_label": "CAS COVID-19 Anti-Viral Candidate Compounds",
    "object_id": "Q90481889",
    "object_description": "no-desc",
    "context": "Benzamide, N-[9-(2-O-methyl-β-D-arabinofuranosyl)-9H-purin-6-yl]- is in the catalog of CAS COVID-19 Anti-Viral Candidate Compounds.",
    "subjectCQ": "What is in the catalog of CAS COVID-19 Anti-Viral Candidate Compounds?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q90519486$D98D6C19-238B-4AF5-B33C-1D6432923424",
    "theme": "ChemicalCompound",
    "subject_label": "D-glycero-D-galacto-Non-2-enonic acid, 5-(acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-, 7-[[6-[[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]amino]hexyl]carbamate]",
    "subject_id": "Q90519486",
    "subject_description": "chemical compound",
    "property_label": "catalog",
    "property_id": "P972",
    "object_label": "CAS COVID-19 Anti-Viral Candidate Compounds",
    "object_id": "Q90481889",
    "object_description": "no-desc",
    "context": "D-glycero-D-galacto-Non-2-enonic acid, 5-(acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-, 7-[[6-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-",
    "subjectCQ": "What is the name of the acid?",
    "propertyCQ": "What is the name of the acid in the D-glycero-D-galacto-Non-2-enonic acid?",
    "objectCQ": "What is the name of the compound that is used to treat HIV?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q90518042$6FA6AF55-7C71-4C5A-ADA1-62D65E7F28DA",
    "theme": "ChemicalCompound",
    "subject_label": "Carbamic acid, [2-hydroxy-3-[[(4-hydroxyphenyl)sulfonyl](2-methylpropyl)amino]-1-(phenylmethyl)propyl]-, tetrahydro-3-furanyl ester, [3S-[3R*(1R*,2R*)]]-",
    "subject_id": "Q90518042",
    "subject_description": "chemical compound",
    "property_label": "catalog",
    "property_id": "P972",
    "object_label": "CAS COVID-19 Anti-Viral Candidate Compounds",
    "object_id": "Q90481889",
    "object_description": "no-desc",
    "context": "Carbamic acid, [2-hydroxy-3-[((4-hydroxyphenyl)sulfonyl](2-methylpropyl)amino]-1-(phenylmethyl)propyl]-, tetrahydro-3-furanyl ester, [3S-[3R*(1R*,2R*)]- is in the catalog of CAS COVID-19 Anti-Viral Candidate Compounds.",
    "subjectCQ": "What is in the catalog of CAS COVID-19 Anti-Viral Candidate Compounds?",
    "propertyCQ": "Where is carbamic acid found?",
    "objectCQ": "Where is carbamic acid found?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q90522923$786663C8-ACAD-447C-B76E-A2FB0F5B4007",
    "theme": "ChemicalCompound",
    "subject_label": "1099829-95-4",
    "subject_id": "Q90522923",
    "subject_description": "chemical compound",
    "property_label": "catalog",
    "property_id": "P972",
    "object_label": "CAS COVID-19 Anti-Viral Candidate Compounds",
    "object_id": "Q90481889",
    "object_description": "no-desc",
    "context": "1099829-95-4 is a catalog for CAS COVID-19 Anti-Viral Candidate Compounds.",
    "subjectCQ": "What is the name of the catalog for CAS COVID-19 Anti-Viral Candidate Compounds?",
    "propertyCQ": "What is 1099829-95-4?",
    "objectCQ": "What is the 1099829-95-4 catalog for?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q90532690$966D9EB2-4616-4993-9B5C-382340CCD7CF",
    "theme": "ChemicalCompound",
    "subject_label": "2,4,6(1H,3H,5H)-Pyrimidinetrione, 1,3-dimethyl-5-[1-[2-[4-(4-morpholinyl)-6-[(phenylmethyl)amino]-1,3,5-triazin-2-yl]hydrazinyl]ethylidene]-",
    "subject_id": "Q90532690",
    "subject_description": "chemical compound",
    "property_label": "catalog",
    "property_id": "P972",
    "object_label": "CAS COVID-19 Anti-Viral Candidate Compounds",
    "object_id": "Q90481889",
    "object_description": "no-desc",
    "context": "2,4,6(1H,3H,5H)-Pyrimidinetrione, 1,3-dimethyl-5-[1-[2-[4-(4-morpholinyl)-6-[(phenylmethyl)amino]-1,3,5-triazin-2-yl]hydrazinyl]ethylidene]- is in the catalog of CAS COVID-19 Anti-Viral Candidate Compounds.",
    "subjectCQ": "What is in the catalog of CAS COVID-19 Anti-Viral Candidate Compounds?",
    "propertyCQ": "",
    "objectCQ": "What is the name of the compound that contains Pyrimidinetrione?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q106512863$A297FEAA-B765-476C-B11E-FC557C93513D",
    "theme": "ChemicalCompound",
    "subject_label": "KCNMA1:KCNMB1:LRRC52 [plasma membrane]",
    "subject_id": "Q106512863",
    "subject_description": "An instance of macromolecular complex in Homo sapiens with Reactome ID (R-HSA-9667800)",
    "property_label": "has part",
    "property_id": "P527",
    "object_label": "KCNMA1:KCNMB1 [plasma membrane]",
    "object_id": "Q106512862",
    "object_description": "An instance of macromolecular complex in Homo sapiens with Reactome ID (R-HSA-9667777)",
    "context": "KCNMA1:KCNMB1:LRRC52 [plasma membrane] has part of it.",
    "subjectCQ": "What part of the body is a KCNMA1?",
    "propertyCQ": "What part of the membrane does KCNMB1:LRRC52 have?",
    "objectCQ": "What is part of the KCNMA1?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50255573$F32047B2-5864-45EC-A3F3-74234949B243",
    "theme": "ChemicalCompound",
    "subject_label": "p-FGFR1 mutant fusions:PI3K [cytosol]",
    "subject_id": "Q50255573",
    "subject_description": "An instance of macromolecular complex in Homo sapiens with Reactome ID (R-HSA-1839055)",
    "property_label": "has part",
    "property_id": "P527",
    "object_label": "p-FGFR1 fusion mutant dimers:PIK3R1 [cytosol]",
    "object_id": "Q50255571",
    "object_description": "An instance of macromolecular complex in Homo sapiens with Reactome ID (R-HSA-1839052)",
    "context": "P-FGFR1 mutant fusions:PI3K [cytosol] have part of p-FGFR1 fusion mutant dimers:PIK3R1 [cytosol].",
    "subjectCQ": "What have part of p-FGFR1 fusion mutant dimers?",
    "propertyCQ": "What part of p-FGFR1 fusion mutant dimers does PI3K have?",
    "objectCQ": "What do P-FGFR1 mutant fusions:PI3K [cytosol] have part of?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50255203$9C3FBD72-A5D0-43BF-BE41-71D78F471F70",
    "theme": "ChemicalCompound",
    "subject_label": "HOXB1:PBX1:PKNOX1 and MEIS1 at active HOXB1 chromatin [nucleoplasm]",
    "subject_id": "Q50255203",
    "subject_description": "An instance of macromolecular complex in Homo sapiens with Reactome ID (R-HSA-5693638)",
    "property_label": "has part",
    "property_id": "P527",
    "object_label": "HOXB1:PBX1:PKNOX1 [nucleoplasm]",
    "object_id": "Q50255206",
    "object_description": "An instance of macromolecular complex in Homo sapiens with Reactome ID (R-HSA-5617660)",
    "context": "HOXB1:PBX1:PKNOX1 and MEIS1 at active HOXB1 chromatin [nucleoplasm] has part of HOXB1:PBX1:PKNOX1 [nucleoplasm].",
    "subjectCQ": "What has part of HOXB1:PBX1:PKNOX1 [nucleoplasm]?",
    "propertyCQ": "What part of HOXB1:PBX1:PKNOX1 does?",
    "objectCQ": "What part of HOXB1 chromatin is a part of?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q100148865$3C8BDD1B-DB62-4E8C-9471-1325265A0210",
    "theme": "ChemicalCompound",
    "subject_label": "GRIN1:GRIN2A di-heterotetramer [endoplasmic reticulum membrane]",
    "subject_id": "Q100148865",
    "subject_description": "An instance of macromolecular complex in Homo sapiens with Reactome ID (R-HSA-9609783)",
    "property_label": "has part",
    "property_id": "P527",
    "object_label": "Glutamate ionotropic receptor NMDA type subunit 1",
    "object_id": "Q21118862",
    "object_description": "mammalian protein found in Homo sapiens",
    "context": "GRIN1:GRIN2A di-heterotetramer [endoplasmic reticulum membrane] has part of Glutamate ionotropic receptor NMDA type subunit 1.",
    "subjectCQ": "What is part of Glutamate ionotropic receptor NMDA type subunit 1?",
    "propertyCQ": "What part of GRIN2A is present in the Glutamate ionotropic receptor NMDA type subunit 1?",
    "objectCQ": "What does GRIN2A have a part of?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50266425$BFB86720-7F22-4A8B-98B5-5E85560B1BA3",
    "theme": "ChemicalCompound",
    "subject_label": "PXLP-K258-NFS1-2 dimer [cytosol]",
    "subject_id": "Q50266425",
    "subject_description": "An instance of macromolecular complex in Homo sapiens with Reactome ID (R-HSA-947509)",
    "property_label": "has part",
    "property_id": "P527",
    "object_label": "PXLP-K258-NFS1-2 [cytosol]",
    "object_id": "Q99979918",
    "object_description": "An instance of entity with accessioned sequence in Homo sapiens with Reactome ID (R-HSA-947562)",
    "context": "PXLP-K258-NFS1-2 dimer [cytosol] has part of it.",
    "subjectCQ": "What part of the cytosol is a part of?",
    "propertyCQ": "What part of the cytosol does the PXLP-K258-NFS1-2 dimer have?",
    "objectCQ": "What part of the protein is part of?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q100147038$62683469-330C-40C6-AB82-9D8E443AD16D",
    "theme": "ChemicalCompound",
    "subject_label": "activated RAF1 mutant:scaffold:p-2S MAP2K:p-2T MAPK complex [plasma membrane]",
    "subject_id": "Q100147038",
    "subject_description": "An instance of macromolecular complex in Homo sapiens with Reactome ID (R-HSA-9656185)",
    "property_label": "has part",
    "property_id": "P527",
    "object_label": "RAF/MAPK scaffolds [cytosol]",
    "object_id": "Q50256200",
    "object_description": "An instance of candidate set in Homo sapiens with Reactome ID (R-HSA-5672717)",
    "context": "The activated RAF1 mutant:scaffold:p-2S MAP2K:p-2T MAPK complex [plasma membrane] has part of RAF/MAPK scaffolds [cytosol].",
    "subjectCQ": "What has part of RAF/MAPK scaffolds?",
    "propertyCQ": "",
    "objectCQ": "What does the RAF1 mutant have a part of?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50256467$F4CB01B2-2554-4C86-8260-C0914D6105D3",
    "theme": "ChemicalCompound",
    "subject_label": "CCR5/CXCR4:CD4:Env gp120 (second conformation change) complex [plasma membrane]",
    "subject_id": "Q50256467",
    "subject_description": "An instance of macromolecular complex in Homo sapiens with Reactome ID (R-HSA-171293)",
    "property_label": "has part",
    "property_id": "P527",
    "object_label": "CCR5, CXCR4 [plasma membrane]",
    "object_id": "Q50256463",
    "object_description": "An instance of defined set in Homo sapiens with Reactome ID (R-HSA-175536)",
    "context": "CCR5/CXCR4:CD4:Env gp120 (second conformation change) complex [plasma membrane] has part of CCR5/CXCR4 [plasma membrane].",
    "subjectCQ": "What has part of CCR5/CXCR4?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q106512844$0BA69B3F-2385-47AE-AC4A-3399FBF23B27",
    "theme": "ChemicalCompound",
    "subject_label": "Stereocilium rootlet [cytosol]",
    "subject_id": "Q106512844",
    "subject_description": "An instance of macromolecular complex in Homo sapiens with Reactome ID (R-HSA-9662398)",
    "property_label": "has part",
    "property_id": "P527",
    "object_label": "Spectrin beta, non-erythrocytic 1",
    "object_id": "Q21112182",
    "object_description": "mammalian protein found in Homo sapiens",
    "context": "Stereocilium rootlet [cytosol] has part of Spectrin beta, non-erythrocytic 1.",
    "subjectCQ": "What has part of Spectrin beta?",
    "propertyCQ": "What part of Spectrin beta does stereocilium rootlet have?",
    "objectCQ": "Stereocilium rootlet has part of what?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18211640$AD3740E8-B421-4B48-8F4A-89A2D76520E6",
    "theme": "ChemicalCompound",
    "subject_label": "Гипофосфит лития",
    "subject_id": "Q18211640",
    "subject_description": "chemical compound",
    "property_label": "has part",
    "property_id": "P527",
    "object_label": "phosphorus",
    "object_id": "Q674",
    "object_description": "chemical element with symbol P and atomic number 15",
    "context": "Гипофосфит лития has part of phosphorus.",
    "subjectCQ": "What has part of phosphorus?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50254399$2383DAC1-22CE-4451-A454-543C8D8ADDBA",
    "theme": "ChemicalCompound",
    "subject_label": "ROBO2:SLIT2 [plasma membrane]",
    "subject_id": "Q50254399",
    "subject_description": "An instance of macromolecular complex in Homo sapiens with Reactome ID (R-HSA-9010899)",
    "property_label": "has part",
    "property_id": "P527",
    "object_label": "Roundabout guidance receptor 2",
    "object_id": "Q21134297",
    "object_description": "mammalian protein found in Homo sapiens",
    "context": "ROBO2:SLIT2 [plasma membrane] has part of Roundabout guidance receptor 2.",
    "subjectCQ": "What has part of Roundabout guidance receptor 2?",
    "propertyCQ": "What part of Roundabout guidance receptor 2 does ROBO2:SLIT2 have?",
    "objectCQ": "What does ROBO2:SLIT2 have a part of?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20986187$D5B63B9F-DAAF-438A-808B-CEA4EA15E357",
    "theme": "ChemicalCompound",
    "subject_label": "Сульфит родия(III)",
    "subject_id": "Q20986187",
    "subject_description": "chemical compound",
    "property_label": "has part",
    "property_id": "P527",
    "object_label": "oxygen",
    "object_id": "Q629",
    "object_description": "chemical element with symbol O and atomic number 8",
    "context": "Сульфит родия(III) has part of oxygen.",
    "subjectCQ": "What has part of oxygen?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27140577$32CADF2A-4041-4A03-81EF-AC57EBCC06FC",
    "theme": "ChemicalCompound",
    "subject_label": "Glu-Ile-Val",
    "subject_id": "Q27140577",
    "subject_description": "chemical compound",
    "property_label": "mass",
    "property_id": "P2067",
    "object_label": "359.206 dalton",
    "object_id": "",
    "object_description": "unit of mass",
    "context": "Glu-Ile-Val has a mass of 359.206 dalton.",
    "subjectCQ": "What has a mass of 359.206 dalton?",
    "propertyCQ": "What is the mass of Glu-Ile-Val?",
    "objectCQ": "What is the mass of Glu-Ile-Val?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q1720750$AAA4751B-E101-49B4-9023-FD87483C7911",
    "theme": "ChemicalCompound",
    "subject_label": "tiflorex",
    "subject_id": "Q1720750",
    "subject_description": "chemical compound",
    "property_label": "mass",
    "property_id": "P2067",
    "object_label": "263.096 dalton",
    "object_id": "",
    "object_description": "unit of mass",
    "context": "Tiflorex has a mass of 263.096 dalton.",
    "subjectCQ": "What is the name of the plant that has a mass of 263.096 dalton?",
    "propertyCQ": "What is Tiflorex's metric?",
    "objectCQ": "What is Tiflorex's mass?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27106464$20585F7A-4C77-46A4-BEC2-D36A2C2315D9",
    "theme": "ChemicalCompound",
    "subject_label": "echinocystic acid",
    "subject_id": "Q27106464",
    "subject_description": "chemical compound",
    "property_label": "mass",
    "property_id": "P2067",
    "object_label": "472.355 dalton",
    "object_id": "",
    "object_description": "unit of mass",
    "context": "Echinocystic acid has a mass of 472.355 dalton.",
    "subjectCQ": "What has a mass of 472.355 dalton?",
    "propertyCQ": "What is the echinocystic acid's what?",
    "objectCQ": "What is the mass of echinocystic acid?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27286410$D5FD5678-230B-447B-A7A5-F306093831E3",
    "theme": "ChemicalCompound",
    "subject_label": "2-amino-N-isopropylbenzamide",
    "subject_id": "Q27286410",
    "subject_description": "chemical compound",
    "property_label": "mass",
    "property_id": "P2067",
    "object_label": "178.111 dalton",
    "object_id": "",
    "object_description": "unit of mass",
    "context": "2-amino-N-isopropylbenzamide has a mass of 178.111 dalton.",
    "subjectCQ": "What has a mass of 178.111 dalton?",
    "propertyCQ": "What is the 178.111 dalton of 2-amino-N-isopropylbenzamide?",
    "objectCQ": "What is the mass of 2-amino-N-isopropylbenzamide?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27271459$39E682C4-690E-41B7-81C8-1602A5D62ACF",
    "theme": "ChemicalCompound",
    "subject_label": "isotretinoin anisatil",
    "subject_id": "Q27271459",
    "subject_description": "chemical compound",
    "property_label": "mass",
    "property_id": "P2067",
    "object_label": "448.261 dalton",
    "object_id": "",
    "object_description": "unit of mass",
    "context": "The isotretinoin anisatil has a mass of 448.261 dalton.",
    "subjectCQ": "What has a mass of 448.261 dalton?",
    "propertyCQ": "What is the amount of isotretinoin anisatil?",
    "objectCQ": "What is the mass of isotretinoin anisatil?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27222677$6B264AE4-9FB7-4F29-8AF8-90DF5D54B68D",
    "theme": "ChemicalCompound",
    "subject_label": "[(3aR,4R,9bS)-4-(hydroxymethyl)-8-(3-methoxyphenyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-(1,3-benzodioxol-5-yl)methanone",
    "subject_id": "Q27222677",
    "subject_description": "chemical compound",
    "property_label": "mass",
    "property_id": "P2067",
    "object_label": "472.2 dalton",
    "object_id": "",
    "object_description": "unit of mass",
    "context": "[(3aR,4R,9bS)-4-(hydroxymethyl)-8-(3-methoxyphenyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-(1,3-benzodioxol-5-yl)methanone has a mass of 472.2 dalton.",
    "subjectCQ": "What has a mass of 472.2 dalton?",
    "propertyCQ": "What is the mass of methanone?",
    "objectCQ": "What is the mass of methanone?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27113884$EBBB9E36-7454-4F31-8CEF-1874ED07CFEB",
    "theme": "ChemicalCompound",
    "subject_label": "disilicon",
    "subject_id": "Q27113884",
    "subject_description": "chemical compound",
    "property_label": "mass",
    "property_id": "P2067",
    "object_label": "55.953853 dalton",
    "object_id": "",
    "object_description": "unit of mass",
    "context": "The disilicon has a mass of 55.953853 dalton.",
    "subjectCQ": "What has a mass of 55.953853 dalton?",
    "propertyCQ": "What is the disilicon's what?",
    "objectCQ": "What is the mass of the disilicon?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27452188$41D4014F-9863-4E6B-A0FA-924567A852FD",
    "theme": "ChemicalCompound",
    "subject_label": "6-({(1S,5R)-3-[2-(3,4-dimethoxyphenoxy)ethyl]-2-oxo-3,9-diazabicyclo[3.3.1]non-9-yl}sulfonyl)-1,3-benzothiazol-2(3H)-one",
    "subject_id": "Q27452188",
    "subject_description": "chemical compound",
    "property_label": "mass",
    "property_id": "P2067",
    "object_label": "533.129 dalton",
    "object_id": "",
    "object_description": "unit of mass",
    "context": "6-({(1S,5R)-3-[2-(3,4-dimethoxyphenoxy)ethyl]-2-oxo-3,9-diazabicyclo[3.3.1]non-9-yl}sulfonyl)-1,3-benzothiazol-2(3H)-one has a mass of 533.129 dalton.",
    "subjectCQ": "What has a mass of 533.129 dalton?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27186775$F4395306-C7A7-462A-B65A-D4B193BACFB5",
    "theme": "ChemicalCompound",
    "subject_label": "1-(2-furanyl)-3-(phenylthio)-3-thiophen-2-yl-1-propanone",
    "subject_id": "Q27186775",
    "subject_description": "chemical compound",
    "property_label": "mass",
    "property_id": "P2067",
    "object_label": "314.044 dalton",
    "object_id": "",
    "object_description": "unit of mass",
    "context": "1-(2-furanyl)-3-(phenylthio)-3-thiophen-2-yl-1-propanone has a mass of 314.044 dalton.",
    "subjectCQ": "What has a mass of 314.044 dalton?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27177221$E8922BD7-52A1-4721-9FD8-17EE9EDB95DD",
    "theme": "ChemicalCompound",
    "subject_label": "4-[3-[(3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-6-[(4-methyl-1-piperazinyl)-oxomethyl]-1,3-dihydropyrrolo[3,4-c]pyridin-4-yl]phenyl]benzonitrile",
    "subject_id": "Q27177221",
    "subject_description": "chemical compound",
    "property_label": "mass",
    "property_id": "P2067",
    "object_label": "571.261711 dalton",
    "object_id": "",
    "object_description": "unit of mass",
    "context": "4-[3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-6-[(4-methyl-1-piperazinyl)-oxomethyl]-1,3-dihydropyrrolo[3,4-c]pyridin-4-yl]phenyl]benzonitrile has a mass of 571.261711 dalton.",
    "subjectCQ": "What has a mass of 571.261711 dalton?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27253555$A6C4AA7E-C4AD-4F31-9AAF-DF63CDFDBE5F",
    "theme": "ChemicalCompound",
    "subject_label": "(R)-am-1241",
    "subject_id": "Q27253555",
    "subject_description": "chemical compound",
    "property_label": "mass",
    "property_id": "P2067",
    "object_label": "503.071 dalton",
    "object_id": "",
    "object_description": "unit of mass",
    "context": "(R)-am-1241 has a mass of 503.071 dalton.",
    "subjectCQ": "What has a mass of 503.071 dalton?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27592931$CA9039BC-42E2-426C-AFB7-0D088608AF29",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-1537-5p",
    "subject_id": "Q27592931",
    "subject_description": "human mature microRNA",
    "property_label": "regulates (molecular biology)",
    "property_id": "P128",
    "object_label": "SLC9A8",
    "object_id": "Q18037085",
    "object_description": "protein-coding gene in the species Homo sapiens",
    "context": "Hsa-miR-1537-5p regulates (molecular biology) and SLC9A8.",
    "subjectCQ": "What regulates SLC9A8?",
    "propertyCQ": "What does Hsa-miR-1537-5p do?",
    "objectCQ": "What does Hsa-miR-1537-5p regulate?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27593348$4585F165-D775-4167-9ED2-2C750BD9F97B",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-548ar-3p",
    "subject_id": "Q27593348",
    "subject_description": "human mature microRNA",
    "property_label": "regulates (molecular biology)",
    "property_id": "P128",
    "object_label": "PITPNB",
    "object_id": "Q18037630",
    "object_description": "protein-coding gene in the species Homo sapiens",
    "context": "Hsa-miR-548ar-3p regulates (molecular biology) and PITPNB.",
    "subjectCQ": "What regulates PITPNB?",
    "propertyCQ": "What does Hsa-miR-548ar-3p do?",
    "objectCQ": "What does Hsa-miR-548ar-3p regulate?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27594944$A625935F-5CCA-4757-8448-347C01791A62",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-4468",
    "subject_id": "Q27594944",
    "subject_description": "human mature microRNA",
    "property_label": "regulates (molecular biology)",
    "property_id": "P128",
    "object_label": "NPM1",
    "object_id": "Q18030194",
    "object_description": "protein-coding gene in the species Homo sapiens",
    "context": "Hsa-miR-4468 regulates (molecular biology) NPM1.",
    "subjectCQ": "What regulates NPM1?",
    "propertyCQ": "What does Hsa-miR-4468 do?",
    "objectCQ": "What does Hsa-miR-4468 regulate?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27594461$0FA9FC31-0D10-4DF8-93E9-AF8AE6A67A64",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-466",
    "subject_id": "Q27594461",
    "subject_description": "human mature microRNA",
    "property_label": "regulates (molecular biology)",
    "property_id": "P128",
    "object_label": "FGF2",
    "object_id": "Q20969945",
    "object_description": "protein-coding gene in the species Homo sapiens",
    "context": "Hsa-miR-466 regulates (molecular biology) FGF2.",
    "subjectCQ": "What regulates FGF2?",
    "propertyCQ": "What does Hsa-miR-466 do?",
    "objectCQ": "What does Hsa-miR-466 regulate?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27594974$AAB9D602-DF00-40B2-B09D-8D92C08DD26D",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-320a",
    "subject_id": "Q27594974",
    "subject_description": "human mature microRNA",
    "property_label": "regulates (molecular biology)",
    "property_id": "P128",
    "object_label": "TOE1",
    "object_id": "Q18048937",
    "object_description": "protein-coding gene in the species Homo sapiens",
    "context": "Hsa-miR-320a regulates (molecular biology) TOE1.",
    "subjectCQ": "What regulates TOE1?",
    "propertyCQ": "What does Hsa-miR-320a do?",
    "objectCQ": "What does Hsa-miR-320a regulate?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27593002$1519258D-FA7A-4217-A03E-6F56471C5B00",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-1307-3p",
    "subject_id": "Q27593002",
    "subject_description": "human mature microRNA",
    "property_label": "regulates (molecular biology)",
    "property_id": "P128",
    "object_label": "IL6R",
    "object_id": "Q18027836",
    "object_description": "protein-coding gene in the species Homo sapiens",
    "context": "Hsa-miR-1307-3p regulates (molecular biology) IL6R.",
    "subjectCQ": "What regulates IL6R?",
    "propertyCQ": "What does Hsa-miR-1307-3p do?",
    "objectCQ": "What does Hsa-miR-1307-3p regulate?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27593406$6D783EA4-974D-4E3B-8E8C-D83C569C1632",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-431-5p",
    "subject_id": "Q27593406",
    "subject_description": "human mature microRNA",
    "property_label": "regulates (molecular biology)",
    "property_id": "P128",
    "object_label": "BRMS1L",
    "object_id": "Q18047558",
    "object_description": "protein-coding gene in the species Homo sapiens",
    "context": "Hsa-miR-431-5p regulates (molecular biology) BRMS1L.",
    "subjectCQ": "What regulates BRMS1L?",
    "propertyCQ": "What does Hsa-miR-431-5p do?",
    "objectCQ": "What does Hsa-miR-431-5p regulate?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27593357$5C6FECC2-6AEF-4CBF-9CD5-0BA78A5FA790",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-7703",
    "subject_id": "Q27593357",
    "subject_description": "human mature microRNA",
    "property_label": "regulates (molecular biology)",
    "property_id": "P128",
    "object_label": "OTUD7B",
    "object_id": "Q18042708",
    "object_description": "protein-coding gene in the species Homo sapiens",
    "context": "Hsa-miR-7703 regulates (molecular biology) OTUD7B.",
    "subjectCQ": "What regulates OTUD7B?",
    "propertyCQ": "What does Hsa-miR-7703 do?",
    "objectCQ": "What does Hsa-miR-7703 regulate?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27595321$E5FC448D-F484-435F-AD7F-A5D74628DF27",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-507",
    "subject_id": "Q27595321",
    "subject_description": "human mature microRNA",
    "property_label": "regulates (molecular biology)",
    "property_id": "P128",
    "object_label": "DNAJC15",
    "object_id": "Q18039606",
    "object_description": "protein-coding gene in the species Homo sapiens",
    "context": "Hsa-miR-507 regulates (molecular biology) and DNAJC15.",
    "subjectCQ": "What regulates DNAJC15?",
    "propertyCQ": "What does Hsa-miR-507 do?",
    "objectCQ": "What does Hsa-miR-507 regulate?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27594953$2CF208A8-ECA2-484B-A4D4-24360EC0AE93",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-3674",
    "subject_id": "Q27594953",
    "subject_description": "human mature microRNA",
    "property_label": "regulates (molecular biology)",
    "property_id": "P128",
    "object_label": "PLAG1",
    "object_id": "Q18030577",
    "object_description": "protein-coding gene in the species Homo sapiens",
    "context": "Hsa-miR-3674 regulates (molecular biology) PLAG1.",
    "subjectCQ": "What regulates PLAG1?",
    "propertyCQ": "What does Hsa-miR-3674 do?",
    "objectCQ": "What does Hsa-miR-3674 regulate?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27594184$075E5017-4EE8-48DD-B2BB-F60A55C55029",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-4436a",
    "subject_id": "Q27594184",
    "subject_description": "human mature microRNA",
    "property_label": "regulates (molecular biology)",
    "property_id": "P128",
    "object_label": "CMTM4",
    "object_id": "Q18051441",
    "object_description": "protein-coding gene in the species Homo sapiens",
    "context": "Hsa-miR-4436a regulates (molecular biology) and CMTM4.",
    "subjectCQ": "What regulates CMTM4?",
    "propertyCQ": "What does Hsa-miR-4436a do?",
    "objectCQ": "What does Hsa-miR-4436a regulate?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q76545451$4B78C15D-DFD7-4E43-A64F-9051565D5CC6",
    "theme": "ChemicalCompound",
    "subject_label": "5-[[(2S)-2-cyclopropyl-7,8-dimethoxy-3,4-dihydro-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine",
    "subject_id": "Q76545451",
    "subject_description": "chemical compound",
    "property_label": "isomeric SMILES",
    "property_id": "P2017",
    "object_label": "COC1=C(C2=C(CC[C@H](O2)C3CC3)C(=C1)CC4=CN=C(N=C4N)N)OC",
    "object_id": "",
    "object_description": "no-desc",
    "context": "5-[(2S)-2-cyclopropyl-7,8-dimethoxy-3,4-dihydro-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine has isomeric SMILES. COC1=C(C2=C(CC[C@H](O2)C3CC3)C(=C1)CC4=CN=C(N=C4N)N)OC.",
    "subjectCQ": "What has isomeric SMILES?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27280671$30FEA8EE-0E37-45A3-9AC2-F1C402248204",
    "theme": "ChemicalCompound",
    "subject_label": "travoprost 5,6-trans isomer",
    "subject_id": "Q27280671",
    "subject_description": "chemical compound",
    "property_label": "isomeric SMILES",
    "property_id": "P2017",
    "object_label": "CC(C)OC(=O)CCC/C=C/C[C@H]1[C@H](C[C@H]([C@@H]1/C=C/[C@H](COC2=CC=CC(=C2)C(F)(F)F)O)O)O",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Travoprost 5,6-trans isomer has isomeric SMILES. CC(C)OC(=O)CCC/C=C/C[C@H]1[C@H]([C@H]1/C=C/[C@H](COC2=CC=CC(=C2)C(F)(F)O)O)O.",
    "subjectCQ": "What has isomeric SMILES?",
    "propertyCQ": "",
    "objectCQ": "What is the SMILE of Travoprost?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q104888894$50F3A4AE-577A-427D-BA11-8958BB7E037E",
    "theme": "ChemicalCompound",
    "subject_label": "(2S)-N-[(3S,4R,7R,10Z)-5,8-dihydroxy-3-isopropyl-7-(2-methylpropyl)-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-4-methylpentanimidic acid",
    "subject_id": "Q104888894",
    "subject_description": "chemical compound",
    "property_label": "isomeric SMILES",
    "property_id": "P2017",
    "object_label": "CC(C)C[C@@H](C(O)=N[C@H]1C(O)=N[C@H](CC(C)C)C(O)=N/C=C\\c2ccc(cc2)O[C@H]1C(C)C)N(C)C",
    "object_id": "",
    "object_description": "no-desc",
    "context": "(2S)-N-[(3S,4R,7R,10Z)-5,8-dihydroxy-3-isopropyl-7-(2-methylpropyl)-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-4-methylpentanimidic acid is isomeric SMI",
    "subjectCQ": "What is the isomeric SMI?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q105181292$0DE91F0E-2099-47F3-8D65-323F3DABEE70",
    "theme": "ChemicalCompound",
    "subject_label": "(1R,3R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (1R,2S,3S,4S,5R)-3,4-dihydroxy-6,6-dimethylbicyclo[3.1.1]heptane-2-carboxylate",
    "subject_id": "Q105181292",
    "subject_description": "chemical compound",
    "property_label": "isomeric SMILES",
    "property_id": "P2017",
    "object_label": "CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)[C@@H]1[C@H](O)[C@@H](O)[C@@H]3C[C@H]1C3(C)C)C2",
    "object_id": "",
    "object_description": "no-desc",
    "context": "CN1[C@H]2CC[C@H](OC(=O)[C@@H](O)[C@@H](C(O)[C@@H](C(O)[C@@H](C(O)[C@@H](C(O)[C@@H](C(O)[C@@H](C(O)[C@@H](C(O)[C@@H]",
    "subjectCQ": "What is the name of the octan-3-yl?",
    "propertyCQ": "What type of SMILES are there?",
    "objectCQ": "What is the name of the organization that is responsible for the operation of the computer?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q104970386$7F799A85-5611-43A8-AEED-707C10DBD378",
    "theme": "ChemicalCompound",
    "subject_label": "5-hydroxy-2-(3-hydroxy-4-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-7-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}chromen-4-one",
    "subject_id": "Q104970386",
    "subject_description": "chemical compound",
    "property_label": "isomeric SMILES",
    "property_id": "P2017",
    "object_label": "C[C@@H]1O[C@@H](Oc2cc(O)c3c(=O)c(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c(-c4ccc(O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)c(O)c4)oc3c2)[C@H](O)[C@H](O)[C@H]1O",
    "object_id": "",
    "object_description": "no-desc",
    "context": "C[C@@H](Oc2cc(O)c3c(O(C@@H)(CO)[C@@H](C@H](O)[C@H](O)[C@H](O)[C@H](O)[C@H](O)[C@H](O)[C@H](O)[C@H](O)[C@H](O)[C@H]",
    "subjectCQ": "What is the name of the 5-hydroxy-2-(3-hydroxy-4-<unk>[(2S,3R,4S,5S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy<unk>pheny",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q76620930$9B14DBE9-9F98-4874-A60D-6513D8C75C8F",
    "theme": "ChemicalCompound",
    "subject_label": "(2R,3R,5S,6R)-3-amino-6-methyloxane-2,5-diol",
    "subject_id": "Q76620930",
    "subject_description": "chemical compound",
    "property_label": "isomeric SMILES",
    "property_id": "P2017",
    "object_label": "C[C@@H]1[C@H](C[C@H]([C@@H](O1)O)N)O",
    "object_id": "",
    "object_description": "no-desc",
    "context": "2R,3R,5S,6R)-3-amino-6-methyloxane-2,5-diol are isomeric SMILES. C[C@@H]1[C@H]([C@@H](O1)O)N)O.",
    "subjectCQ": "What isomeric SMILES are?",
    "propertyCQ": "",
    "objectCQ": "What is the name of the isomeric SMILES?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q104952380$3C928978-C8C3-48BC-9264-8C3FEBDA4A40",
    "theme": "ChemicalCompound",
    "subject_label": "(1S,4S,5R,8R,9R,13R,14R,17S,18R,19S,20R)-9-(hydroxymethyl)-4,5,9,13,19,20-hexamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosane-10,16-dione",
    "subject_id": "Q104952380",
    "subject_description": "chemical compound",
    "property_label": "isomeric SMILES",
    "property_id": "P2017",
    "object_label": "C[C@H]1[C@H](C)CC[C@@]23CC[C@]4(C)[C@](OC2)(C(=O)C[C@@H]2[C@@]5(C)CCC(=O)[C@@](C)(CO)[C@@H]5CC[C@]24C)[C@H]13",
    "object_id": "",
    "object_description": "no-desc",
    "context": "(1S,4S,5R,8R,9R,13R,14R,17S,18R,19S,20R)-9-(hydroxymethyl)-4,5,9,13,19,20-hexamethyl-24-oxahexacyclo[15.5.2.01,18.04,17.05,14.08,13]tetracosane-10,16-dione isomeric SMILES.",
    "subjectCQ": "What isomeric SMILES?",
    "propertyCQ": "",
    "objectCQ": "What is the name of the molecule that is a tetracosane isomeric SMILES?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27088999$680FDE77-C947-4E87-A7EE-B24DEE6F0647",
    "theme": "ChemicalCompound",
    "subject_label": "tirotundin",
    "subject_id": "Q27088999",
    "subject_description": "chemical compound",
    "property_label": "isomeric SMILES",
    "property_id": "P2017",
    "object_label": "C[C@H]1C[C@@H]2[C@@H]([C@@H](C[C@@]3(CC[C@]1(O3)O)C)OC(=O)C(C)C)C(=C)C(=O)O2",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The isomeric SMILES of tirotundin are C[C@H]1C[C@@H]2[C@@H]([C@@H]([CC[C@]1(O3)O)C)OC(=O)C(=C)C(=O)O2).",
    "subjectCQ": "What isomeric SMILES are C[C@H]1C[C@@H]2[C@@H]?",
    "propertyCQ": "",
    "objectCQ": "What are the isomeric SMILES of tirotundin?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q105155579$50C1FDBC-4DE3-426A-824E-80FDC2007708",
    "theme": "ChemicalCompound",
    "subject_label": "LQJQZJOGDGMAIX-AIWCGGGXSA-N",
    "subject_id": "Q105155579",
    "subject_description": "chemical compound",
    "property_label": "isomeric SMILES",
    "property_id": "P2017",
    "object_label": "CCCCCCCCCCC[C@H](C)[C@@H]1CC(O)=N[C@H]([C@H](C)O)C(O)=N[C@H](C)C(O)=N[C@H](C)C(O)=N[C@H](CCC(=N)O)C(O)=N[C@H](Cc2ccc(C)cc2)C(O)=N[C@H]([C@@H](C)CC)C(=O)O1",
    "object_id": "",
    "object_description": "no-desc",
    "context": "LQJQZJOGDGMAIX-AIWCGGGXSA-N contains isomeric SMILES. CCCCCCCCC[C@H]([C@H](C)O)C(O)=N[C@H](Cc2ccc(C)cc2)C(O)=N[C@H]([C@H](C(C)C(O)=N[C@H]([C@H](C",
    "subjectCQ": "What contains isomeric SMILES?",
    "propertyCQ": "What does the LQJQZJOGDGMAIX-AIWCGGGXSA-N contain?",
    "objectCQ": "What is the name of the isomeric SMILES?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q105153389$AC278880-16E6-47E4-BFF9-7C3C3091D42A",
    "theme": "ChemicalCompound",
    "subject_label": "(1'S,2R,2'S,4'S,7'S,8'R,9'S,12'S,13'S,14'R,16'S,17'S,18'R)-7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-14',16',17',18'-tetrol",
    "subject_id": "Q105153389",
    "subject_description": "chemical compound",
    "property_label": "isomeric SMILES",
    "property_id": "P2017",
    "object_label": "C=C1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC[C@]5(O)[C@@H](O)[C@@H](O)C[C@@H](O)[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C",
    "object_id": "",
    "object_description": "no-desc",
    "context": "C=C1CC[C@@]2(OC1)O[C@H]3[C@@H](C(C)[C@@H](C(C)[C@@H](C)[C@@H](C)[C@@H](C)[C@@H](C)[C@@H](C)[C@@H](C)[C@@H](C)[C@@H](",
    "subjectCQ": "What is the name of the oxane that is used in the manufacture of oxane?",
    "propertyCQ": "What type of SMILES are there?",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q104397467$859BE82A-5341-4D42-AE56-B6716C861076",
    "theme": "ChemicalCompound",
    "subject_label": "(1S,3E,5R,7R)-3-[hydroxy(phenyl)methylidene]-6,6-dimethyl-1,5,7-tris(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione",
    "subject_id": "Q104397467",
    "subject_description": "chemical compound",
    "property_label": "found in taxon",
    "property_id": "P703",
    "object_label": "Clusia pernambucensis",
    "object_id": "Q15354473",
    "object_description": "species of plant",
    "context": "(1S,3E,5R,7R)-3-[hydroxy(phenyl)methylidene]-6,6-dimethyl-1,5,7-tris(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione is found in the taxon Clusia pernambucensis.",
    "subjectCQ": "What is found in the taxon Clusia pernambucensis?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18302875$FF72837F-000D-4047-9047-3F34FDD2F371",
    "theme": "ChemicalCompound",
    "subject_label": "B430212C06Rik",
    "subject_id": "Q18302875",
    "subject_description": "non-coding RNA in the species Mus musculus",
    "property_label": "found in taxon",
    "property_id": "P703",
    "object_label": "house mouse",
    "object_id": "Q83310",
    "object_description": "species of mammal",
    "context": "B430212C06Rik is found in the taxon house mouse.",
    "subjectCQ": "What is the taxon house mouse?",
    "propertyCQ": "Where is B430212C06Rik found?",
    "objectCQ": "What taxon is B430212C06Rik found in?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q103787031$1949A696-91A6-4C55-8215-7FB5D4F48FB9",
    "theme": "ChemicalCompound",
    "subject_label": "methyl (1R,9R,16R,18R,21S)-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7,14-tetraene-18-carboxylate",
    "subject_id": "Q103787031",
    "subject_description": "chemical compound",
    "property_label": "found in taxon",
    "property_id": "P703",
    "object_label": "Kopsia arborea",
    "object_id": "Q15358450",
    "object_description": "species of plant",
    "context": "Methyl (1R,9R,16R,18R,21S)-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7,14-tetraene-18-carboxylate is found in the taxon Kopsia arborea.",
    "subjectCQ": "What is found in the taxon Kopsia arborea?",
    "propertyCQ": "Where is henicosa found?",
    "objectCQ": "Where is henicosa found?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q412366$B3BB3D89-4AA4-4EC4-9C42-79C36AAD0C15",
    "theme": "ChemicalCompound",
    "subject_label": "palmitoleic acid",
    "subject_id": "Q412366",
    "subject_description": "chemical compound",
    "property_label": "found in taxon",
    "property_id": "P703",
    "object_label": "Oenothera villosa",
    "object_id": "Q15251034",
    "object_description": "species of plant",
    "context": "Palmitoleic acid is found in the taxon Oenothera villosa.",
    "subjectCQ": "What is found in the taxon Oenothera villosa?",
    "propertyCQ": "Where is palmitoleic acid found?",
    "objectCQ": "What taxon is palmitoleic acid found in?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27120911$2DB88A3D-98D6-4F50-9C86-4551857E56C0",
    "theme": "ChemicalCompound",
    "subject_label": "4-methyleneglutamic acid",
    "subject_id": "Q27120911",
    "subject_description": "chemical compound",
    "property_label": "found in taxon",
    "property_id": "P703",
    "object_label": "Lilium candidum",
    "object_id": "Q159811",
    "object_description": "species of plant",
    "context": "4-methyleneglutamic acid is found in the taxon of Lilium candidum.",
    "subjectCQ": "What is found in the taxon of Lilium candidum?",
    "propertyCQ": "Where is 4-methyleneglutamic acid found?",
    "objectCQ": "What plant has 4-methyleneglutamic acid?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q425004$F982BC90-FF4A-4B7C-B472-4549197EA6D9",
    "theme": "ChemicalCompound",
    "subject_label": "stigmasterol",
    "subject_id": "Q425004",
    "subject_description": "chemical compound",
    "property_label": "found in taxon",
    "property_id": "P703",
    "object_label": "Symphyotrichum novi-belgii",
    "object_id": "Q1537333",
    "object_description": "Species of flowering plant in the family Asteraceae native to northeastern North America",
    "context": "Stigmasterol is found in the taxon Symphyotrichum novi-belgii.",
    "subjectCQ": "What is found in the taxon Symphyotrichum novi-belgii?",
    "propertyCQ": "Where is stambuterol found?",
    "objectCQ": "Where is stambuterol found?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q7050291$58593F51-A5EE-4783-B05B-0526563D917D",
    "theme": "ChemicalCompound",
    "subject_label": "Norbergenin",
    "subject_id": "Q7050291",
    "subject_description": "chemical compound",
    "property_label": "found in taxon",
    "property_id": "P703",
    "object_label": "Ardisia japonica",
    "object_id": "Q858326",
    "object_description": "species of plant",
    "context": "Norbergenin is found in the taxon Ardisia japonica.",
    "subjectCQ": "What is found in the taxon Ardisia japonica?",
    "propertyCQ": "Where is Norbergenin found?",
    "objectCQ": "Where is Norbergenin found?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q29698858$AEFEF2C8-D92D-405F-9BD1-FEC348B9CC11",
    "theme": "ChemicalCompound",
    "subject_label": "21ur-12267",
    "subject_id": "Q29698858",
    "subject_description": "non-coding RNA in the species Caenorhabditis elegans",
    "property_label": "found in taxon",
    "property_id": "P703",
    "object_label": "Caenorhabditis elegans",
    "object_id": "Q91703",
    "object_description": "free-living species of nematode",
    "context": "21ur-12267 is found in the taxon of Caenorhabditis elegans.",
    "subjectCQ": "What is the name of the chemical found in the taxon of Caenorhabditis elegans?",
    "propertyCQ": "Where is 21ur-12267 found?",
    "objectCQ": "What taxon is 21ur-12267 found in?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q104917814$DD041FC4-9900-40F1-BADF-DD19E3562355",
    "theme": "ChemicalCompound",
    "subject_label": "2-(3,4-dihydroxy-5-methoxyphenyl)-5-hydroxy-7-{[(2S,3R,4S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one",
    "subject_id": "Q104917814",
    "subject_description": "chemical compound",
    "property_label": "found in taxon",
    "property_id": "P703",
    "object_label": "Stachys scardica",
    "object_id": "Q15369004",
    "object_description": "species of plant",
    "context": "2-(3,4-dihydroxy-5-methoxyphenyl)-5-hydroxy-7-{[(2S,3R,4S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one is found in the taxon Stachys scardica.",
    "subjectCQ": "What is found in the taxon Stachys scardica?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50260183$DA1E3AE6-445A-4E92-9A9A-D6855D196F67",
    "theme": "ChemicalCompound",
    "subject_label": "Antigen peptide bound class I MHC [integral component of lumenal side of endoplasmic reticulum membrane]",
    "subject_id": "Q50260183",
    "subject_description": "An instance of macromolecular complex in Homo sapiens with Reactome ID (R-HSA-983114)",
    "property_label": "found in taxon",
    "property_id": "P703",
    "object_label": "Homo sapiens",
    "object_id": "Q15978631",
    "object_description": "species of mammal",
    "context": "Antigen peptide bound class I MHC (integral component of lumenal side of endoplasmic reticulum membrane) is found in the taxon Homo sapiens.",
    "subjectCQ": "What is found in the taxon Homo sapiens?",
    "propertyCQ": "Where is antigen peptide bound class I MHC found?",
    "objectCQ": "What taxon is antigen peptide bound class I MHC found in?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q2317288$93402D8C-8178-4B4D-A870-AFCF8E977568",
    "theme": "ChemicalCompound",
    "subject_label": "luteoloside",
    "subject_id": "Q2317288",
    "subject_description": "chemical compound",
    "property_label": "found in taxon",
    "property_id": "P703",
    "object_label": "Hieracium coloriscapum",
    "object_id": "Q104850018",
    "object_description": "no-desc",
    "context": "Luteoloside is found in the taxon of Hieracium coloriscapum.",
    "subjectCQ": "What is the name of the substance found in the taxon of Hieracium coloriscapum?",
    "propertyCQ": "Where is Luteoloside found?",
    "objectCQ": "Luteoloside is found in the taxon of what plant?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q82403657$A3E36D8A-BBBD-4D67-AB12-BD331FA86D56",
    "theme": "ChemicalCompound",
    "subject_label": "2-Bromo-5-[3-(bromomethyl)phenyl]furan",
    "subject_id": "Q82403657",
    "subject_description": "chemical compound",
    "property_label": "canonical SMILES",
    "property_id": "P233",
    "object_label": "C1=CC(=CC(=C1)C2=CC=C(O2)Br)CBr",
    "object_id": "",
    "object_description": "no-desc",
    "context": "2-Bromo-5-[3-(bromomethyl)phenyl]furan is canonical SMILES. C1=CC(=CC(=C1)C2=CC=C(O2)Br)CBr.",
    "subjectCQ": "What is canonical SMILES?",
    "propertyCQ": "",
    "objectCQ": "What is the C1 of the SMILES?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q82807922$49E10339-2CBD-41AD-BC13-E602D2DBB96B",
    "theme": "ChemicalCompound",
    "subject_label": "2,4-Dichloro-5-[(methylsulfanyl)methyl]pyrimidine",
    "subject_id": "Q82807922",
    "subject_description": "chemical compound",
    "property_label": "canonical SMILES",
    "property_id": "P233",
    "object_label": "CSCC1=CN=C(N=C1Cl)Cl",
    "object_id": "",
    "object_description": "no-desc",
    "context": "2,4-Dichloro-5-[(methylsulfanyl)methyl]pyrimidine is canonical SMILES. CSCC1=CN=C(N=C1Cl)Cl.",
    "subjectCQ": "What is canonical SMILES?",
    "propertyCQ": "",
    "objectCQ": "What is the CSCC1?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q83035680$8F3546EF-3390-4E57-B6AA-67953A5B8476",
    "theme": "ChemicalCompound",
    "subject_label": "Methane, dichlorodinitro-",
    "subject_id": "Q83035680",
    "subject_description": "chemical compound",
    "property_label": "canonical SMILES",
    "property_id": "P233",
    "object_label": "C([N+](=O)[O-])([N+](=O)[O-])(Cl)Cl",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Methane, dichlorodinitro- is canonical SMILES. C([N+](=O)[O-])(Cl)Cl.",
    "subjectCQ": "What is canonical SMILES?",
    "propertyCQ": "What is methane?",
    "objectCQ": "What is the chemical name of the molecule that is a SMILES?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27160123$41E82FF4-08ED-4F29-BF10-4EB62917871A",
    "theme": "ChemicalCompound",
    "subject_label": "Congo corinth (acid form)",
    "subject_id": "Q27160123",
    "subject_description": "chemical compound",
    "property_label": "canonical SMILES",
    "property_id": "P233",
    "object_label": "C1=CC=C2C(=C1)C(=CC(=C2N)N=NC3=CC=C(C=C3)C4=CC=C(C=C4)N=NC=5C=C(C6=CC=CC=C6C5O)S(O)(=O)=O)S(O)(=O)=O",
    "object_id": "",
    "object_description": "no-desc",
    "context": "C1=CC=C2C(=C1)C(=CC(=C2N)N=NC3=CC(C3)C4=CC(C4)N=NC=5C=C(C6=CC=C6C5O)S(O)(=O)(=O)=O.",
    "subjectCQ": "What type of corinth is C1?",
    "propertyCQ": "What is the name of the SMILES?",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q81997661$BDA4E37F-6476-464F-B41A-76F01A0AC2D5",
    "theme": "ChemicalCompound",
    "subject_label": "Benzoic acid, 2-amino-5-[(4-aminophenyl)methyl]-, butyl ester",
    "subject_id": "Q81997661",
    "subject_description": "chemical compound",
    "property_label": "canonical SMILES",
    "property_id": "P233",
    "object_label": "CCCCOC(=O)C1=C(C=CC(=C1)CC2=CC=C(C=C2)N)N",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Benzoic acid, 2-amino-5-[(4-aminophenyl)methyl]-, butyl ester is canonical SMILES. CCCCOC(=O)C1=C(C(C1)CC2=CC(C2)N)N.",
    "subjectCQ": "What is canonical SMILES?",
    "propertyCQ": "What is Benzoic acid?",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27272042$0C928071-F210-4EEE-8307-0EC6917F8757",
    "theme": "ChemicalCompound",
    "subject_label": "pd-0210293",
    "subject_id": "Q27272042",
    "subject_description": "chemical compound",
    "property_label": "canonical SMILES",
    "property_id": "P233",
    "object_label": "CCN(CC)CCCCNC1=NC2=CC(=C(C=C2N=C1C3=CC4=CC=CC=C4O3)Cl)Cl",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Pd-0210293 canonical SMILES is CCN(CC)CCCCNC1=NC2=CC(=C(C2N=C1C3=CC4=CC=CC=C4O3)Cl)Cl.",
    "subjectCQ": "What is the canonical number for SMILES?",
    "propertyCQ": "",
    "objectCQ": "What is the Pd-0210293 canonical SMILES?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27198379$981E1621-0EB6-4175-8EE8-B0FA3E4B1AD9",
    "theme": "ChemicalCompound",
    "subject_label": "2-methoxy-N-[(4R,7S,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide",
    "subject_id": "Q27198379",
    "subject_description": "chemical compound",
    "property_label": "canonical SMILES",
    "property_id": "P233",
    "object_label": "CC1CN(C(COC2=C(C=C(C=C2)NC(=O)COC)C(=O)N(CC1OC)C)C)C(=O)COC",
    "object_id": "",
    "object_description": "no-desc",
    "context": "2-methoxy-N-[(4R,7S,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide is canonical SMILES.",
    "subjectCQ": "What is canonical SMILES?",
    "propertyCQ": "What is 2-methoxy-N-acetamide?",
    "objectCQ": "What is the canonical SMILES?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q83062707$CC403DD4-4E26-4DEC-8DFA-02E7A9F622BC",
    "theme": "ChemicalCompound",
    "subject_label": "Hpr 611",
    "subject_id": "Q83062707",
    "subject_description": "chemical compound",
    "property_label": "canonical SMILES",
    "property_id": "P233",
    "object_label": "C1CN(CCC1O)C(=O)CN2C3=C(C=CC(=C3)Cl)SC2=O",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Hpr 611 canonical SMILES is C1CN(CCC1O)C(=O)CN2C3=C(C=CC(=C3)Cl)SC2=O.",
    "subjectCQ": "What is the canonical SMILES?",
    "propertyCQ": "",
    "objectCQ": "What is the Hpr 611 canonical SMILES?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27172050$2894B91E-EA87-412F-AE20-6F0D33C712BC",
    "theme": "ChemicalCompound",
    "subject_label": "(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-N-propan-2-yl-14-(2,2,2-trifluoroethylsulfonylamino)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide",
    "subject_id": "Q27172050",
    "subject_description": "chemical compound",
    "property_label": "canonical SMILES",
    "property_id": "P233",
    "object_label": "CC1CN(C(COC2=C(C=C(C=C2)NS(=O)(=O)CC(F)(F)F)C(=O)N(CC1OC)C)C)C(=O)NC(C)C",
    "object_id": "",
    "object_description": "no-desc",
    "context": "(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-N-propan-2-yl-14-(2,2,2-trifluoroethylsulfonylamino)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide are canonical SMILES.",
    "subjectCQ": "What are canonical SMILES?",
    "propertyCQ": "",
    "objectCQ": "What is the name of the canonical SMILES?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q82029749$55F09662-4763-4007-9A44-CBAE024D4542",
    "theme": "ChemicalCompound",
    "subject_label": "5-bromo-3-methylpyrimidine-2,4(1h,3h)-dione",
    "subject_id": "Q82029749",
    "subject_description": "chemical compound",
    "property_label": "canonical SMILES",
    "property_id": "P233",
    "object_label": "CN1C(=O)C(=CNC1=O)Br",
    "object_id": "",
    "object_description": "no-desc",
    "context": "5-bromo-3-methylpyrimidine-2,4(1h,3h)-dione is canonical SMILES and is CN1C(=O)C(=CNC1=O)Br.",
    "subjectCQ": "What is canonical SMILES?",
    "propertyCQ": "",
    "objectCQ": "What is the canonical SMILES?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q82438510$E9364268-DB92-4C5C-8A31-954F1A1C0442",
    "theme": "ChemicalCompound",
    "subject_label": "1,3,11,12-Tetrahydroxy-6-methyltetracene-2-carboxamide",
    "subject_id": "Q82438510",
    "subject_description": "chemical compound",
    "property_label": "canonical SMILES",
    "property_id": "P233",
    "object_label": "CC1=C2C=C3C=C(C(=C(C3=C(C2=C(C4=CC=CC=C14)O)O)O)C(=O)N)O",
    "object_id": "",
    "object_description": "no-desc",
    "context": "1,3,11,12-Tetrahydroxy-6-methyltetracene-2-carboxamide is canonical SMILES. CC1=C2C=C3C=C(C(C2=C(C4=CC=C14)O)O)C(=O)N)O.",
    "subjectCQ": "What is canonical SMILES?",
    "propertyCQ": "",
    "objectCQ": "What is the canonical SMILES?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q81996438$2F1CB2AD-8C9E-4514-8FBF-036F3D91A8DC",
    "theme": "ChemicalCompound",
    "subject_label": "Isodecyl tridecyl phthalate",
    "subject_id": "Q81996438",
    "subject_description": "chemical compound",
    "property_label": "chemical formula",
    "property_id": "P274",
    "object_label": "C₃₁H₅₂O₄",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Isodecyl tridecyl phthalate has a chemical formula of C31H52O4.",
    "subjectCQ": "What is the chemical formula of C31H52O4?",
    "propertyCQ": "What is C31H52O4?",
    "objectCQ": "What is the chemical formula of isodecyl tridecyl phthalate?",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q76736884$E3717136-C6A6-42A7-9E55-8E8809B64FD8",
    "theme": "ChemicalCompound",
    "subject_label": "[(2S)-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-docos-11-enoate",
    "subject_id": "Q76736884",
    "subject_description": "chemical compound",
    "property_label": "chemical formula",
    "property_id": "P274",
    "object_label": "C₅₇H₁₀₀O₆",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The chemical formula for [(2S)-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-docos-11-enoate is C57H100O6.",
    "subjectCQ": "What is the chemical formula for C57H100O6?",
    "propertyCQ": "What is C57H100O6?",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q105149120$844434DD-94B0-4CF1-AA34-3BB87F49CCE5",
    "theme": "ChemicalCompound",
    "subject_label": "4-hydroxy-6-(prop-1-en-1-yl)pyran-2-one",
    "subject_id": "Q105149120",
    "subject_description": "chemical compound",
    "property_label": "chemical formula",
    "property_id": "P274",
    "object_label": "C₈H₈O₃",
    "object_id": "",
    "object_description": "no-desc",
    "context": "4-hydroxy-6-(prop-1-en-1-yl)pyran-2-one has the chemical formula of C8H8O3.",
    "subjectCQ": "What is the chemical formula of C8H8O3?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q82033032$1D911972-D997-4810-B90D-DC5C5E40BBEC",
    "theme": "ChemicalCompound",
    "subject_label": "2,4-difluoro-N-(2-nitrophenyl)aniline",
    "subject_id": "Q82033032",
    "subject_description": "chemical compound",
    "property_label": "chemical formula",
    "property_id": "P274",
    "object_label": "C₁₂H₈F₂N₂O₂",
    "object_id": "",
    "object_description": "no-desc",
    "context": "2,4-difluoro-N-(2-nitrophenyl)aniline has the chemical formula C12H8F2N2O2.",
    "subjectCQ": "What is the chemical formula of C12H8F2N2O2?",
    "propertyCQ": "What is C12H8F2N2O2?",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27458647$C048CEE3-E006-4154-9C9D-852FA8FE8402",
    "theme": "ChemicalCompound",
    "subject_label": "2'-deoxy-4'-thiocytidine 5'-(dihydrogen phosphate)",
    "subject_id": "Q27458647",
    "subject_description": "chemical compound",
    "property_label": "chemical formula",
    "property_id": "P274",
    "object_label": "C₉H₁₄N₃O₆PS",
    "object_id": "",
    "object_description": "no-desc",
    "context": "2'-deoxy-4'-thiocytidine 5'-(dihydrogen phosphate) has the chemical formula C9H14N3O6PS.",
    "subjectCQ": "What has the chemical formula C9H14N3O6PS?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q82391573$047E3A3C-2F88-47E4-9468-995497DA5AE0",
    "theme": "ChemicalCompound",
    "subject_label": "[Bis(trimethylsilyl)methylidene](phenylethynyl)phosphane",
    "subject_id": "Q82391573",
    "subject_description": "chemical compound",
    "property_label": "chemical formula",
    "property_id": "P274",
    "object_label": "C₁₅H₂₃PSi₂",
    "object_id": "",
    "object_description": "no-desc",
    "context": "The chemical formula for [Bis(trimethylsilyl)methylidene](phenylethynyl)phosphane is C15H23PSi2.",
    "subjectCQ": "What is the chemical formula for?",
    "propertyCQ": "What is C15H23PSi2?",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q90561578$EC9B82D3-B375-4A6A-B673-F2A535ABA94C",
    "theme": "ChemicalCompound",
    "subject_label": "Tricyclo[3.3.1.13,7]decan-1-amine, N-[1-(4-methoxyphenyl)ethyl]-",
    "subject_id": "Q90561578",
    "subject_description": "chemical compound",
    "property_label": "chemical formula",
    "property_id": "P274",
    "object_label": "C₁₉H₂₇NO",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Tricyclo[3.3.1.13,7]decan-1-amine, N-[1-(4-methoxyphenyl)ethyl]- has the chemical formula C19H27NO.",
    "subjectCQ": "What has the chemical formula C19H27NO?",
    "propertyCQ": "What is C19H27NO?",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q82552122$C7119930-4E8A-41C9-9CA8-0B5C9B4B3128",
    "theme": "ChemicalCompound",
    "subject_label": "4-(2-Bromobenzoyl)benzonitrile",
    "subject_id": "Q82552122",
    "subject_description": "chemical compound",
    "property_label": "chemical formula",
    "property_id": "P274",
    "object_label": "C₁₄H₈BrNO",
    "object_id": "",
    "object_description": "no-desc",
    "context": "4-(2-Bromobenzoyl)benzonitrile has the chemical formula C14H8BrNO.",
    "subjectCQ": "What has the chemical formula C14H8BrNO?",
    "propertyCQ": "What is C14H8BrNO?",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q82599848$310C564A-7913-4CE8-82D1-0CBB1CB4F606",
    "theme": "ChemicalCompound",
    "subject_label": "5-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline",
    "subject_id": "Q82599848",
    "subject_description": "chemical compound",
    "property_label": "chemical formula",
    "property_id": "P274",
    "object_label": "C₁₂H₁₇BFNO₂",
    "object_id": "",
    "object_description": "no-desc",
    "context": "5-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline has the chemical formula C12H17BFNO2.",
    "subjectCQ": "What is the chemical formula of C12H17BFNO2?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q82611504$70832C0C-CBB2-45E6-BE01-0D8E02DBD829",
    "theme": "ChemicalCompound",
    "subject_label": "3',4'-Difluoro-5-methoxy[1,1'-biphenyl]-3-ol",
    "subject_id": "Q82611504",
    "subject_description": "chemical compound",
    "property_label": "chemical formula",
    "property_id": "P274",
    "object_label": "C₁₃H₁₀F₂O₂",
    "object_id": "",
    "object_description": "no-desc",
    "context": "3',4'-Difluoro-5-methoxy[1,1'-biphenyl]-3-ol has the chemical formula C13H10F2O2.",
    "subjectCQ": "What is the chemical formula of C13H10F2O2?",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q82689773$C01BBE34-1A45-4D8A-9E57-E3194915BFEE",
    "theme": "ChemicalCompound",
    "subject_label": "Methyl 5-(piperazin-1-yl)pentanoate",
    "subject_id": "Q82689773",
    "subject_description": "chemical compound",
    "property_label": "chemical formula",
    "property_id": "P274",
    "object_label": "C₁₀H₂₀N₂O₂",
    "object_id": "",
    "object_description": "no-desc",
    "context": "Methyl 5-(piperazin-1-yl)pentanoate has the chemical formula C10H20N2O2.",
    "subjectCQ": "What is the chemical formula of C10H20N2O2?",
    "propertyCQ": "What is C10H20N2O2?",
    "objectCQ": "",
    "generalizedSubjectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  }
]
